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ABSTRACT 
Blood shortage is one of the biggest concerns of the World Health Organization. The reason: while around 
30% of the industrialized world population will require a life­saving transfusion sometime during their lives, 
only 6% of the total population actually donates blood that can only be stored for up to 42 days. Despite 
the huge efforts that have been made to awaken the population to proactively donate blood (according to 
the World Health Organization 2009a, approximately 85 million units of blood are collected annually 
worldwide), there is still a large shortage around the world. Hence, other alternatives have been suggested 
to address this. Since the first attempts, in the late 1940s, to produce an alternative to blood donation in 
the laboratory, several breakthroughs were made, most of them focusing on the synthetic route: the search 
for a chemical molecule that could replace the main vital function of red blood cells (RBCs) – oxygenation of 
the body cells (Kimball 1994). Nevertheless, several issues, mainly regarding the stability and controlled 
oxygen release by these molecules, still pose serious barriers for the success of this option (Kimball 1994). 
Hence, the focus on blood substitutes is now being directed to blood itself. My PhD project in the 
Department of Chemical Engineering of Imperial College London aimed at mimicking nature’s bioreactor to 
produce human blood: the Bone Marrow (BM), a three­dimensional (3D) structure comprised of a 
vascularized support matrix, cellular constituents, and humoral factors. The BM 3D spatial configuration 
generates micro­concentration gradients that modulate cellular self­renewal, differentiation and apoptosis 
– mimicked by a 3D scaffold that can be rendered bioactive by coating with extracellular proteins. On the 
other hand, the BM vascular system ensures the supply of nutrients and removal of harmful metabolites, as 
well as the collection of maturing cells formed in the marrow cavity – mimicked by an intricate selectively­
permeable membrane system that both renews the microenvironment and harvests mature RBCs. I have 
combined these two bio­inspired characteristics of the marrow into the first ex vivo 3D dual hollow fibre 
bioreactor (DHFB) that allows addressing mass transfer challenges faced by state­of­the­art technology and 
the continuous production and release of RBCs. This system was shown to be biocompatible, and allowed 
the differentiation of cord blood stem cells into mature enucleated RBCs under a cocktail composed of 
100ng.mL
­1
 stem cell factor and 2,000mU.mL
­1
 erythropoietin over 31 days. Mature enucleated RBCs could 
be produced exclusively ex vivo in a 3­dimension feeder­free culture. This technology has the potential to 
allow cost­effective production of clinically­relevant numbers of red blood cells with selective cell 
harvesting in a closed hematopoietic system.
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CHAPTER 1 
CHAPTER 1.
INTRODUCTION
“(…) for the life of the flesh is in the blood.” 
Moses 4th book; Leviticus 17:11 
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1.1. PROJECT MOTIVATION AND GOAL
According to the New York Blood Center, one out of three Americans will require a life­saving transfusion 
sometime during their lifetime, whilst over 18,000L of red blood cells are required every day for 
transfusions (New York Blood Center 2006), just in the US (the equivalent to over three Olympic­size 
swimming pools of blood per year). This picture becomes even more dramatic if one considers that a great 
part of today’s medical care relies on blood transfusion – 38% of the blood collected by the British NHS 
Blood & Transplant is used in general medicine, mainly surgeries (World Health Organization 2007). 
Moreover, a single bone marrow transplant (e.g., to help treating patients with leukaemia) may require 
platelets from over 100 donors and red cells from other 20 (New York Blood Center 2006). The idea of 
producing blood cells in the laboratory is not new and, effectively, there have been several attempts to 
overcome the problems related to producing this vital tissue, which starts with the short life­span of these 
cells when stored (e.g., red cells can only survive for up to 42 days ex vivo). Being also the most used cell 
type in the world to alleviate an infinite number of diseases and traumas, the search for a substitute of red 
blood cells in the clinical arena has been a constant effort by research groups. Since the first attempts, in 
the late 1940s, there have been several breakthroughs in this area, most of them focusing on the synthetic 
route: the search for a chemical molecule that could replace the main vital function of red blood cells – 
transport of oxygen to all the cells in the body (Kimball 1994). Alternatives such as perfluorocarbons and 
haemoglobin itself in the free­form, mostly with the intent to transport oxygen in the patient’s body until a 
source of blood is found (Chen et al. 2009), have been proposed. Nevertheless, several issues, mainly 
regarding the stability and controlled oxygen release by these molecules, still pose serious barriers for the 
success of this option (Kimball 1994). Moreover, despite the fact that a red blood cell substitute has been 
searched for over 70 years, there is currently no oxygen­carrying molecule that is approved by the Food 
and Drug Administration (FDA) (Grethlein and Rajan May 2010). Hence, the focus on blood substitutes is 
now being directed to... blood itself. In order to overcome this issue, the large­scale production of red 
blood cells ex vivo appears to be a feasible approach, especially considering the promising developments in 
the last few years in the field of Tissue Engineering (figure 1). 
The market for cell therapies approved in Europe or the US is currently worth between £60m and £120m; 
however, it is expected that within the next two to three decades, this could become a multi­billion pound­
a­year industry (Cooper 2010). On the other hand, the global market of blood or blood components is 
estimated to be worth £3 billion (Gwang­lip 2011). And apart from the large market value forecasted, the 
human value and the potential for improving the quality of life of the general population is a great driving 
force in the development of this project. As an example, one of the greatest advantages in the production 
of RBCs from umbilical cord blood stem cells is related with the age of the cells produced. Even though the 
only currently available method to alleviate blood transfusions is in fact blood donation by healthy 
volunteers, RBC consumption increases significantly with age (for example, 70­ to 80­year­olds have an 
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eightfold higher RBC consumption than 20­ to 40­year­olds) (Ali et al. 2010). This is related with the 
increasing loss of oxygen transport capacity by these cells with the ageing; hence, a patient receiving a 
blood donation from an older individual may need a larger number of RBCs to compensate for this loss of 
capacity. For patients where this is used in a regular basis (e.g. to treat β­thalassaemia major, an inherited 
blood disorder that remains one of the major health problems particularly in developing countries (Ikram et 
al. 2004) and kills thousands of children every year in the middle Eastern alone), larger amounts of 
transfused RBCs increase the iron amount infused into the patient, which is highly toxic to tissues (Wood et 
al. 2010). Taking into account that a unit of red blood cells transfused contains approximately 250mg of 
iron, while the body cannot excrete more than 1 mg of iron per day (Ikram et al. 2004), this iron overload 
can cause clinical complications. As an example, it has already been correlated with cardiac failures and 
arrhythmias in patients, which in turn are responsible for as many as 71% of deaths in patients with β­
thalassaemia major (Wood et al. 2010). Producing cells from young umbilical cord­derived stem cells, could 
in principle allow transfusing a much lower amount of RBCs, and thus reducing the problems derived from 
the accumulation of iron in the blood. 
Figure 1. The concept of tissue engineering. Adapted from: Langer and Vacanti 1993; Clemson University 2008. 
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1.2. AIMS AND OBJECTIVES
The main aim of this project is the development of a novel, bio­inspired, 3­dimensional dual hollow fibre 
bioreactor to support the ex vivo expansion of haematopoietic stem cells (specialized cells within the 
human bone marrow that exists within the protection of human bones), whilst producing and continually 
harvesting mature enucleated red blood cells. This will be sought after through an intrinsic ex vivo
biomimicry of the human bone marrow, the natural blood factory with the capacity to produce daily nearly 
3 billion red blood cells per kg body weight of an adult, whilst reducing the costs of production. Towards 
achieving this main goal, a 3­dimensional hollow fibre system incorporating two different types of hollow 
fibres that allow recycling expensive molecules fed into the bioreactor and harvesting of the produced red 
blood cells has been conceptualized in this work (figure 2) and will be further developed. To achieve this, 
different fields of research, from membrane engineering to cell biology, will be applied in the following 
specific objectives: 
Objective 1. To develop a membrane system in which small molecules such as nutrients and metabolites, 
and larger molecules such as serum proteins and growth factors can be selectively exchanged by diffusion 
with an external reservoir. Included in the purpose of this objective is the conceptualization and testing of 
two different membrane types that can later be used in the setup depicted in figure 2, namely: a high­
uptake membrane (HUM) for the exchange of small molecules and prevent the waste of larger proteins and 
growth factors; and a low­uptake membrane (LUM) to allow for the recycling of the larger molecules and 
harvesting of mature red blood cells. 
Objective 2. Design and fabrication of a novel 3D dual hollow fibre bioreactor, including the further 
development of the two different types of membranes (high­ and low­uptake) conceptualized in objective 1 
to incorporate three novel features into this design: 1) a 3D hollow fibre bioreactor, composed of a porous 
polymeric scaffold immersed with hollow fibres; 2) the integration of a dual hollow fibre system for the 
recycling of GFs whilst discarding and renewing cell culture media; and 3) the inclusion within the 
bioreactor design of an automated and continuous harvesting of mature red blood cells; 
Objective 3. Evaluation of the novel 3D hollow fibre bioreactor structure and its feasibility in supporting 
cytokine­free expansion of human cord blood mononuclear cells; 
Objective 4. Production of human red blood cells as a proof of concept, by running the bioreactor over a 
period of a month, during which red blood cells will be harvested and analysed for their functionality 
(morphology, surface markers’ expression and viability).  
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1.3. THESIS OUTLINE
There is an estimated worldwide shortage of 75­90 million units of red blood cells per year according to the 
World Health Organization (2009b). Even though the large­scale production of red blood cells is a sought­
after goal by many research groups around the world, no feasible alternative to produce these cells in 
sufficient numbers to alleviate this blood shortage has yet been presented, although several milestones 
concerning the knowledge on the differentiation pathway of stem cells into the oxygen­carrying cells have 
been achieved (Giarratana et al. 2005). In order to overcome the current challenges towards making it 
possible, the engineering aspects of this biomedical field need to be addressed, particularly in what 
concerns to space and cost requirements. This thesis has been structured to assess the state­of­the­art 
technology in Chapter 2, wherein different methods for the ex vivo expansion of stem cells and their 
targeted differentiation into red blood cells are discussed. This chapter also presents a review on current 
bioreactors used for stem cell bioprocessing, with a higher focus into the hollow fibre design and current 
applications of this design. Chapter 3 encompasses all the experimental methods and materials used for the 
design of the bioreactor; the development, characterization and evaluation of the membranes used; and 
finally culturing and characterizing cord blood stem cells. To assess the feasibility of the conceptual 
characteristics required for the high­ and low­uptake membranes in the design of the bioreactor, chapter 4 
includes the initial trials performed to study each membrane in flat­sheet configuration. This is then 
followed by Chapter 5, wherein the concept of a 3D Dual Hollow Fibre (HF) Bioreactor is introduced, and 
both membranes are developed accordingly. Several challenges are to be addressed through the inclusion 
of a number of features into this design, namely: 1) selectively permeable hollow fibre membranes 
immersed within a porous polymeric scaffold; 2) continuous harvesting of cells; and 3) reduction of costs in 
the culture media (through the recycling of growth factors). After the development stage of the 
membranes, chapter 6 discusses their assembly into the bioreactor and the scaffold production, to 
determine and mitigate possible challenges arising from this combination, as well as testing the 
biocompatibility of the bioreactor components by culturing mononuclear cells in a cytokine­free 
environment. The ultimate objective of this thesis is the proof­of­concept that will be achieved in chapter 7 
– to run the 3D dual HF bioreactor over a period of a month for the production of enucleated red blood 
cells. Finally, the overall conclusions from this work and future directions to bring this technology closer to 
the clinic are presented in chapter 8. 
Throughout this thesis, a number of references are made to costs and market values, and in order to allow 
an easier comparison between these values, all values are displayed in £ (GBP), using an exchange rate 
from $ (USD) of 0.625 when required. 
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CHAPTER 2 
CHAPTER 2.
BACKGROUND
“Engineering is the art of organizing and directing men and controlling the forces and 
materials of nature for the benefit of the human race.” 
Henry G. Stott 
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2.1. BLOOD
William Harvey, leading physician of his day, was the first to demonstrate that blood circulates around the 
body in 1628 (National Blood Service UK accessed 2010). From then on, it was found that blood plays an 
important role on maintaining the body healthy and alive, by circulating continuously throughout its 
intricate network of veins, arteries and capillaries (figure 3), delivering nutrients and oxygen to the cells, 
eliminating their metabolites, working as an active barrier against infections or strange bodies (such as 
bacteria or virus), and other vital jobs. A single drop of blood contains over 250 million cells (Wikipedia
retrieved December 2006). It is a sticky red fluid, three times more viscous than water, mainly composed of 
a watery plasma with seven types of cells and cell fragments in suspension, which can be described and 
grouped the following way (Britannica accessed October 2006): 
 Red blood cells (RBCs) or erythrocytes  
 Platelets or thrombocytes 
 Five types of white blood cells (WBCs) or leukocytes  
o Three types of granulocytes  
 Neutrophils 
 Eosinophils 
 Basophils 
o Two types of leukocytes without granules in their cytoplasm  
 Lymphocytes 
 Monocytes 
Figure 3. Blood is one of the most important tissues in the human body. Produced in the bone marrow, it flows through every organ 
and nourishes every cell to maintain the homeostasis of the body. Being a mixture of several different cells, each with their own 
function, red blood cells are the most represented cell type in human blood, composing over 95% of its cellular population. Picture 
drawn using SmartDraw2008 and adapted from Encyclopaedia Britannica, Inc. (accessed December 2006).
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Produced in the bone marrow (BM) (further detailed in section 2.7, p. 55), the soft and spongy­like material 
found within the protection of the bones, blood cells originate from the differentiation course of resident 
hematopoietic stem cells, on a process termed haematopoiesis (further detailed in section 2.5.2, p. 45) 
(Cabral 2001; Mantalaris et al. 2004b). After full maturation and in order to accomplish their task, blood 
cells lose the capability to self­replicate, and nevertheless they do have a life cycle that is much shorter 
than their host (e.g., red blood cells have a limited life­span of around 120 days in vivo, as shown in table 1). 
Therefore, the BM is adapted to supply the conditions for the development of these stem cell sources, and 
their differentiation into the different blood cells, according to the requirements of body, maintaining 
during the entire life of the body the stemness of these cells, so this reproducibility can be kept. On 
average, the body of a man weighing 70kg produces around 4x1011 blood cells per day (Koller and Palsson 
1993), although under stress this value can increase up to 10­fold. 
Table 1. Estimated in vivo blood cell production rates, and their life-span. Adapted from: Koller and Palsson 1993. 
Cell type 
Concentration in 
the blood      
(x107 cells.mL-1) 
Life-span 
(days) 
Production rate 
(billions per day) 
Red blood cells 500 120 208 
Platelets 20 8 125 
White blood cells 0.5 0.5 50 
TOTAL Production 383 
Analysing the cellular composition of human blood (figure 4), RBCs are the most represented cell type, 
making more than 95% of the total cell number. RBCs are also the most common cell type in the human 
body, and due to their vital functions, particularly the delivery of oxygen to all the cells around the body, 
these are also the most required cell type in clinical therapies (World Health Organization 2007). RBCs are 
essential to treat a number of clinical complications: 38% of the blood collected by the British NHS Blood & 
Transplant is used in general medicine, mainly surgeries (World Health Organization 2007), whilst a single 
bone marrow transplant (e.g., to help treating patients with leukaemia) may require platelets from over 
100 donors and red cells from other 20 (New York Blood Center 2006), amongst other applications. The 
only available alternative, however, is blood donation by healthy individuals. 
Figure 4. Relative cellular composition of human blood in healthy individuals.
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2.2. THE CHALLENGE: BLOOD SHORTAGE
Blood transfusion saves lives and improves health, but millions of patients needing transfusion do not have 
timely access to safe blood. According to the programme of the World Health Organization (WHO) on Blood 
Transfusion Safety Survey, in 2007 there were 85.4million blood donations amongst the 162 countries the 
study comprised (accounting for a total of 5.9billion people, representing 92% of the global population). 
The report covers 7,997 blood centres that collected on average 9,000 donations per centre. In developed 
countries, the average annual collection per blood centre was 13,600, in transitional countries 6,000 and in 
developing countries 2,800 (World Health Organization 2009a). Moreover, 50% of all blood donations are 
collected in developed countries, which account for only 16% of the World’s population (Schaefer 2010). 
However the problem is not limited to developing nations: in 2002, 7% of elective surgeries in the US were 
postponed due to blood shortages (Whitaker and Henry 2007). 
Figure 5. Percentage of voluntary unpaid blood donations in 2007 (World Health Organization 2009a). 
To have an idea of the blood shortage distribution around the World, figure 5 presents the percentage of 
voluntary unpaid blood donation. It is possible to observe that in the majority of the developed countries, 
unpaid voluntary blood donations cover for 100% of the blood requirements. However, for the majority of 
the World population (84%), blood shortage is still a major problem, with a great percentage of the blood 
used having to be either bought (e.g. from other countries) or not used for therapies at all – with some of 
them having to bear over 75% of their blood demand through this route. 
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2.3. CURRENT ANSWER: BLOOD DONATION
The first blood transfusion in a human being was performed by Jean‐Baptiste Denis, Physician in Ordinary 
to Louis XIV, and the surgeon Paul Emmerez in Paris in 1667. They treated a febrile young patient suffering 
from symptoms of anaemia, who greatly improved following the transfusion with lamb blood (Jelkmann 
2007). In 1825, James Blundell, an obstetrician in London, performed the first successful homologous blood 
transfusion in a human being, a woman suffering from postpartum haemorrhage whose husband donated 
the blood (Jelkmann 2007). However, sometimes there were “unexpected” outcomes, particularly resulting 
in the patient’s death, due to what we today know as blood type incompatibilities. Hence, blood 
transfusions started to become current practice only in the 20th century, since the different blood types 
were identified in 1900 by Dr Karl Landsteiner, a leading doctor in Vienna (National Blood Service UK 2010). 
Towards establishing a global blood donor bank that could provide blood to treat patients, the first 
voluntary blood service was created by the British Red Cross Members who in 1921 decided to give blood 
themselves. The first blood bank was opened in 1936 at Cook County Hospital (Chicago, USA), whilst the 
first British blood bank was opened a year later, in 1937, at Ipswich (National Blood Service UK 2010). 
Nowadays, blood donor banks are established in the majority of the countries, although with better 
performances in the developed world (Schaefer 2010). After collection of the blood, it is usually then 
separated into its main components for separate use: packed RBCs, platelets, plasma, WBCs, etc. One unit 
of packed RBCs contains approximately 200mL of RBCs, 100mL of a solution such as Optisol AS‐5® 
(commercialized by Terumo Co. to extend storage life) and around 30mL plasma that must be stored 
between 1‐6°C with a shelf life of 42 days (Gernsheimer 2010). 
In order to assess the need of an individual to receive a blood transfusion, the haemoglobin content of his 
own blood is measured. According to the US Department of Health and Human Services, an haemoglobin 
(Hb) concentration of 100g.L‐1 is usually needed to safeguard an adequate oxygen transport, and most 
patients will suffer uncomfortable symptoms if their Hb concentration falls below 70g.L
‐1
 (NGC 2008). On 
transfusion into a 70 kilogram adult, one unit of RBCs usually increases his/her blood haematocrit (the 
proportion of blood volume that is occupied by RBCs) by 3‐4% (Gernsheimer 2010). Blood can be classified 
into four main types, according to its phenotype – O, A, B and AB –, and explaining the reason why blood 
transfusions in the past had so many unexpected outcomes, since each person can only receive blood of a 
certain type or types, depending on their blood phenotype. As an example, individuals with blood type 
ORh(neg), also known as universal donors, can only receive transfusions from individuals with the same blood 
group, a limitation that requires the establishment of greater stocks of that blood type, which is also used 
in cases of emergency when the blood type is uncertain. The distribution of these phenotypes highly 
depends on the geography, as seen in figure 6. Nowadays, 8,000 units of blood are required every day in all 
the hospitals of England and North Wales, which are managed by the British National Blood Service. In this 
region, blood stock levels are maintained through healthy volunteers at a positive balance, as observed in 
figure 7.
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Figure 6. Distribution of the different blood groups in terms of percentage throughout the most represented ethnicities in the World. 
Adapted from: http:www.blood.co.uk (accessed 28 October 2010).
The ageing population contributes negatively for these statistics. With the ageing of the body, donated 
RBCs start losing their attributes, particularly their oxygen transport capacity, with 70‐ to 80‐year‐olds 
having an eightfold higher RBC consumption than 20‐ to 40‐year‐olds (Ali et al. 2010). This results in the 
need for more frequent or intense blood transfusions to compensate for this loss of capacity. However, the 
demographic evolution predicted in the United States, and in the developed World generally, indicates an 
important increase in the proportion of people older than 60 years, from 18% in 2000 to 25% in 2030 
(Douay and Andreu 2007). This will have a great consequence in the quality of donated blood, with the 
need for a higher consumption of RBCs, further augmenting the main challenge with this approach: blood 
shortage. 
Figure 7. Current stock levels for each blood type (as of the end of October 2010) in the England and North Wales blood banks (A), 
and the evolution of blood stocks from June through to October 2010 in the same region (B). Source: NHS Blood and Transplant, 
http://www.nhsbt.nhs.uk (accessed 28 October 2010). 
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2.4. ALTERNATIVE SOLUTION: RED BLOOD CELL SUBSTITUTES
Apart from the shortage of available donors in many parts of the World, other risks related with 
homologous blood cell transfusion include febrile non‐haemolytic transfusion reactions, graft‐vs.‐host‐
disease (even though rarely, it can happen even when the same blood group is used), acute or delayed 
haemolytic reactions and transmission of prions, viruses, protozoans and bacteria (Jelkmann 2007). Being 
also the most used cell type in the world to alleviate an infinite number of diseases and traumas, the search 
for a substitute of RBCs in the clinical arena has been a constant effort by research groups. Since the first 
attempts, in the late 1940s, there have been several breakthroughs in this area, most of them focusing on 
the synthetic route: the search for a chemical molecule that could replace the main vital function of red 
blood cells – transport of oxygen to all the cells in the body (Kimball 1994). Alternatives such as 
perfluorocarbons and haemoglobin itself in the free‐form, mostly with the intent to transport oxygen in the 
patient’s body until a source of blood is found (Chen et al. 2009), have been proposed (figure 8). 
Nevertheless, several issues, mainly regarding the long‐term use of these molecules, in terms of stability 
and controlled oxygen release, still pose serious barriers for the success of this option (Kimball 1994). 
Figure 8. Relative size comparison of the human red blood cell alongside two of the most common blood substitutes – haemoglobin-
based oxygen carriers and perfluorocarbons (Wilson 2007).
Despite the fact that a RBC substitute has been searched for over 70 years, there is currently no oxygen‐
carrying molecule that is approved by the USA Food and Drug Administration (Grethlein and Rajan May 
2010). On the other hand, the developments of Tissue Engineering in the last few years, offering the 
potential for the development of biological substitutes to restore, maintain or improve tissue function 
(Langer and Vacanti 1993) were proven with the successful first transplant of a human windpipe in 2008 
(Roberts 2008), amongst many other breakthroughs (Douay and Giarratana 2009). Hence, the development 
of a biological substitute to traditional blood donations could help alleviating these hurdles. The next 
section, mechanisms of differentiation, will provide further insights into this possibility. 
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2.5. MECHANISMS OF DIFFERENTIATION
2.5.1. Stem cells 
Stem cells are characterized by two distinct features: the capacity for self‐renewal (to proliferate and 
replenish the cells that are lost through natural processes) and the potential to differentiate into the 
different cell types that compose our body. Both these characteristics are inverse‐proportionally related 
(figure 9) – the more committed a cell is to a specific cellular lineage, the lower will be its self‐renewal 
capacity –, originating different stem cell sources: from the embryo (embryonic stem cells, or ESCs) or from 
the adult body (adult stem cells) (Polak et al. 2008). Adult stem cells can be found in a number of locations 
in the body: from the foetal liver before birth, to the umbilical cord blood (UCB) on delivering and the bone 
marrow (BM), peripheral blood and a number of other organs/tissues in the adult body, such as the heart 
(Zimmermann and Eschenhagen 2007). Each of these resident adult stem cells has already undergone 
commitment to the specific cellular lineages required to replenish the tissue where they nest, hence having 
lost part of their self‐renewal capacity. For this reason, from the expansion point of view, embryonic stem 
cells are the best source of cells, due to their greater replenishing capacity (Polak et al. 2008). Nevertheless, 
due to the greater number of cell divisions they need to undergo to produce a functional mature cell, the 
differentiation process from this stage is more difficult to control than using adult stem cell sources. 
Moreover, from the ethical point of view, the development of a system that would require the sacrifice of 
human embryos (required for harvesting of ESCs) to obtain the cellular raw material carries heavy 
legislative and moral burdens. 
Figure 9. Differentiation pathway of in vivo stem cells towards enucleated RBCs. The two characteristic features of stem cells 
are self-renewal and commitment to a specific cellular lineage, which are antagonists to each other. SC: stem cell; BFU-E: 
erythroid burst-forming unit.
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2.5.2. Natural blood production: haematopoiesis 
Haematopoiesis (from the ancient Greek: “haima” blood; “poiesis” to make) is the complex process that 
leads to the production of blood cells from haematopoietic stem cells (HSCs). In vivo, these specialized stem 
cells grow and differentiate in a three‐dimensional (3‐D) microenvironment, within the protection of the 
BM. Composed of a defined geometry (Cabral 2001) and a close and intricate net of different molecules 
(stromal cells, extracellular matrix (ECM) proteins, and an array of soluble and ECM‐bound growth factors) 
(Mantalaris et al. 1998; Cabral 2001; Pathi et al. 2004; Pathi 2005), these conditions define the 
Haematopoietic Inductive Microenvironment (HIM), which is thought to be a key condition factor for the 
expansion of HSCs ex vivo (figure 10) (Mantalaris et al. 2004a). Since Schofield et al. 1994 suggested that 
the in vivo proliferation and development of stem cells take place in a microenvironment, the existence of 
stem cell niches has been testified by a great number of studies (Yin and Li 2006; Hofmeister et al. 2007). 
The HIM induces and maintains three different tasks: self‐renewal of the stem cells in order to maintain 
their multipotency (or ability to differentiate into different cell lineages), commitment to a specific cell 
lineage (progenitor cells) and differentiation into fully mature and functional cells. Within this 
microenvironment, a complex signalling structure regulates these processes, by defining the fate of each 
HSC: continue onto the self‐renewal route to produce more HSCs or start the differentiation process 
towards a mature blood cell and losing its potential to self‐division. The expansion of HSCs in order to 
reconstitute a functioning synthetic BM is a rapidly developing area and has a broad range of biomedical 
applications (Palsson et al. 1993b; Cabrita et al. 2003). 
Figure 10. The Haematopoietic Inductive Microenvironment, as thought to be in vivo the vital responsible for the proliferation, 
commitment and differentiation of HSCs, is composed by several molecules, grouped here according to their main role in 
haematopoiesis – growth factors, cellular elements and extracellular components (Mantalaris et al. 2004a).
SCF: stem cell factor; FL: fms-like tyrosine kinase-3 ligand; IL’s: interleukins; CSF’s: colony-stimulating factors; LIF: leukaemia inhibitory factor; 
p21: cyclin-dependent kinase inhibitor 1; MIP-1α: macrophage inflammatory protein-1α; TNF-α: tumour necrosis factor alpha. 
The commonly accepted theory governing haematopoiesis is called the monophyletic theory, according to 
which a single type of stem cell is in the origin of all the different mature blood cells in the body – the 
pluripotent stem cell or HSC (Pathi 2005). However, not all HSCs are identical. These can be divided into 
three types: long‐term self‐renewing HSCs (LT‐HSCs), short‐term self‐renewing HSCs (STHSCs) and not self‐
renewing multipotent progenitors (MPPs) (Cabrita et al. 2003). Studies have shown that the LT‐HSCs self‐
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renew throughout the lifespan of the body (Yuan et al. 2004), maintaining haematopoiesis by 
differentiating into ST‐HSCs and then to MPPs, cells with shorter duration. The latter cells will differentiate 
again into the lineage‐committed progenitor cells which, as their name suggests, give rise to blood cells of 
specific lineages (figure 11) (Pathi 2005). This differentiation process is mainly governed by GFs (further 
explained in section 2.5.4, p. 48). During this specialization process, the HSCs become committed to a 
certain cellular lineage (e.g. erythrocyte, neutrophil, T‐lymphocyte) through a number of divisions, with an 
extensive expansion and maturation process (e.g., accumulation of haemoglobin in erythrocytes). A single 
committed HSC may produce several million mature cells (Nielsen 1999). 
Different sources of stem cells (SCs) are known, particularly embryonic stem cells and adult stem cells, 
which include the umbilical cord blood (UCB), bone marrow and peripheral blood (table 2). Embryonic stem 
cells represent the youngest source of stem cells, with a large expansion potential and the capability to 
differentiate into almost every cell in the human body (Thomson et al. 1998). On the other hand, adult 
stem cells present a more limited expansion potential than embryonic SCs and, due to their older source, 
have already been committed to specific lineages, having lost part of the differentiation potential that 
characterizes their embryonic counterpart (Jiang et al. 2002). However, only in January 2009 the first 
human clinical trial using embryonic SCs as a therapy was approved by the FDA (Winslow 2009), and only in 
October 2010 the first human trial to help treating spinal injury victims was started (Roberts 2010). The 
delay in using this as source is related to the difficulties in controlling the differentiation of embryonic SCs, 
which after transplantation have a high likelihood to develop into teratomas (a tumour) and have a higher 
rejection rate than adult stem cells, which in turn have already been successfully applied to treat e.g. 
leukaemia and related bone/blood cancers through bone marrow transplants (UCSF Benioff Children's 
Hospital 2010). Ethical issues, mainly due to the need to destroy human embryos for the harvesting of cells 
for expansion, have also hampered the research into embryonic SCs, with the US government having 
limited the research in this field for some time. Because adult stem cells can be harvested relatively easy 
from an adult recipient, these cells represent an important source to study and develop stem cell therapies. 
Table 2. Comparison of the different stem cells sources in terms of cell expansion potential, availability, risk of teratoma 
development and of immune rejection after transfusion into a patient. 
Stem cell source 
Expansion 
potential 
Availability 
Risk of teratoma 
development 
Risk of immune 
rejection 
Embryonic stem cells ++++ ++++ High High 
Cord Blood +++ ++ Low Low 
Bone marrow + + Low Low 
Peripheral blood + + Low Low 
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2.5.3. Haematopoietic source: the umbilical cord 
HSCs are found within the BM at typically very low percentages (0.01–0.05%), on the peripheral blood at 
even lower percentages (around 0.001%) and on other sources, such as the UCB or the foetal liver (Cabrita
et al. 2003). The UCB is the best known source of these cells in the adult: the blood from a single UCB (80 to 
120mL volume) contains as many HSCs as a normal sample of 800 to 1200mL of BM from a donor (Placzek
et al. 2009). These cells also possess a much higher proliferative capacity when collected from the UCB due 
to their younger source. Moreover, UCB cells are widely available, the harvesting of the cells immediately 
after giving birth is completely harmless to both the child and the mother, are easily preserved and after 
transplantation trigger less immune‐rejection than “older” sources such as the BM (Kohler et al. 1999; 
Rocha et al. 2000). The only disadvantages in the use of UCB stem cells are related with the need for their 
cryopreservation for future use, the limited volume of cells collected per harvest and their lower 
proliferation rate when compared to embryonic stem cells. For this reason, UCB is an attractive source of 
cells for transplantation therapies and regenerative medicine (Gammaitoni et al. 2006; Slatter and Gennery 
2006). 
Nevertheless, the comparative low‐doses of UCB available to treat adult patients that result in higher rates 
of graft failure, longer time to engraftment and transplantation‐related mortality have been hampering the 
translation of this therapy into clinical practices (Wyrsch et al. 1999; Gunsilius et al. 2001). It is therefore 
necessary to develop ex vivo culture systems that are capable of scaling up the expansion of UCB‐HSCs and 
their progenitors prior to transplantation. And in fact this has already been proven (Wagner and Verfaillie 
2004; Hofmeister et al. 2007). The first transplant performed using human UCB stem cells was made in 
1988 by Gluckman and co‐workers to treat a child with Fanconi’s disease, a condition that affects the 
proximal tubule in the kidney preventing the organ from reabsorbing certain metabolites such as glucose 
and amino‐acids (Gluckman et al. 1989; Senegaglia et al. 2009). Up to today, more than 10,000 transplants 
using UCB have been made around the World, and there are more than 200 public and private cord blood 
banks globally, which overall store around 2 million units (Senegaglia et al. 2009). Procedures for collecting, 
banking and storing cord blood donations are determined by several organisations such as the American 
Association of Blood Banks, the American Red Cross, Eurocord, NETCORD and the National Bone Marrow 
Donor program to ensure the quality and standards of UCB units used for transplantation (Bradley and 
Cairo 2005; Lim 2008). 
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2.5.4. Role of cytokines in haematopoiesis 
The process that mediates stem cell expansion and differentiation is very complex, producing the different 
cells that compose our heterogeneous body tissues, and particularly blood. Figure 11 illustrates the 
hierarchy of blood production, or haematopoiesis, comprising the three stages through which stem cells 
undergo to produce blood cells: proliferation, commitment and differentiation (Mantalaris et al. 2004a). 
Proliferation is probably the most important stage from the industrial point of view, in the way that for this 
process to be commercially attractive, it must provide the greatest cell proliferation in the least possible 
time. Alongside the other two stages (commitment to arise on a middle‐term cell, such as the myeloid stem 
cell or the lymphoid stem cell, and differentiation into a definitive blood cell, such as platelets or 
erythrocytes) these processes are mediated by a mixture of hormones and cytokines, the so‐called growth 
factors (GFs), as represented alongside the same hierarchy in figure 11. These are a family of glycoproteins 
that simulate cellular processes by recognising and interacting with specific cell‐surface receptors. 
Figure 11. Hierarchical relationship of pluripotent hematopoietic stem cells (HSCs), progenitors, and mature cells of the 
myelopoietic, erythrocyte, and platelet lineages together with major cytokine sources and actions. These cytokines have overlapping 
actions during hematopoietic differentiation, as indicated, and, for most lineages, optimal development requires a combination of 
early- and late-acting factors. 
CFU-GEMM: granulocyte, erythrocyte, monocyte, megakaryocyte colony-forming unit; BFU-E: erythroid burst-forming unit; CFU-E: erythroid 
colony-forming unit; CFU-MEG: megakaryocyte colony-forming unit; CFU-G: granulocyte colony-forming unit; CFU-M: monocyte colony-forming 
unit; CFU-Baso: basophil colony-forming unit; CFU-Eo: eosinophil colony-forming unit; SF: steel factor (or stem cell factor); IL: interleukin; GM-CSF: 
granulocyte-macrophage colony-stimulating factor; G-CSF, granulocyte colony-stimulating factor; M-CSF, macrophage colony-stimulating factor. 
Adapted from: Kimball 1994; Mantalaris et al. 1998; Cabral 2001; Takagi 2005; Sieff 2006; Kaushansky et al. 2010.
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Progressive differentiation of blood cell lineages often requires the interaction of several GFs, some of 
which may be lineage‐specific, such as erythropoietin (EPO), which stimulates erythrocyte production, and 
interleukin (IL)‐2, which stimulates T‐cell production, whilst others such as stem cell factor (SCF), IL‐3 and 
FLT‐3 ligand (FL) work across lineage boundaries (Quesenberry and Colvin 2001). These non‐lineage specific 
GFs do not usually act independently, but rather in conjunction with other GFs to activate the required 
cellular functions. Of these, SCF, IL‐3, and FL stimulate the survival and proliferation of early progenitor cells 
including HSCs (Kurzrock 2003). Others, such as granulocyte‐macrophage colony stimulating factor (GM‐
CSF) and granulocyte colony stimulating factor (G‐CSF) help in the differentiation of the myeloid lineages 
(Quesenberry and Colvin 2001; Kurzrock 2003). Table 3 summarizes the major functions of some of the best 
known cytokines involved in haematopoiesis. HSCs usually differentiate during ex vivo expansion in the 
presence of large doses of cytokines and/or feeder cells, hence seriously losing their stemness and their 
expansion potential (Mohamed et al. 2006). This leads to unsatisfying transplantation outcomes (Rocha et 
al. 2000). Therefore, the key lays on the search for reasonable ex vivo expansion protocols that would not 
only further promote the amplification of HSCs but also effectively maintain their stemness for as long as 
required. 
Table 3. Some cytokines known to influence human haematopoietic stem cells expansion (adapted from: Cabrita et al. 2003). CSF, 
colony-stimulating factor; Fms, fibromyalgia syndrome gene.
Cytokine (abbreviation) Function
Fms-like tyrosine kinase-3 ligand (FL) 
Potentiates the effects of other cytokines and promotes survival of 
HSCs 
Granulocyte CSF (G-CSF) Mobilization of HSCs to peripheral blood 
Interleukin 2 (IL-2) Stimulates T-cell production 
Interleukin 3 (IL-3) Together with interleukin 6 (IL-6), promotes proliferation of HSCs 
Interleukin 10 (IL-10) Helps proliferation of HSCs 
Interleukin 11 (IL-11) Shortens the G0 period of the cell cycle of HSCs 
Jagged-1 Regulates HSC self-renewal 
Platelet-derived growth factor (PDGF) Mitogen for connective tissue cells 
Stem cell factor (SCF) Growth factor for HSC progenitor cells 
Thrombopoietin (TPO) Stimulator of megakaryocytopoiesis 
Erythropoietin (EPO) Stimulator of erythropoiesis 
On the other hand, commercially available cytokines are produced either using mice and rats to produce 
ascites fluids after inoculating them with a monoclonal antibody‐producing hybridoma (McCullough and 
Raymond 1990) or cell lines expressing human erythropoietin, such as the CHO cell line (Wang et al. 2000). 
However, these approaches are very costly: according to McCullough and Raymond 1990, to produce 1kg of 
pure antibody the first technique requires around 40,000 animals whereas the second a bioreactor tank of 
around 5,000L volume. For this reason, the use of exogenously‐added cytokines in ex vivo expansion 
protocols, despite important, also carries enormous costs due to the high premium of these molecules.
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2.6. PROPERTIES OF TISSUES AND ORGANS
2.6.1. Cellular organization 
The human in vivo architecture of cellular tissue is a well‐organized system. Within it, both cellular and non‐
cellular components share a common specialized microenvironment characterized by its homeostasis that 
promotes viability and function‐specific characteristics to the different tissues. The combination of different 
types of tissues into a functional unit constitutes an organ. Different organs (e.g., liver or lung) have also 
distinct and specialized functions (respectively, blood purification and blood oxygenation) that cooperate to 
maintain the body within healthy conditions. Different cell types are required to perform these different 
tasks (mainly, hepatocytes in the liver and pneumocytes in the lung). To promote their function, non‐
cellular components support their healthy development by providing physical, biochemical and electrical 
signals. These signals are also important strategies, developed to maintain a tight control on all the 
biological processes being undertaken by each individual organ or tissue, to augment the stability and 
regulation of the whole body. 
All tissues are comprised of a well‐defined structural hierarchy. Different levels of hierarchy are often 
observed within an organ, which allows for a better organization of the overall organ as well as a faster 
exchange of molecules between the blood and tissues. This not only promotes the maintenance of a stable 
environment, but also reduces the risk of alterations in the transport processes across and within tissues, 
which could otherwise develop into several different diseases, such as atherosclerosis, cancer, and kidney 
diseases (Truskey et al. 2004). The idea of a “functional subunit” within an organ comprises thus the 
smallest possible association of cellular and non‐cellular components (or a portion of the tissue) that can 
solely undertake the basic function of the tissue/organ they represent. This is usually in the order of 100µm 
tissue, which contains its own dedicated vascular system (at a basic level, this is to provide nutrients and to 
remove metabolites). As an example, the human kidney, roughly the size of the human fist, is comprised of 
about 600,000 copies of its functional unit, the so‐called nephron, a highly vascularized structure that 
allows the detoxification of blood from metabolic products. A lower number of these structures in the 
kidney is thought to be related with a number of clinical complications, including the low weight of new‐
borns (Manalich et al. 2000). Thus, most attempts nowadays to expand tissues ex vivo focus on mimicking 
this small functional unit, with the idea of scaling‐out afterwards, by means of assembling a structure to 
repeat these units. However, the integrity of each unit will be compromised if the coefficient of mass 
transfer of the overall organ is lower than that of a single unit, requiring careful attention from the 
engineering point of view. 
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2.6.2. The Endothelial Membrane 
As the human BM, many organs have a composite structure in which epithelial cells play one of the most 
important tasks while connective tissue and blood vessels support and provide nourishment to this 
epithelium (Ratner et al. 1997). Within the BM, several micro environmental conditions are set in order to 
provide cells with nutrients, oxygen and a supportive structure, as well as renewing it by removing dead 
cells and metabolites produced. Moreover, this overall picture would never be able to work if the bone 
marrow was not also capable of selectively injecting the differentiated blood cells into the blood stream, 
whilst retaining the un­specialized HSCs and other blood progenitors within the protective 
microenvironment, thus promoting the continuity of this life­cycle. This is achieved by the vascular system. 
And, in fact, the complex vascular network that composes the bone marrow (figure 13, p. 56) has been 
shown to be responsible for collecting the differentiated blood cells from their production site, injecting 
them into the blood stream, while limiting the passage of the other undifferentiated cells (Inoue and 
Osmond 2001). So, an important question arises from this observation: “which characteristics compose the 
membrane of these sinusoids that allow the distinction between these two cell types?” 
According to Inoue and Osmond 2001, the sinusoidal wall is composed of three layers: an inner 
endothelium, surrounded by a basement membrane and an outer layer of adventitial cells. The 
endothelium is a continuous layer in which adjoining cells often interdigitate and are bound to one another 
through maculae occludentes; it is composed of a “living membrane”, made of the endothelial cells. The 
second layer, the basement membrane, is a specialized extracellular matrix structure composed essentially 
of collagen type IV, laminin and perlecan (Laurie et al. 1982). And the outer layer, the adventitial cell, 
resides only partially about the sinusoidal wall, covering approximately 60% of the wall in the rat bone 
marrow (Inoue and Osmond 2001). In a model described by Butcher and Picker in Science, the trafficking 
and homing of lymphocytes through the endothelial membrane is represented by an integrated process of 
the leukocyte rolling on the blood vessel wall, followed by activation, firm adherence, and transmigration 
into the tissue (Butcher and Picker 1996). This process is further detailed in section 2.7.5. Cellular 
harvesting (p. 59). 
The degradable basement membrane layer is usually the main subject of study of the three layers, mainly 
because its composition is the less known and its job in the sinusoid wall considered to be crucial (Grant et 
al. 1981; Laurie et al. 1982; Kleinman et al. 1986; Albini et al. 1987; Butcher and Picker 1996; Inoue and 
Osmond 2001; Liapis et al. 2002; Vande Broek et al. 2004; Ribatti et al. 2007). These are thin, but 
continuous, sheets that separate epithelial tissues from stroma and surround nerves, muscle fibres, smooth 
muscle cells, and fat cells. The predominant components of basement membranes are collagen type IV, the 
glycoproteins laminin, entactin and nidogen, and heparan sulphate proteoglycans (Kleinman et al. 1986). 
These membranes form barriers that block the passage of cells and macromolecules but become 
permeable during tissue development and repair, at inflammatory sites, and are resorbed in areas where 
basement membranes contact invasive neoplasms (Albini et al. 1987). They appear on many different sites 
in the body, but present different functions and slight different compositions according to the site they 
nest. The properties of basement membranes, serving as natural tissue barriers, are unclear, but some 
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researchers speculate that a high degree of cross­linking between the components could be involved.
According to a review by Grant et al. 1981, the main roles of the basement membrane are: filtration, elastic 
support, structural rigidity, substratum for enzyme action, morphogenesis, anchorage of cells, 
cytodifferentiation and maintenance of tissue architecture. Vande Broek et al. 2004 published one of 
several studies on the basement membrane. According to this paper, and as stated before, the membrane 
that separates the BM from the circulating blood contains endothelial cells, which aid on the filtering and 
barring process. In order to mimic this in vitro, they have used Matrigel, a reconstituted basement 
membrane commercially available, with endothelial cells dispersed. The addition of endothelial cells to this 
membrane is also stated to induce a closer similarity to the in vivo structure, as stated by others as well 
(Kleinman et al. 1986 and Albini et al. 1987). 
2.6.3. The extracellular matrix 
The ECM is the skeleton of the in vivo niche that protects and supplies vital signals to all the cells residing 
within it, forming a specialized microenvironment directly related with the main function of the organ 
where it occurs. It is secreted by virtually every cell in the body, thus can be tailored to the special needs of 
the organ or tissue where it resides. It is also responsible for several general tasks: 1) mechanical support 
for cell anchorage; 2) determination of cell orientation; 3) control of cell growth; 4) maintenance of cell 
differentiation; 5) scaffolding for orderly tissue renewal; 6) establishment of tissue microenvironment; 7) 
sequestration, storage and presentation of soluble regulatory molecules (Ambrosio et al. 2007). The bone 
marrow ECM, as well as the ECM produced by cultured marrow stromal cells, has shown to be composed of 
collagens I, III, IV, V, and VI, fibronectin, laminin, and other adhesive proteins, as well as large molecular 
weight proteoglycans such as syndecan, perlecan, members of the small leucine­rich proteoglycan family 
including biglycan and decorin, and hyaluronan, a glycosaminoglycan (Chen et al. 2007). 
The presence of the ECM within tissues, surrounding the microenvironment where cells also reside, is the 
main reason for mass transfer limitations, particularly of oxygen and nutrients. To have an idea of this, a 
cylinder with 1cm diameter composed of material similar to a frog’s nerve, if suddenly placed in oxygen, 
would take 185min to attain 90 per cent of its full saturation with that gas. However, the vascularization of 
this structure in vivo is responsible to promote a faster intake, and an actual nerve 0.7mm thick would in 
fact take only 54s to reach the same saturation level (Hill 1928). 
2.6.4. Mass transfer within tissues and organs 
Two physical phenomena are involved in the transport of molecules: diffusion and convection. Diffusion is 
the random motion of molecules that arises from thermal energy transferred by molecular collisions, while 
convection is a mechanism of transport resulting from the bulk motion of fluids (Truskey et al. 2004). 
Length scales in biological systems range from over eight orders of magnitude (from the small protein 
molecules in the 10
­8
 m scale to the human body in the 10
0
 m scale) (Truskey et al. 2004). To promote 
molecular transport across these different scales, different approaches are required: while for short 
distances (within the capillary range of 10
­4
 m) diffusion is very efficient (oxygen can diffuse through a 
100μm­thick tissue in 5s), as the distances required increase beyond this threshold the diffusion becomes 
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limiting (reducing by an exponential factor of 0.5), thus convective transport is used to cover larger 
distances. This convective flow is typically the bulk transport of molecules by the blood flow, through the 
capillary network, while the diffusional flow is the motion of individual molecules at the cellular level, 
through the capillaries’ epithelial membrane (Truskey et al. 2004). 
Coincidentally, the spacing between capillaries in all tissues is in the range of 10
­4
 m (Truskey et al. 2004). 
This allows the efficient use of the less disruptive diffusional flow for the delivery and renewal of the 
sensitive cellular microenvironment in situ, leaving the bulk transport of nutrients throughout the body for 
the convective flow within the vascular system. This convective transport could be detrimental for the 
survival of the cells, as it would be disruptive for the sensitive microenvironment by increasing the shear 
stress exerted over the cells. Thus, diffusive transport, having a lower efficient transport throughout large 
distances, but much less disruptive at local levels, is responsible for exchanging and renewing the cellular 
microenvironment. At this level, oxygen is typically the limiting nutrient and is specially so in bioreactors, 
where its relatively high consumption rate and low initial concentration (~0.2mM at 37°C, 1atm) combine 
to make it difficult to provide adequate levels. The molecular transport within the body is thus 
accomplished through three different routes (table 4): 1) body blood flow (mainly convective), 2) vascular 
trans­membrane (diffusional) and 3) cellular tissue (diffusional) (Bassingthwaighte 1970). 
Table 4. Typical flow parameters in the human blood circulatory system (King 2006).
Structure 
Diameter 
(cm) 
Blood velocity 
(cm.s
­1
) 
Tube Reynolds 
number
Ascending aorta 2.0 – 3.2 63 3600 – 5800 
Descending aorta 1.6 – 2.0 27 1200 – 1500 
Large arteries 0.2 – 0.6 20 – 50 110 – 850 
Arterioles 0.001 – 0.015 0.5 – 1.0 0.014 – 0.43 
Capillaries 0.0005 – 0.001 0.05 – 0.1 0.0007 – 0.003 
Venules 0.001 – 0.02 0.1 – 0.2 0.0029 – 0.11 
Large veins 0.5 – 1.0 15 – 20 210 – 570 
Vena cavae 2.0 11 – 16 630 – 900 
Solute transport through the tortuous and intricate net of the frequently dense ECM can greatly affect the 
molecular transport of nutrients as well as metabolites to be renewed / exchanged with the blood flow, 
respectively. Tackling this mass transport limitation within tissues is the main reason for the maintenance 
of the viability and growth of cells. The density of cells in liver and kidney, for example, is typically much 
higher than that in connective tissues, such as ligament, tendon and cartilage (Lanza et al. 2000), also 
leading to not only higher consumption / production rates of nutrients / metabolites, respectively, but also 
to higher resistances to the mass transfer of these molecules, required for their exchange with the blood 
supply. As an example, pancreatic cells consume in average 1­2µLoxygen.min
­1.g­1 (Sweet et al. 2002), while 
the liver requires around 22µLoxygen.min
­1.g­1 (Coritsidis 2008). This makes the need for vascularization in 
these tissues also different: while the pancreas requires a lower capillary density (~19mm2 of surface area 
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per gram of tissue), the liver presents a much higher surface of ~167mm
2
 of surface area per gram of tissue 
(table 5). 
The difference between the oxygen needs by different cells is therefore an intimate parameter that relates 
with the design of the system. Table 5 presents an overview of some of the characteristics of organs within 
the human body. It is curious to note the fact that the cardiac output, or the amount of blood per minute 
that flows from the heart, is higher for organs with higher oxygen demand. A 70kg healthy man has a 
cardiac output of around 6L.min
­1
 (during vigorous exercise, this value can increase to as much as 500%) 
(Iversen 1997), and a quarter of it is actually directed to the liver (which represents only 2% of the body 
mass), while 20% goes to the kidney (0.4% of the body mass). These two organs are in fact the most 
oxygen­demanding: the kidney alone consumes over 100 times more than the BM per gram of tissue. 
Table 5. Representative values for the transport properties of some human organs in an average healthy human male with 70kg 
body weight. 
* Blood perfusion is given in volume of blood per unit time per organ volume; ** surface area per mass of organ available for contact between 
arterial blood stream and organ tissue; ***Calculated assuming organ is irrigated by capillaries with 10μm diameter with a blood average velocity of 
0.1cm.s-1 (King 2006); †Oxygen consumption rate of pancreatic islets of Langerhans only; ‡ In the rat; ¤value for the medulla in healthy kidneys, 
whereas the cortex has an ADC of 2.55 × 10-3 mm2.s-1 (Namimoto et al. 1999).
Organ 
Weight 
(g) 
Blood 
perfusion 
flow* 
(mL.min
­1
.g
­1
) 
Cardiac 
output 
(%) 
Oxygen 
consumption 
(μLoxygen.min
­1
.gtissue
­1
) 
Surface 
area per 
mass 
(mm
2
.g
­1
)** 
ADC 
(x10
3
 mm
2
.s
­1
) 
Bone 
marrow 
700 – 1750 
(Iversen 1997)
0.1 
(Iversen 1997)
3 
(Iversen 1997)
0.66 
(Peng and Palsson 1996)
2*** 
0.3 
(Berg et al.
1998)
Pancreas 
100 
(Williams and 
Leggett 1989)
0.6 
(Williams and 
Leggett 1989)
1 
(Williams and 
Leggett 1989)
1­2† 
(Sweet et al. 2002)
19‡ 
(Weaver 
1997)
1.94 
(Ichikawa et al.
1999)
Liver 
1,500 
(Plaats 2005)
1 
(Plaats 2005)
25 
(Plaats 2005)
22 
(Coritsidis 2008)
167 
(Nahmias 
2007)
3.45 
(Koinuma et al.
2005)
Kidney 
310 
(Williams and 
Leggett 1989)
4 
(Williams and 
Leggett 1989)
19 
(Williams and 
Leggett 1989)
68
(Coritsidis 2008)
70*** 
2.84
¤
(Namimoto et 
al. 1999)
Another parameter that can provide an idea on the mass transfer within human organs is direct 
measurement of the in vivo diffusion coefficients. However, because this can be affected by factors other 
than true diffusion, e.g., temperature, perfusion, magnetic susceptibility in the tissue, or other types of 
motion, the term “apparent diffusion coefficient” (ADC) rather than “diffusion coefficient” is used to refer 
to the water diffusion throughout the capillary network of in vivo organs (Ichikawa et al. 1999). This is the 
overall diffusion of water and is a specific characteristic of living tissues related to tissue perfusion by the 
blood (Le et al. 1986). Magnetic resonance imaging (MRI) is currently the best imaging method for the 
quantification of this parameter, which combines the effects of capillary perfusion and diffusion of water 
(Le et al. 1986; Sotak 2004; Koinuma et al. 2005). Observing the measured ADC values of different human 
tissues (table 5), it is possible to observe the difference in terms of blood irrigation in each of them, and 
hence their oxygen requirements. The BM (with an ADC of 0.3x10
­3
mm
2
.s
­1
) has a much lower blood 
irrigation than the other organs studied, which can be correlated with the lower oxygen consumption 
observed within this organ (0.66µLoxygen.min
­1
.gtissue
­1
).
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2.7. THE HUMAN BONE MARROW: A SPECIALIZED 3D ARCHITECTURE FOR IN VIVO BLOOD PRODUCTION
2.7.1. Structural organization 
The BM is a highly functional and complex organ within which a myriad of important biological processes 
take place in parallel, including the production of the majority of the blood cells in the human body. It is so 
sensitive and fundamental for life that resides within the protection of the bone shell (figure 12). It has an 
intricate three dimensional (3D) architecture that is highly vascularised, consisting of the central sinus, the 
sinusoid network, nutrient arteries, and the radial arteries, collectively known as the intra­vascular space 
(Ma et al. 2005). Within this vital organ, resident HSCs have the task to replenish the numerous blood cells 
that every day enter apoptosis in the body (in average, the body of a man weighing 70kg produces around 
10
11
 blood cells per day) (Cabral 2001). As every stem cell, these progenitor cells retain two characteristic 
functions: the ability to self­renew (thus the capacity to expand into greater numbers of cells) and to 
undertake differentiation (arising into the specialized and non­proliferative mature blood cells). These 
processes require a very specialized environment, where both physical and biochemical signals are 
important for their regulation as well as viability. 
Figure 12. The human bone marrow is a sponge-like structure found within the protection of the bone shell, and is responsible for 
the production of the blood cells that every day enter apoptosis in vivo (Adapted from:CRS 2010). 
A close and intricate net of different molecules and accessory cells that composes the HIM, promote the 
necessary biochemical support (Mantalaris et al. 2004c). On the other hand, an intricate three dimensional 
(3D) architecture provides the physical support, allowing a higher surface for cellular adhesion while 
promoting closer contact between the cells, not only to exchange biochemical signals between each other 
but also with the surrounding microenvironment (Mantalaris et al. 2004c). However, this 3D architecture 
has the downside of offering high resistance to the mass transfer required to renew this microenvironment 
(supply of nutrients, oxygen and other important molecules depleted during the cellular metabolism and 
removal of the metabolites, carbon dioxide and other debris). The high vascularization of the bone marrow 
allows overcoming this problem (Ma et al. 2005), being the blood vessels responsible for an in situ delivery 
of important metabolic reagents and removal of its products. 
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Figure 13 shows the well­organized architecture inside the BM that allows for the provision of an optimal 
environment within which HSCs undertake several steps until entering the blood stream as mature blood 
cells, through a transmembrane crossing of the venous sinusoid. The trabeculae – the site, within the bone, 
where bone marrow lays – and the BM stroma are the key elements that physically support and 
physiologically maintain the haematopoietic tissue (Panoskaltsis et al. 2005). A large number of cells that 
populate this organ benefit from this architecture, particularly because different conditions are provided 
depending on the distance the cell is from the blood vessel. The cellular distribution in the BM is roughly as 
depicted in figure 14, composed mostly of mature erythrocytes, mature lymphocytes and granulocytes 
progenitors (Chow et al. 2001). 
Figure 13. (A) Schematic diagram of the bone marrow structure and its blood vasculature to replenish the hematopoietic sites. (B) 
Schematic drawing of the bone marrow cellular environment indicating the stem cell niche and maturational niches towards the 
sinusoid. OB, osteoblast; HSC, hematopoietic stem cell; Gr, granulocyte; AD, adipocytes; MK, megakaryocyte; MΦ, macrophage; T, 
T cells; B, B cells; E, erythroid progenitors; RE, reticular endothelial cells (Panoskaltsis et al. 2005; Kaushansky et al. 2010). 
Figure 14. Typical cellular composition of the Bone Marrow in terms of the lineage-committed progenitor and mature blood cells, 
excluding adipocytes. Adapted from: Chow et al. 2001. 
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2.7.2. Oxygen gradients in the bone marrow 
Hypoxia is another feature of hematopoietic niches in the BM. Stem cell niches are often located in regions 
further away from the blood vessels and are characterized by their low oxygen tension (pO2). This is 
typically associated with the decrease of the rate of stem cell differentiation and enhancement of stem cell 
proliferative potential (Koller et al. 1992). Koller and colleagues cultured HSCs from UCB ex vivo under 5% 
O2 tension (Koller et al. 1992). They have found that several lineages of progenitor cells had a very high 
expansion rate under hypoxic conditions, and their differentiation and maturation were not triggered. A 
possible explanation could be that the low oxygen tension used is close to that in vivo in sites further away 
from the sinusoids, which could reduce the formation of oxygen­derived free radicals or increase the 
production of cytokines (Song et al. 2010a). Moreover, increased sensitivity to EPO in the Dexter culture 
(Dexter et al. 1977) when the oxygen level was reduced from 20% to 5% has been reported (Mantalaris et 
al. 1998). It has also been shown that the plasma EPO levels rise under hypoxic conditions, but begins to fall 
within 1−2 days, and returns to near normal levels after 3−4 days of sustained hypoxia (Mantalaris et al.
1998). 
The BM extra­capillary space is composed of several different types of cells (mainly, HSCs and progenitors 
and mature cells of different blood lineages, such as erythrocytes). As mentioned before, each of the 
different types of cells that populate the BM (as observed in figure 14) has a different metabolism with 
different oxygen needs. This is provided through a heterogeneous distribution of oxygen tension: due to 
diffusion limitations through the 3D tissue that composes this structure, the oxygen tension will decline 
with the increasing distance from the sinusoids. This originates the oxygen micro­gradients that nurture 
each cell type according to their specific needs (table 6) (Chow et al. 2001): whilst mature erythrocytes 
have a maximum specific oxygen uptake rate of 0.16x10
­14
 moloxygen.cell
­1
.h
­1
, megakaryocytes have an 
increase of almost 900­fold in the consumption rate, with about 144.0x10
­14
 moloxygen.cell
­1
.h
­1
, requiring the 
latter cell type to live closer to the blood vessels. 
Table 6. Cellular parameters of individual cell types in the bone marrow haematopoietic compartment. † interval corresponds to 
differences between progenitor and mature cells (Chow et al. 2001).
Parameter Erythrocytes Lymphocytes Granulocytes Monocytes Megakaryocytes Adipocytes 
Cell diameter (average) 
(µm) 
7.35 14.5 17.5 31.0 95.0 175.0 
Specific cell volume 
x10
9
 (cm
3
.cell
­1
) 
0.208 1.60 2.80 15.6 448.90 2806.0 
Max specific O2 uptake 
rate
†
x10
14
 (moloxygen.cell
­1
.h
­1
) 
0.162­0.649 0.07­5.0 2.2­64.9 2.2­64.9 144.0 32.4 
Max Volumetric O2
consumption rate 
x10
9
 (moloxygen.cm
­3
.s
­1
) 
8.7 7.1 64.4 11.6 0.89 0.03 
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2.7.3. General characteristics of the human bone marrow 
The BM of a healthy adult with 70kg body weight is characterized by the following features: 
 Weight: 700g – 1750g (Iversen 1997); 
 Cellular density: up to 5x10
8
 cells.mL
­1
 (Peng and Palsson 1996); 
 Total cell number: 500­1000x10
9
 cells (Timmins and Nielsen 2009); 
 RBC production rate: 0.1 blood units.day
­1
 (2x10
11
 cells.day
­1
) (Timmins and Nielsen 2009); 
 Blood perfusion flow: 0.1mL.min
­1
.g
­1
 (Iversen 1997); 
 Percentage of the cardiac output: 3% (Iversen 1997); 
 Oxygen consumption: 0.66μLoxygen.min
­1
.gtissue
­1
 (Peng and Palsson 1996); 
 Surface area of capillaries per organ mass: 2mm
2
.g
­1
, calculated assuming blood irrigation by capillaries with 
10μm diameter with a blood average velocity of 0.1cm.s
­1
 (King 2006); 
 Average serum levels of growth factors: EPO (0.2ng.mL
­1
) (Kaushansky 2006); IL­3 (0.03ng.mL
­1
) (Uppenkamp 
1998); GM­CSF (0.01ng.mL
­1
) (Uppenkamp 1998); SCF (3.3ng.mL
­1
) (Langley et al. 1993); TPO (0.3ng.mL
­1
) 
(Uppenkamp 1998); 
 Composition of the ECM (which has also been shown to be produced by cultured marrow stromal cells):
collagens I, III, IV, V, and VI, fibronectin, laminin, and other adhesive proteins, as well as large molecular 
weight proteoglycans such as syndecan, perlecan, members of the small leucine­ rich proteoglycan family 
including biglycan and decorin, and hyaluronan, a glycosaminoglycan (Chen et al. 2007); 
 Ex vivo consumption rates of growth factors by HSCs: EPO (0.82x10
12
nmol.cell
­1
.day
­1
); IL­3 
(1.71x10
12
nmol.cell
­1
.day
­1
); GM­CSF (2.54x10
12
nmol.cell
­1
.day
­1
); SCF (8.24x10
12
nmol.cell
­1
.day
­1
) (Koller et al.
1995); 
2.7.4. Bone marrow transplants 
According to the US Department of Health and Human Services, the average cost of an allogeneic or 
autologous transplantation in 2008 for a single BM transplant was around £423,000 or £188,000, 
respectively (Hauboldt and Hanson April 2008). A total of 19,526 transplantations were performed in that 
year alone in the US (Hauboldt and Hanson April 2008), this corresponds to a total annual bill of £5.6bn in 
BM transplants, which has been growing at a steady pace (figure 15). These are usually performed to 
recover the haematopoietic lineage of patients after radiation and chemotherapy, which was the first 
transplant type to use stem cells as a therapy, in the late 1950s (Thomas et al. 1957; Senegaglia et al. 2009). 
Figure 15. Bone marrow transplants performed in the United States per year, distinguished from autologous or allogeneic (Hauboldt 
and Hanson April 2008). 
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2.7.5. Cellular harvesting: the transendothelial crossing 
Methods for the ex vivo cell harvesting have been sought after due to limitations in current bioreactor 
designs in allowing the continuous production of RBCs for large­scale applications. The low cellular density 
that most bioreactors can support requires large initial volumes, which carry heavy costs alongside. One of 
the methods suggested in the literature, is by culturing the cells in suspension while promoting cellular 
differentiation and use a cyclic negative pressure in the culture chamber for discharging of the cells (Dutra 
2009). This would not allow distinguishing between different cellular products, and the stem cells would be 
discharged alongside the intended product. Moreover, the pressure required to harvest the liquid could be 
deleterious for cells, and particularly this would not allow the culture of the cells into 3D tissues. An 
alternative presented to reduce the bioreactor volume required by allowing a continuous cell harvesting of 
mature RBCs is by separating the mature cells from the culture media by partially or fully deoxygenating 
haemoglobin in the erythrocytes and afterwards attracting them to a surface using magnetic beads (Zhang
et al. 2011). The complexity of this technique is obvious, and would be unfeasible for 3D porous structures. 
Hence, the best method to perform this task could be by mimicking nature. 
The human BM is known to produce around 200 billion RBCs per day. One of its most important features is 
the capacity to release the cells it produces constantly into the blood stream (Liapis et al. 2002), in a 
process termed “transendothelial crossing” (at a rate of about 2x10
11
 RBCs.day
­1
). It is known as such 
because the walls of the vascular system replenishing the BM are composed of endothelial cells, specialized 
cells highly resistant to blood flow shear stresses and also capable of reorganizing to allow the crossing of 
RBCs (figure 16) (refer to section 2.6.2 in p. 51 for more information on the endothelial layer of vascular 
membranes). A marked deformation of other cells such as leukocytes has also been observed, which also 
traverse the endothelial layer particularly in sites of inflammation (Kaushansky et al. 2010). 
Figure 16. Scanning electron microphotograph of a normal murine red blood cell (red arrow) passing from a splenic cord (below) 
through the sinusoidal barrier and into the splenic sinusoid (above) (Narla 2006).
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The cell migration from the BM occurs between adventitial cells and through endothelial cell channels that 
develop at the time of cell transit (Kaushansky et al. 2010). This transmigration through the vessel wall is 
accompanied by a retraction of the adventitial cells to clear the surface of the endothelium, allowing cells 
to pass through, followed by the degradation of the subendothelial basement membrane (Laurie et al.
1982; Inoue and Osmond 2001), as observed in figure 17 (Liapis et al. 2002). The diameter of these gaps is 
around 3µm in capillaries and 2 to 3µm in the reticuloendothelial sinusoids. Being 7 to 8 µm sized, an 
erythrocyte is able to accomplish this task by elongating, tank treading, and otherwise deforming to pass 
through. Thus, during its 120­day life span, the erythrocyte must undergo extensive passive deformation 
and must be stable to resist fragmentation (Narla 2006). Progenitor cells are anchored to adventitial 
stromal cells through adhesion molecules, such as lectin. This close contact is gradually lost with the 
maturation of the cell, which could allow its migration towards the sinus wall (Kaushansky et al. 2010). 
Moreover, transient changes in the glycoproteins existing at the surface of the cellular membrane of 
maturing marrow myeloid cells decrease the strength of adhesion to stromal cells and fibronectin (an ECM 
protein) and may favour contact with endothelium, which in turn favours cellular egress from the BM 
(Kaushansky et al. 2010). 
Figure 17. (A) Transendothelial crossing of a red blood cell through an opening in the basement membrane; (B) serial section 
demonstrates the reconstruction of the endothelial gap after crossing of the red cell by filling the opening with vesicular cytoplasmic 
organelles and (C) reconstruction of the gap with endothelial lining covering the opening (Liapis et al. 2002).
Neutrophil­derived vascular endothelial growth factor (VEGF) is thought to increase endothelial 
permeability. In fact, topical administration or subcutaneous injection of VEGF in animals has been shown 
to induce endothelial gaps (transcellular pores) and increased permeability within 1–10 min (Burns et al.
2003). RBCs are known to deform into various shapes on account of flow forces and the size restrictions 
presented by the capillaries during transendothelial crossing (Jayavanth et al. 2008), whilst the BM itself 
has been shown to have a pulsatile pressure that promotes sufficient pressures to cause egress in transient 
periods (Kaushansky et al. 2010). This may also contribute to promote the deformation of the RBC 
membrane in order to cross the sinusoidal wall. On the other hand, the mechanical stresses that 
approximate the close­packing of cells within the BM may also facilitate the cellular egress, whilst being a 
necessary condition for proper maturation of red blood cells. The lack in promoting such forces within 
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bioreactors may explain why the production of healthy red cells has proven to be so challenging in vitro
(King 2006). 
The normal human RBC at rest has a biconcave discoid shape with a major diameter of about 8μm and a 
mean cell volume (CV) of around 90fL. The mean surface area (SA) of the cell is ~140μm
2
, which is 
considerably greater than the 97μm
2
 required to enclose a sphere with a volume of 90fL (Chien 1987). This 
excess surface area is a major factor in allowing the RBC to deform uniaxially at constant SA and CV under a 
variety of physiological conditions, including its deformation during transit through narrow capillaries and 
passage through the thin slits of splenic sinusoids. The deforming stress (force per unit area) is usually 
applied from outside the cell, e.g. by fluid shear stress or local membrane aspiration, but it can also 
originate from within the cell, e.g. RBC swelling in hypotonic medium or fibre formation in deoxygenated 
sickle cells (Chien 1987). 
The RBC membrane deformability, and its resistance to different pressures, has been the focus of several 
studies in literature. One of the many methods employed consists of forcing the cells through filters (e.g. 
polycarbonate sieves) with ≥3μm pores under constant pressure or constant flow (Chien 1987). The 
pioneering work in this field was accomplished by Gregerson et al. in 1967, who evaluated the resistance to 
flow of dilute suspensions of RBCs by the perfusion of polycarbonate sieves composed of cylindrical pores, 
typically 5μm in diameter (Chien et al. 1967; Lipowsky et al. 1993). In one experiment performed by 
Lipowsky et al. in 1993 polycarbonate filters composed of cylindrical pores with mean pore size of 5μm, 
13mm diameter and 11μm thickness were used. A constant flow rate of 2.06mL.min
­1
 through the 
membrane was employed and the deformability measured (Lipowsky et al. 1993). In another experiment, 
by Cabrales 2007, the same filter was used, and the pressure drop across it was measured. Using an 
haematocrit of 18% (i.e., a solution composed of 18 wt% RBCs), a flow rate of 500μL.min
­1
 of this solution 
through the membrane can be achieved with a differential pressure of around 3.5mmHg (~5mbar). The 
number of RBCs that crossed the membrane was not reported. The osmolality of the medium where the 
cells reside also plays an important role on the transendothelial crossing. An increase of this parameter 
leads to a decrease in the CV at constant SA, facilitating the passage of the RBC through narrower channels. 
Tests using polycarbonate sieves of 2.6μm have helped to conclude that the least resistance to filtration is 
actually achieved at 200mOsm.L
­1
 (Chien 1987). 
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2.8. EX VIVO BLOOD PRODUCTION (STATE OF THE ART) 
2.8.1. Expansion of haematopoietic stem cells 
HSCs can be used in the fields of gene therapy, tumour defecation, bone marrow transplantation, etc. 
Particularly, HSC transplantation, which is widely applied in hematopoietic functional reconstruction for 
cancer patients who have undergone radioactive therapy, has become a routine therapeutic method. 
However, the limited cell numbers from one unit of cord blood (CB) have up to now confine the clinical 
potential of HSCs. An effective way to solve this problem is by promoting the large­scale ex vivo
amplification of HSCs, especially of those expressing the CD34 phenotype (or CD34
+
 cells), which have been 
shown to be important in clinical practices for the treatment of blood disorders (Kondo et al. 2003; 
Robinson et al. 2005). Two different protocols for expansion of HSCs and their progenitors are currently 
used: culture in the presence of various exogenously added cytokines, and co­culture with stromal cells 
supplemented with cytokines. 
Stromal cells are composed of the adventitial reticular cells, endothelial cells, adipocytes and macrophages, 
consisting of layers of adherent cells that can be grown ex vivo from haematopoietic tissues (Morrison et al.
1995). These accessory cells have an important role in conditioning the environment in which expansion 
takes place, by producing themselves essential cytokines that regulate haematopoiesis (Cabrita et al. 2003). 
Many stromal cell lines have been used as feeder­layers, such as mesenchymal stem cells (MSCs) (Kadereit
et al. 2002; Zhang et al. 2004; Koh et al. 2005), human osteoblasts (Song et al. 2010a), human bone marrow 
(BM) stromal cells (Kohler et al. 1999; Silva et al. 2005; Kawano et al. 2006) and murine stromal cells 
(Takagi 2005). Cultures containing a stromal layer or stroma­derived factors have greater longevity and 
progenitor cell expansion in comparison to cultures without stroma (Pathi 2005). However, the harvesting 
of the stroma­containing cultures is labour­intensive and requires enzymatic treatment and the culture 
requires the introduction of foreign human or animal antigens to a graft product meant for human use, due 
to the origin of stromal cells, increasing the risks of cross­contamination and viral infection (Sandstrom et 
al. 1996; Panoskaltsis et al. 2005; Pathi 2005). Hence, alternatives to stroma­dependent cultures have been 
proposed, with evidences that ex vivo cultures in stroma­noncontact and stroma­free environments also 
maintain “long­term” engrafting cells, defined by their capacity to engraft secondary or tertiary hosts 
(Sandstrom et al. 1996; Lewis et al. 2001; Cabrita et al. 2003). Moreover, stromal cells can always be 
replaced by defined factors, by frequent medium exchanges, and by the addition of a sufficient amount of 
growth factors. 
On the other hand, culture with cytokines only has been shown to increase the total number of cells 
(Gammaitoni et al. 2003; Yao et al. 2003; Yao et al. 2004), but due to an incomplete understanding of the 
regulation of HSCs, it has been proven difficult to retain primary HSCs in their undifferentiated state, which 
dramatically reduces their expansion potential. Nevertheless, considering the disadvantages on the use of 
stromal cells, optimization of stroma­free cultures has seen a large focus from research groups. Cytokines, 
PhD Thesis by H. Macedo 
© Imperial College 2011 63
however, are usually very expensive to be added into the culture media, or excessive concentrations trigger 
uncontrolled differentiation of HSCs, which quickly start losing their stemness (Mohamed et al. 2006). For 
scale­up purposes, the use of these molecules could hence seriously hinder the development of a 
sustainable system for the production of blood cells, and therefore efforts have been made towards 
optimizing their use. Towards this aim, Blanco et al. 2009 have successfully grown human umbilical cord 
blood stem cells in a stroma­free and cytokine­free environment, through the support of 3D polymeric 
scaffolds. 
As examples of current technologies for the expansion of HSCs, three feeding strategies have been hand­
picked in order to compare with the in vivo conditions, and are summarized in table 7. The first chosen 
protocol resulted in one of the best expansion rates so­far for the ex vivo production of RBCs (Timmins and 
Nielsen 2009), proposed by Giarratana et al. 2005. This protocol used a static 2D fed­batch system, by co­
culturing CD34
+
 stem cells collected from human UCB with human or murine stromal cells, having achieved 
an expansion of up to 20x10
5
­fold of the initial seeded cells. 
Another culture system studied the expansion potential of HSCs for use in BM transplantations within 
spinner flasks, which provide a stirred suspension culture (Kim 1998). An initial cell density of 1x10
6
cells.mL
­1
 was supplemented with stromal feeders in combination with growth­promoting (IL­3 and SCF) 
and growth­inhibiting (MIP­1α) cytokines, resulting in an expansion of 17­fold over a 14­day culture period. 
Finally, a commercially available system was also used for comparison. Engelhardt et al. 2001 used the 
perfusion Aastrom RepliCell System for the expansion of mononuclear cells (MNCs) harvested from donor 
BM for transplantation into patients. A cassette with a total volume of 280mL was used for the 
experiments, within which 1.1x106 cells.mL­1 were cultured in direct contact with a stromal layer, 20% 
serum, 5ng.mL
­1
 GM­CSF­IL3 fusion protein, 25ng.mL
­1
 flt3 ligand and 100mU.mL
­1
 EPO. These conditions 
achieved a 4.5­fold expansion of the nucleated cells after 12 days of culture, without indication of the 
number of erythroid cells produced. All cultures described used a source of stromal cells to supplement 
further the provided GFs, and none of the systems used a 3D structure to provide a closer environment to 
the in vivo conditions. 
From table 7, it is possible to observe the under­optimized feeding strategies applied in the different 
culture systems used nowadays, which provide a large excess of GFs when compared to the serum levels in 
the human body. This originates a high increase in the costs associated to the expansion of stem cells as 
well as the difficulties in maintaining their stemness, as discussed above. 
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2.8.2. Ex vivo production of blood cells 
It was shown that the human BM has the plasticity to produce a large range of different cells, which all 
together compose the blood tissue. The importance of RBCs has already been discussed (with around 85 
million units transfused annually worldwide), whilst around 4 million units of platelets are transfused every 
year into patients who have difficulty exhibiting normal blood clotting, and mature granulocytes are 
required for patients with weaker immune system, such as during chemotherapy or the healing of burn 
wounds (Pathi 2005). Hence, the ex vivo targeted differentiation of stem cells towards blood cells could in 
principle alleviate this necessity. 
The maturation process of HSCs into fully mature RBCs is dependent on a large number of factors, being a 
very complex process that is not yet fully understood (Lu et al. 2008). For this reason, the ex vivo
production of fully functional enucleated RBCs has been very challenging, with a reported method to 
achieve terminal differentiation being the infusion of ex vivo produced cells into non­obese diabetic, severe 
combined immunodeficient (NOD/SCID) mice. After 4 days of infusion of the cells, the authors found that 
28% of the total cells in the peripheral blood of the mice were derived from the injected human cells, which 
mainly expressed adult haemoglobin while transporting O2 in a similar fashion to adult human peripheral 
blood RBCs (Neildez­Nguyen et al. 2002). One of the important factors regulating this process is the 
addition of EPO into the culture media, which enhances the differentiation pathway into the erythroid 
lineage (figure 18). This has been found to be a determinant factor in the development of RBCs, being used 
alone in the second of a three­stage protocol for the production of enucleated RBCs from CD34
+
 cells 
(Neildez­Nguyen et al. 2002; Douay and Andreu 2007). In fact, erythroid colony­forming units (CFU­E), one 
of the cell stages through which HSCs undergo during their differentiation pathway towards mature 
erythrocytes, has been found to be the most EPO­sensitive cell in the body (Devemy et al. 1994). 
Figure 18. Process of haematopoiesis, highlighting the steps that lead to the differentiation of HSCs into mature enucleated RBCs 
(erythropoiesis). Lineages: B/CFU = burst/colony forming unit, GEMM = granulocyte-erythrocyte macrophage and monocytes, Ba = 
basophil, Eo = eosinophil, Meg = megakaryocyte, E = erythrocyte, NK = natural killer. Adapted from: Lim 2008.
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However, the presence of EPO alone is not enough to promote erythropoiesis, as in vitro experiments have 
shown (Douay et al. 1991). Hence, other overseen factors are important to promote the differentiation of 
HSCs towards the erythroid lineage and enucleation of RBCs. Amongst these, the presence of macrophages, 
one of the cell types derived from HSCs, has been linked to this process: in vivo observations have shown 
that RBCs usually appear near macrophages, which in turn are responsible to degrade the nucleus after 
exclusion from within the cytoplasm of the erythrocytes (Miharada et al. 2006). Moreover, it was found 
that not only terminal differentiation, but also the proliferation of erythroblasts was significantly reduced in 
macrophage‐depleted erythroid cultures (Fujimi et al. 2008). 
Miharada et al. 2006 seeded 1x10
4
 UCB CD34
+
 cells.mL
‐1
 in 10mL serum‐free medium. The protocol 
involved a four‐step culture: in the first step, cells were cultured in the presence of 50ng.mL
‐1
 SCF, 
6,000mU.mL
‐1
 EPO, 10ng.mL
‐1
 IL‐3, 10ng.mL
‐1
 VEGF and 250ng.mL
‐1
 IGF‐II for the first 6 days; afterwards, 
50ng.mL
‐1
 SCF and 6,000mU.mL
‐1
 EPO only were used; next, cells were cultured in the presence of 50ng.mL
‐
1 SCF and 2,000mU.mL‐1 EPO for 6 days; the final step was dedicated to the full enucleation of RBCs by 
culturing the produced cells in IMDM supplemented with 0.5% Plasmanate® cutter (human serum), 
14.57mg.mL
‐1
 D‐mannitol, 0.14mg.mL
‐1
 adenine, 0.94mg.mL
‐1
 disodium hydrogen phosphate 
dodecahydrate, and 1mM mifepristone (an antagonist of glucocorticoid receptor). A percentage of 77.5% 
enucleated RBCs was found after the 20 days of culture, which was statistically higher than the cells 
cultured in the absence of VEGF and IGF‐II, two GFs that have been reported to promote the survival, 
proliferation and differentiation of hematopoietic progenitors (Miharada et al. 2006). 
Fujimi et al. 2008 seeded 500 UCB CD34+ cells on a monolayer of human telomerase catalytic subunit gene‐
transduced stromal cells (hTERT stroma) in a 75‐cm
2
 tissue culture flask with 10 mL serum‐free medium, 
supplemented with a cocktail of 10ng.mL‐1 SCF, 50 ng.mL‐1 TPO and 50ng.mL‐1 Flt‐3/Flk‐2 ligand. A four‐step 
protocol was required over the period of up to 34 days, wherein in the last step produced erythroblasts 
were co‐cultured with macrophages in the presence of 4,000mU.mL‐1 EPO to expand and promote full 
differentiation. This resulted in the production of 61% orthochromatic erythroblasts and 39% RBCs. The 
total cell expansion of 30x10
5
‐fold is regarded as the largest reported in literature (Fujimi et al. 2008). 
The three‐step protocol developed by Giarratana et al. 2005, and introduced above, involved seeding UCB‐
CD34+ stem cells  at a concentration of 10,000 cells.mL‐1 and culturing for 8 days in a serum‐free 
environment with 3,000mU.mL‐1 EPO, 5ng.mL‐1 IL‐3, 100ng.mL‐1 SCF; the second step lasted 3 days and the 
cells were cultured on top of a stromal layer with 3,000mU.mL
‐1
 EPO; finally, all GFs were removed and the 
cells were cultured for further 10 days on top of the stromal cells. A total cell number expansion of up to 
20x10
5
‐fold with 100% terminal differentiation into mature enucleated RBCs was observed after 21 days of 
culture. It is worth to note that this protocol, when performed in the absence of the stromal cells, achieved 
a 2x105‐fold expansion after 17 days of culture (10 times less than in the presence of accessory cells) with 
only 4% enucleated cells (Neildez‐Nguyen et al. 2002). These cells, however, reached full maturation after 
injection into NOD/SCID mice. 
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In another experiment, Slukvin et al. 2008 report the expansion of erythroid cells from CD31
+
 and/or CD34
+
cells. The cells were cultured in a serum‐free culture media (SFEM from Stem Cell Technologies) and 
supplemented with 0.3% of EX‐CYTE, 1mg.mL
‐1
 iron saturated transferrin, 10 
−6 
M dexamethasone and 
20ng.mL
‐1
 insulin in tissue culture flasks coated with HEMA, a polymer to prevent cell adherence. For the 
first 5 days, cells were cultured in the presence of 50ng.mL
‐1
 SCF, 2,000mU.mL
‐1
 EPO, 50ng.mL
‐1
 TPO, 
5ng.mL
‐1
 IL‐3 and 10ng.mL
‐1
 IL‐6. The subsequent incubations were performed in the same media with 
insulin, transferrin, dexamethasone, SCF and EPO only, with medium changed every second day. After 50 
days of culture, there was a (2×10
5
)‐fold expansion of erythroid cells, all expressing positively foetal (γ) and 
adult (β) haemoglobins, but not embryonic (ζ) haemoglobin. The erythroid cells proliferated in culture for 
up to 60 days, after which time they stopped proliferating and eventually died.  
Other blood cells also have an immense clinical potential and an increasing attention has been given to the 
ex vivo production of platelets and white blood cells. A very recent study by the Cha group (Lu et al. 2011) 
claims to have been the first in the world to produce human platelets from embryonic stem cells (Connor 
2011). The work claims that the embryonic stem cell‐derived platelets behaved like normal platelets and 
helped retract clots. Others, such as Sullenbarger et al. 2009, have also recently suggested the feasibility of 
continuously producing human platelets ex vivo from stem cells, through the use of synthetic 3D scaffolds, 
made of nonwoven polyester. 
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2.9. BIOREACTORS FOR STEM CELL BIOPROCESSING
The successful transfer of stem cell technology and cellular products into widespread clinical applications 
needs to address issues of cost, automation, standardization and generation of clinically‐relevant cell 
numbers of high quality (Placzek et al. 2009). Laboratories and industry alike have dealt with similar 
problems in the past through the use of bioreactors. Consequently, stem cell bioprocessing will involve the 
use of specialized bioreactor devices that need to facilitate mass transport, high cell density, monitoring 
and feedback, and tissue‐specific functional specialization, thus mimicking the ultimate bioreactors which 
are the tissues/organs within the human body. A successful culture environment would provide proper 
conditions for the proliferation and maintenance of viability of the cells of interest; depending on the final 
intention, it should also be able to provide conditions that can promote targeted commitment and/or 
differentiation in cases when these cells present such capacity. A particular case regards the expansion of 
stem cells, usually found in relatively low amounts in the adult body (adult stem cells) or requiring high 
numbers of embryo sacrifices. However, large numbers are usually required for clinical applications. This 
highlights the need for the in vitro expansion of stem cells prior to their commitment into tissue‐specific 
applications. And with Nature’s expertise accumulated over millions of years, it is worth to learn from it. A 
very interesting example of this can be seen in the human BM, whose engineering mimicry could open 
virtually unlimited doors of opportunities in the field of Medicine and life quality. The potential of 
bioreactors to mimic such structure is demonstrated by their capacity to support high cell densities in 
relatively small volumes, whilst the scaling‐up of the design, usually related with mass transfer limitations, 
will depend on the chosen type of bioreactor. 
The idea of an artificial BM is not a new concept, and in fact there are several reports of attempts to mimic 
its structure ex vivo (Lanza et al. 2000). The establishment of this concept was proven when Dexter et al.
1977 reported the successful culture of long‐term BM cells on flat 2‐dimensional (2D) surfaces. Well‐plates, 
tissue‐culture flasks (T‐flasks) (Mellado‐Damas et al. 1999; Liu et al. 2006), and gas‐permeable blood bags 
(Collins et al. 1998) are widely used in stem cell bioprocessing due to their simplicity, ease of handling and 
low cost, making them the ideal choice for research screening purposes as well as to engineer simple 
tissues, such as skin, bone and cartilage (Bilodeau and Mantovani 2006). However, even though the 2D 
culture of simple tissues such as skin, bone and cartilage have been reported successfully (Bilodeau and 
Mantovani 2006), these present a number of disadvantages. Lack of online monitoring, limitations in 
scaling‐up due to the limited surface area available for cellular growth per volume, as well as an inability to 
support complex cellular growth configurations result in a reduced applicability of 2D surface‐based 
systems for bio‐manufacturing towards clinical applications. Moreover, several groups have reported the 
higher increase in cellular productivity and quality when translating these cultures into 3D 
microenvironments (Sullenbarger et al. 2009). These 3D structures, made of a variety of matrices, such as 
nylon screens (Naughton et al. 1991) and natural and synthetic scaffolds (Placzek et al. 2009), closely 
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resemble the in vivo conditions within which cells proliferate, providing support for cellular growth and 
promoting better interactions between the microenvironment components (Mantalaris et al. 2004b), 
required in many clinically‐relevant cases. These have been shown to be more efficient when compared to 
their 2D counterparts (Mantalaris et al. 2004b) and to allow the structuring of frameworks for the 
development of 3D constructs (Ott et al. 2008). However, 3D cultures with their increased available surface 
area for cellular attachment and growth, higher cell density, and ability for higher cell expansion, face 
increased mass transport limitations. 
Table 9 presents a short summary with the relative comparison of the different bioreactor configurations 
for tissue engineering available in literature. Static cultures, the so‐called static bioreactors (Sardonini and 
Wu 1993), in which the “ingredients” – cells, nutrients, metabolites, oxygen and other important molecules 
– experience mass transport that is exclusively through the process of diffusion, resulting in an 
inhomogeneous environment that can support low cell densities and has a low total cell output 
(Panoskaltsis et al. 2005). To overcome the mass transport limitations of static cultures, bioreactors that 
can accommodate the dynamic culture conditions are required. Primarily, perfusion and stirring have been 
the main means for enhancing mass transport. Stirred suspension bioreactors require careful impeller 
design to avoid high shear stress that can damage the cells (Zandstra et al. 1994), can be operated either in 
batch or continuous mode, and result in at least a 10 fold increase in cell density than the traditional 
methods. The scaling‐up is usually straightforward due to the very good mass transport achieved by 
stirring. However, the flow environment created by the impeller renders them unsuitable for support of 3D 
constructs (Nielsen 1999), although the inclusion of porous microcarrier beads has been considered and 
studied (Zandstra et al. 1994). 
Several perfusion bioreactors have been designed to achieve a low shear stress environment as well as 
enhanced mass transport that facilitates the supply of nutrient and the removal of metabolites – perfusion 
rate having to be optimised based on cell type. A flat‐bed bioreactor has been developed containing 
grooves in the bottom, where cells could establish within the grooves and be protected from the 
perpendicular flow, thus allowing higher fluid velocities. This grooved‐bioreactor has been used for the 
expansion and maintenance of colony‐forming units granulocyte‐macrophage (CFU‐GM) progenitor cells 
and long‐term culture initiating cells (LTC‐IC) in the absence of stromal cells (Cabral 2001). Perfusion 
bioreactors have been automated providing continuous and automated feeding of the cultures. Aastrom 
Biosciences Inc. has developed a design whereby the cells are injected into a disposable cassette and grown 
on top of a previously established layer of stromal cells with nutrients being continually perfused to the 
cassette while a chamber, located just above, is filled with oxygen that diffuses to the cassette through a 
liquid‐impervious/gas‐permeable membrane (Armstrong et al. 1996; Palsson et al. 1997; Armstrong et al.
1999; Armstrong et al. 2000). The system has been used to expand bone marrow mononuclear cells (MNCs) 
and UCB cells for clinical applications. None of these bioreactors, however, are able to accommodate 3D 
growth producing constructs required in many tissue engineering applications.  
PhD Thesis by H. Macedo 
© Imperial College 2011 71
A Novel 3D Dual Hollow Fibre Bioreactor for the Production of Human Red Blood Cells 
© Imperial College 2011 72
A very important parameter in the design of bioreactors, as mentioned above, is the shear stresses cells will 
experience (King and Miller 2007). Shear stress is defined as the force exerted over the cells due to the flow 
of the media (Chen and Hu 2006), and a low rate has been described to result in cell clumping on aggregate 
and embryoid body cultures (leading to lower mass transport to the cells) (King and Miller 2007), while high 
rates could be deleterious for the cells. Different cell types have different sensitivities/necessities in terms 
of the shear stress rate. Thus, an optimal fluid velocity promoting the proper shear stress for the cell type 
being cultured is crucial. As an example, mammary epithelial stem cells aggregate cultures have an optimal 
shear stress that is approximate to the physiological value of 0.2Pa (King and Miller 2007), while endothelial 
cells can support higher rates, in the order of 2.0‐3.0Pa (Sarkar et al. 2007). On the other hand, it has been 
described that the mechanical stimuli promoted this way can be beneficial for certain cell types: shear 
stresses in the order of magnitude of 1.5Pa have promoted differentiation of embryonic stem cells towards 
the lineage of endothelial cells, when compared to static controls (Ahsan and Nerem 2006). Several 
bioreactors have been designed for promoting this scenario in vitro, by promoting controlled shear stress 
levels: using dynamic tension for growing and developing cardiomyocytes, mesenchymal stem cells, skeletal 
muscle and macrophages; compression for chondrocytes; and hydrodynamic pressure for bone cartilage 
(Korossis et al. 2005). Thus, optimal shear stress levels will depend largely on the cell type being 
grown/differentiated, as each type will have different sensitivities and/or stimulation needs (Palsson et al.
1993a). 
Several other bioreactor designs have been implemented with varying degrees of success. These include 
designs such as the packed or fluidized bed bioreactors (widely used for expansion of hepatocytes, 
cardiocytes, osteoblasts and others) (Portner et al. 2005) and the rotating wall vessel bioreactor (successful 
in the culture of HSCs, chondrocytes, cardiac cells, various tumour cells and others), which is a suspension 
culture adapted to provide a lower shear stress environment (Hammond and Hammond 2001; Liu et al.
2006). The main differences in their designs can be associated with mass transport (addressed either by 
diffusion, perfusion or bubbling), shear stresses (by developing ways to enhance mass transfer without 
increasing flow velocity or by which mechanical stimulation can be achieved), the ability to support 3‐D 
constructs or even the end‐purpose (research vs. large‐scale, cell type characteristics, etc.). 
A design that has been having a growing interest in the last few decades is the hollow fibre (HF) bioreactor 
(Ye et al. 2010). It was developed over 45 years ago by the early pioneers in Ultrafiltration (UF) technology, 
particularly for the production of pharmaceuticals. Long and straight HFs, typically polyethersulfone, are 
bundled into a housing and also used for concentration of beverages, cutting oils, water and even waste‐
water. This particular design is able to provide a low‐shear stress environment with still enhanced mass 
transport properties for an in situ delivery by diffusion of nutrients and oxygen to the cells, avoiding the 
shear stresses caused by perfusion. At the same time, the inclusion of membrane technology (further 
developed in section 2.10, p. 75) in the design highly increases the surface area per volume available for 
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cell growth (over 350 times that of a normal T‐flask, as observed in table 9, p. 71), thus allowing higher cell 
densities, whilst still promoting efficient mass transfer of nutrients, oxygen and other important signalling 
molecules. 
The idea of growing cells in HF bioreactors was introduced over thirty years ago (Knazek et al. 2008). 
Nowadays, this design has been widely used in the production of several different proteins from 
mammalian cells (Williams et al. 1997), for the production of cells and in tissue engineering applications, 
such as bioartificial organs (Gramer et al. 1999) and hemodialysis (Tzanakakis et al. 2000). Several 
breakthroughs have been made in the last few years towards the development of artificial organs using the 
HF type bioreactors, mimicking some of the most important organs in the human body, such as the 
bioartificial liver (Rozga et al. 1993; Bader et al. 1995; Gerlach et al. 1995; Wu et al. 1995; Bader et al. 1996; 
Tzanakakis et al. 2000; Legallais et al. 2001; Powers et al. 2002), the bioartificial kidney (Humes et al. 2004; 
Fissell et al. 2007; Tumlin et al. 2008) and the bioartifical pancreas (Monaco et al. 1991; Silva et al. 2006). 
As shown before, the possibility to maintain these systems at near tissue densities can result in an 
increased productivity, making high concentrations of both products and cells available (Williams et al.
1997). 
Cells are typically inoculated outside the fibres in the extracapillary (EC) space, whilst medium is circulated 
from a reservoir, through the fibre intracapillary (IC) space, and returned to the reservoir afterwards. The 
semi‐permeable HF membranes are usually characterized as ultrafiltrative (molecular weight cutoff of 10–
100 kDa) or microporous (0.1–0.2 µm pores) (Gramer et al. 1999). Yamazoe and Iwata 2006 demonstrated 
that dopaminergic neurons were effectively induced from embryonic stem (ES) cells enclosed in semi‐
permeable HF membranes. The paper suggested that differentiation of ES cells in HF bioreactors is a 
promising approach to realize cell therapy of Parkinson’s disease. This design has also provided a solution 
for many of the difficulties associated with hematopoietic stem cell gene transfer (Pan et al. 2004). It was 
shown that CD34
+
 progenitors could be cultured and transduced in an HF bioreactor without losing their 
CD34 identity while maintaining viability. Much higher transduction efficiencies were achieved in primary 
colony‐forming cells produced in the HF bioreactor compared with traditional gas‐permeable bags. 
A major drawback to this reactor design is the presence of axial nutrient gradients. As medium flows 
through the inlet of the fibre, the bulk nutrient concentrations start to be depleted and cells at the outlet 
end of the reactor may be non‐viable due to substrate exhaustion (Chresand et al. 1988). This problem can 
be overcome either by reducing the length of the bioreactor (and increasing the number of HFs to 
compensate) or increasing the inlet concentration of the molecule to be provided. Another major 
drawback, and a limitation of state‐of‐art technology to scale‐up production, is related to the harvesting of 
cells, after maturation. Due to the semi‐permeable properties of the membranes, the bioreactor usually 
requires to be sacrificed in order to access the area where cells are grown. In one study by Yu et al. 2003, 
this is somewhat addressed by adapting an outlet port that extends from the site where cells are growing, 
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allowing the periodic harvesting of cells. This kind of procedure, though, does not allow distinguishing 
ready‐to‐collect mature cells from the engrafting HSCs, thus increasing the necessary time to obtain 
clinically relevant numbers of cells. 
Figure 19 highlights the main characteristics of HF bioreactors when compared to other designs reported in 
literature (from table 9 in p. 71). As discussed above, this design offers a high surface area per volume of 
culture for cellular growth due to the packing of permeable hollow fibre membranes, which also heavily 
reduce the shear stresses on the cells caused by the flow of the media. These systems are usually easily 
scaled‐up (or scaled‐out if necessary) and promote a very good mass transfer throughout the cell culture 
environment, being one the most suitable of all the studied designs for 3D cultures. On the other hand, it 
was also discussed the limitations on this design, particularly the difficulties in removing cells after 
expansion. One of the main objectives of this thesis will be to address this issue. 
Figure 19. Advantages and disadvantages of hollow fibre bioreactors when compared to other designs (from table 9).
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2.10. MEMBRANE TECHNOLOGY IN TISSUE ENGINEERING
2.10.1. Introduction 
One of the main focuses of this project will be in the design of a suitable process to separate the growing 
undifferentiated HSCs from differentiated mature RBCs. The use of membrane technology to achieve this 
purpose appears to be one of the best solutions to tackle this problem, especially if one considers that this 
process in vivo is accomplished by a membrane (Grant et al. 1981; Inoue and Osmond 2001; Ribatti et al.
2007). On the other hand, all cells in our body, aside from being originated from the same stem cell, share 
another common denominator: all are surrounded by a (cellular) membrane. This was the way nature 
found to cope with the need for privacy of each cell, by establishing a boundary between its interior and 
exterior, allowing a controlled exchange of material between both sides, thus promoting the viability of the 
cell without the sometimes toxic influence of the surrounding molecules or by maintaining a biological 
homeostasis. This distinctive characteristic did not pass unnoticed, and a growing interest in this field has 
been seen since the 1960s, when synthetic membranes started to be implemented in a variety of medical 
products, such as haemodialyzers, blood oxygenators and plasma filters (Christensen et al. 1997). In these 
processes, a semi‐permeable barrier between two phases is used, which allows for the selective transport 
of components across it (figure 20) (Beerlage 1994). This barrier, or membrane, has the flexibility to be 
handled and adapted easily to a system as to be tailored according to the job to be performed, engineering 
it in order to render it permeable or impervious to certain molecule(s). Membranes will play a critical role 
in the next generation of biomedical devices, such as the artificial pancreas and liver. The market 
associated to this field has grown from £5 million to £1–1.5 billion in the 40 years prior to 2000 (Baker 
2001). 
Figure 20. Scheme of a semipermeable membrane during haemodialysis (Wikipedia  retrieved December 2006). 
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Membrane‐based processes find a large range of domains of applications for processing of liquids (figure 
21). Among their major applications are water desalination (electrodialysis or reverse osmosis), the 
production of tap water, the treatment of waste waters, the preparation of food, beverage, dairy or 
pharmaceutical products, the treatment and the recycling of industrial effluents, etc. Microfiltration and 
ultrafiltration separations are the most commonly used, although the field of nanofiltration has been 
growing at an increasing rate, particularly for applications in waste water treatment (Ayral 2007) and non‐
aqueous liquids for the recovery of organic solvents or catalysts in fine chemistry syntheses in the 
pharmaceutical industry (Livingston et al. 2003). 
Figure 21. Different application fields of membrane-based separations. Adapted from: Ayral 2007. 
2.10.2. Classification and characterization of membranes 
Membranes can be produced out of a variety of materials, being characterized by the main material in their 
composition: either of inorganic or organic origin. Polymeric membranes have been widely used in a variety 
of medical products, such as haemodialyzers, blood oxygenators and plasma filters Christensen et al. 1997. 
Polymeric membranes, made out of the repetition of several smaller carbohydrate molecules (the 
monomers), can be symmetric or asymmetric, with the difference being that asymmetric membranes 
present a gradient in pore size between a top layer and a bottom layer. The top layer can also be a non‐
porous (dense layer) or made from a different material. The latter are classified as composite membranes, 
as opposed to integral membranes, composed of a single material. The top layer determines the transport 
rate through the membrane, while the bottom layer provides support and mechanical strength. Symmetric 
membranes can be porous – formed either by long channel pores or by a porous spongy‐type structure – or 
non‐porous (i.e. homogeneous film) (Beerlage 1994). In industrial applications other than microfiltration, 
symmetrical membranes have been displaced almost completely by asymmetric membranes, which have 
much higher fluxes. Asymmetric membranes have a thin, selective layer supported on a more open porous 
substrate (Baker 2001). 
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Polymeric membranes are by far the most used type in tissue engineering, and in fact thought to play a 
pivotal role in this field, as many of its applications depend upon a core advantage: a well‐defined 
molecular weight cut‐off (MWCO) or size cut‐off. These semi‐permeable membranes serve as 
immunoprotective barriers to support cell growth and function, which allow nutrients, metabolic products, 
and wastes to diffuse through, but not immune cells or antibodies. On the other hand, scaffolds made out 
of these materials are used as support for tissue development ex vivo, which, after fulfilling the templating 
function and implanted into the patient, degrade and disappear, leaving nothing foreign to the biological 
system. The most common of these are the linear aliphatic polyesters, which include the copolymer poly 
(lactic acid‐co‐glycolic acid) (PLGA) that degrades through hydrolysis of the ester bonds in the polymer 
backbone. In addition to the biodegradability and biocompatibility, these polymers are among the few 
synthetic polymers approved by the FDA for human clinical applications such as surgical sutures and 
implantable devices (Ma 2004). 
Inorganic membranes, on the other hand, are composed of materials that render them thermally more 
resistant than polymeric membranes, thus offering some advantages in terms of stability, a characteristic 
that may reveal important for long‐period cultures and when sterilizing the material (where high 
temperatures can be used). On the downside, they are often brittle, lowering their mechanical strength, 
and are not suitable for post‐implantation, as they tend to have a lower degradability in vivo. Four types 
can be distinguished: ceramic membranes, glass membranes, metallic membranes, and zeolitic 
membranes. A number of companies have developed ceramic membranes for ultrafiltration and 
microfiltration applications, which are usually prepared by the sol‐gel process (Baker 2001). 
For porous membranes, the pore size distribution mainly manages the cut‐off of the membrane as well as 
the flow rates through the membrane. However for the retention of the smallest entities by the smallest 
pores, the transport mechanisms are more complex than simple sieving. Specific physical or chemical 
interactions become preponderant and settle the membrane selectivity. In order to determine the pore‐
size distribution of a porous surface, one of the most commonly used methods is mercury porosimetry 
(figure 22). This is based on the capillary law governing liquid penetration into small pores which, in the 
case of a non‐wetting liquid, such as mercury, is expressed by the Washburn equation: 
  	
 ∙  ∙  ∙  (1) 
In equation (1), dpore is the pore diameter, P the applied pressure,  the surface tension of mercury 
(485mN.cm
‐1
) and  the contact angle between mercury and the sample. The volume of mercury (V) 
penetrating the pores is measured directly as a function of the applied pressure, and hence the information 
provided by P vs. V provides a defined characterization of the pore structure, assuming this is round (Ayral 
2007). 
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Figure 22. Principle of mercury porosimetry, based on the interaction between mercury and the surface of the material to be 
analysed – due to the capillary principle, the smaller a pore is, the higher the pressure required to force the liquid to enter it (Ayral 
2007). 
Originally, membranes were developed to be used as flat‐sheets, but the majority of them can be adapted 
to produce membranes in the form of thin tubes or fibres, the so‐called “hollow fibres” (HFs). Formation of 
membranes in this design offers a number of advantages, one of the most important of which being the 
ability to form compact modules with very high surface areas (Baker 2001). The unique design of a HF 
module resembles the vascular system of the human body, which is capable of delivering directly the 
nutrients and important molecules to the cells, thus an interesting strategy to consider (Yu et al. 2003). In 
fact, membranes are deemed to play a critical role in the next generation of biomedical devices, such as the 
artificial pancreas and liver (Tzanakakis et al. 2000; Silva et al. 2006). 
2.10.3. Filtration techniques 
The main advantage on the use membranes, as described above, is the capacity to discriminate between 
different molecules, and thus being used in separation processes. Different filtration techniques are used to 
test their performance. Depending on the driving force used to allow mass transport across the membrane, 
the type of membrane process is defined. Filtration techniques for liquid/liquid separations, during which a 
solution containing dissolved or suspended molecules is forced or put through a membrane filter, involve 
four different processes: microfiltration, ultrafiltration, nanofiltration and reverse osmosis (figure 10), being 
the main difference related to the pore size of the membrane (Mulder 1997). The driving force in these 
processes can be due to a number of gradients between each side of the membrane: pressure, solute or 
solvent concentration, osmotic pressure, electric field, magnetic field and/or pH (Ayral 2007). 
Microfiltration is considered to refer to membranes with pore diameters from 0.1μm to 10μm that are used 
to filter suspended particulates, bacteria, or large colloids from solutions, which are larger than the pore 
size of the membrane. Ultrafiltration refers to membranes having pore diameters in the range 2–100nm, 
which are useful to filter dissolved macromolecules, such as proteins, from solution. Nanofiltration refers to 
separation processes in which particles and dissolved molecules smaller than about 2nm, such as inorganic 
salts or diluted organic molecules, are rejected. Finally, reverse osmosis membranes are made of pores so 
small, in the range 0.5–2nm in diameter, which are within the range of the thermal motion of polymer 
chains, which led to believe that these membranes may not even have permanent pores at all (composed 
of a dense matrix). These are used to separate dissolved microsolutes, such as salt, from water, e.g., in the 
production of drinking water from brackish groundwater or seawater (Baker 2001). 
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Table 10. Characteristics of the main membrane processes for liquid/liquid applications. Adapted from: Ayral 2007.
Process Pore size Origin of selectivity 
Pressure 
gradient (bar) 
Main applications 
Microfiltration 
(MF) 
0.1µm ‐ 10µm Sieving effect 1 ‐ 3 
clarification, debacterisation, 
separation 
Ultrafiltration 
(UF) 
2nm ‐ 0.1µm Sieving effect 3 ‐10 
clarification, purification, 
concentration 
Nanofiltration 
(NF) 
< 2nm 
sieving and interactions 
with the membrane 
10 ‐ 40 
purification, water softening, 
separation, concentration 
Reverse osmosis 
(RO) 
dense 
retention of solutes and 
permeation of solvent 
above osmotic 
pressure 
purification, water 
desalination 
There are different types of continuous flows used in membrane‐based separation devices, distinguished 
according to the International Union of Pure and Applied Chemistry (IUPAC) into the following categories: 
co‐current, completely‐mixed, counter‐current, cross flow and dead‐end flows (figure 23). For liquid 
applications, the most commonly used type is the cross‐flow (figure 23D), which has a reduced likelihood 
for membrane fouling due to the tangential flow filtration (Ayral 2007). 
Figure 23. Types of ideal continuous flows used in membrane-based separation devices. F- feed; R- retentate; P- permeate; S- 
sweep stream. Adapted from: Ayral 2007.
2.10.4. Membrane formation and preparation 
Several techniques exist for the preparation of membranes: sintering, stretching, track‐etching, phase 
inversion, sol‐gel process, vapour deposition, and solution cracking. A description of all these methods in 
better detail can be found elsewhere (Mulder 1997). The widely used polymeric asymmetric membranes 
are prepared by the phase inversion immersion precipitation method, in which a polymer solution is cast as 
a thin film on a suitable support, dried for a few seconds to create a dense top layer, and immersed in a 
coagulation bath containing a non‐solvent. The exchange of solvent and non‐solvent causes the phase 
separation and the precipitation of the polymer, and determines the morphology of the membrane and, 
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therefore, its performance (Mulder 1997). This method has the drawback of using toxic solvents which, if 
not dried/removed completely, could eventually harm the cells. Membranes produced through the phase 
inversion method have an asymmetric pore size distribution, which is beneficial for achieving good 
discrimination of certain solute sizes in ultra‐ and nano‐filtration (Vasconcelos 2010). However, when larger 
pores are used (e.g., for micro‐filtration of cells), a defined symmetric pore size would be more beneficial to 
allow better separation of the solutes of interest, and methods such as track‐etching are used. Membranes 
produced through this method are very thin with tightly controlled pore sizes, which are formed through a 
combination of charged particle bombardment (or irradiation) and chemical etching. 
Hollow‐fibre fabrication methods can be divided into two classes, solution spinning and melt spinning 
(Baker 2001). The most common is the solution spinning, in which a 20–30% polymer solution is extruded 
and precipitated into a bath of a nonsolvent, generally water, which allows fibres with an asymmetric 
structure to be made. An alternative technique is melt spinning, in which a hot polymer melt is extruded 
from an appropriate die and is then cooled and solidified in air or a quench tank. Melt‐spun fibres are 
usually relatively dense and have lower fluxes than solution‐spun fibres, but, because the fibre can be 
stretched after it leaves the die, very fine fibres can be made (Baker 2001). 
2.10.5. Membrane materials 
The materials with which to design the membranes to be used are very important, not only due to the 
characteristics to be achieved, but also because of the desired end‐purpose of the bioreactor (red blood 
cells for transfusion into human recipients). Stability of these membranes for long‐term contact with the 
growing cells is an essential requirement, so toxic or carcinogenic materials should not come into contact 
with the cells. At the same time, it has also been described that HSCs are very sensitive themselves to the 
materials used for their expansion (Nielsen 1999). Testing a range of commonly used materials (15 
polymers, 4 metals, and glass), LaIuppa et al. 1997 found that only a few substrates (polycarbonate, Teflon, 
titanium, and polymethylpentene) supported HSCs development. On the other hand, hollow‐fibre 
membranes used to date, for this type of applications (e.g., haemodialysis), have been composed of 
polymers such as cellulose (regenerated cellulose, chemically modified cellulose, etc.), polyacrylonitrile, 
polymethylmethacrylate, polysulphone, polyethyl vinyl alcohol, polyamide and others (Oishi and Hanai 
2006), making this range a good starting point to start assessing the best approach to design the required 
membranes. 
On the other hand, only in the 1990s membrane materials resistant to organic solvents started to become 
widely available, which were primarily used in the food and refinery industries (Baker 2001). Since then, 
different techniques have been studied to render a wider range of materials better resistance to dissolution 
in contact with organic solvents, such as chemical crosslinking or materials with better chemical stability, 
such as poly(ether sulfone), polyacrylonitrile, poly(vinylidene fluoride), polypropylene, polyamide, 
polyimide, polybenzimidazole, etc. as well as inorganic membranes (Vandezande et al. 2008). 
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2.10.6. Polyacrylonitrile 
A polymeric material that has found a large range of applications, particularly in the pharmaceutical 
industry, is polyacrylonitrile (PAN). This is a polymer that presents excellent properties, such as good 
thermal and mechanical stability, tolerance to most solvents and commercial availability (Zhang et al.
2010), and hence are a very good candidate for solvent contact. It is made of long chains of the acrylonitrile 
monomer (figure 24) and used for applications particularly in the ultrafiltration field, such as pervaporation, 
water treatment, enzyme immobilization and haemodialysis (Wang et al. 2007). It is one of the best 
biocompatible polymers known, however clotting problems due to blood coagulation have been observed, 
and studies to improve the haemocompatibility of these membranes have been published – e.g. by 
immobilizing the surface of the membranes with Chitosan‐Heparin conjugates, it was demonstrated that 
the blood compatibility could be improved (Yang 2002). 
Figure 24: Monomer of polyacrylonitrile.
A common problem found with polymeric membranes is their tendency to foul due to protein adsorption, 
and PAN membranes are not an exception (Valette et al. 1999). Modifying their surface towards more 
hydrophilic characteristics renders them less prone to protein fouling (Jung 2004). On the other hand, 
different approaches have been presented in literature to reduce the pore size of PAN membranes, in order 
to render them more suitable for filtration of specific solute sizes. Both these features can be achieved 
through surface modifications such as hydrolysis (Yang and Tong 1997), annealing (Kim et al. 2002; Jung et 
al. 2005), change of the coagulation bath or the dope solution composition (Kim et al. 2002), plasma‐
initiated graft polymerization and photo‐induced grafting (Zhang et al. 2010). Among these methods, 
surface hydrolysis is one of the most important and most frequently used methods for PAN‐based 
membranes, due to the convenience and favourableness for further modification (Zhang et al. 2010). Both 
acidic and alkaline hydrolysis of PAN fibres have been reported in literature, although the reaction rate in 
acidic conditions is much slower than that in alkaline conditions (Yang and Tong 1997; Deng et al. 2003). 
Alkaline hydrolysis of PAN fibres, which reacts with the nitrile functional group (–C≡N) of the monomer, 
produces compounds that may include those with conjugated sequences of –C=N–, acrylamide, sodium 
acrylate, and amidine from different stages of the hydrolysis (Deng et al. 2003). Nevertheless, the two most 
important products of this hydrolysis are polyacrylamide (PAAm) and polyacrylic acid (PAA), as shown in 
figure 25 (Yang and Tong 1997). Both these molecules are hydrophilic (PAA is also ionisable in water), which 
is in the origin of the hydrophilic performance of PAN membranes after this treatment (Yang and Tong 
1997). 
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Figure 25: Mechanism of PAN hydrolysis by NaOH according to Yang and Tong 1997. Two products are formed as part of the 
hydrolysis of the nitrile group – polyacrylamide (PAAm) and polyacrylic acid (PAA) (Yang and Tong 1997). 
PAN with a certain content of carboxylic groups (–COOH) is easily swollen when exposed to aqueous 
medium. The swollen macromolecules then become more mobile to move towards the pores, decreasing 
the pore size and making the membrane surface smoother (Wang et al. 2007). The kinetics involves not 
only chemical reaction, but also the diffusion of reactants and products. The growth of the resulting 
carboxylic groups with time of hydrolysis is shown in figure 26, which is followed by the production of a thin 
PAA layer on the membrane surface (the layer thickness is proportional to the ionic density). In general, the 
surface density of the carboxylic groups increases with time, temperature and the concentration of the 
NaOH solution (Yang and Tong 1997). After treating with 1M NaOH at 80°C for 25 min, the charge density 
on the surface of PAN hollow fibre can reach 0.27µmol.cm
‐2
. Reaction with higher concentrations of NaOH 
is too vigorous, and can cause severe degradation of the hollow fibres (Yang and Tong 1997). 
Figure 26. Change of the surface density of carboxylic groups with time for hydrolysis in 1M NaOH at three different temperatures 
(Yang and Tong 1997).
Linder et al. 1991 patented a modified PAN solvent stable membrane that could reach nanofiltration 
MWCOs (~600 Da). The membrane was prepared by dissolving PAN in DMF (15% wt.) and then cast onto 
polyester backing by phase inversion in iced‐cold water. This PAN support membrane was then cross‐linked 
by immersion in a 1% (wt/v) sodium ethoxide solution (5 min), drained and then heated to 115 °C for 30 
min. The rejections reported for this modification were 45% for raffinose (~600 Da) and 94 % for dextran 
70kDa at 14bar. After this treatment the membrane was no longer soluble or swellable in DMF, NMP or 
DMSO. Further treatment with diazonium solution and NaOH, crosslinking with cyanuric chloride and 
treated with polyethylene‐imide allowed the production of an even tighter membrane (99% rejection of 
raffinose and Congo red). 
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Wang et al. 2006 reported the production of PAN nanofiltration membranes after treatment with ZnCl2 and 
subsequent hydrolysis of the nitrile groups with NaOH. The ZnCl2 molecule was found to act as a filler to 
reduce the pore size and to prevent the membrane collapse upon heating. The post‐treatment with NaOH 
reduced the membrane pore even further by replacing some of the nitrile groups with bulkier carboxylic 
groups (figure 27). The rejection observed for NaCl in a NaOH treated membrane varied from 25‐40% for 
pressures varying from 6‐17 bar, respectively. 
Figure 27. Preparation of nanofiltration PAN membranes according to Wang et al. 2006. 
Musale and Kumar 2000 investigated the performance of chitosan/PAN composite membranes cross‐linked 
with glutaraldehyde (Gt). The PAN membranes (14wt% in DMF) were prepared by phase inversion using 
water (room temperature) as the non‐solvent. Then the membranes were soaked in a chitosan solution in 
acetic acid (0.3 M), cured in an oven at 50 °C for 24h, and then treated with aqueous NaOH. The membrane 
was cross‐linked with different Gt concentrations 0.02, 0.08 and 0.2%, and during different times 0.5, 1 and 
1.5h. The rejection was measured using aqueous PEG solutions (200‐1500 Da) and analysed by total organic 
carbon (TOC). It was found that the membrane water flux decreased with the increase in Gt concentration. 
The MWCOs observed for the cross‐linked membranes (30 min) were 1500, 700, 550 and 550 Da for 0, 
0.02, 0.08 and 0.2% Gt concentration, respectively. 
Oh and colleagues tested the effect of NaOH treatments on the permeation of PAN/NMP support 
membranes (prepared by phase inversion in water) (Oh et al. 2001a). The PAN membranes were prepared 
with different compositions in NMP 10, 15 and 20% (wt.), and were subjected to different aqueous NaOH 
concentrations (0.1, 0.5, 1 and 2 M) for several time periods (0.5, 1, 2 and 3h). The rejection tests were 
performed with a PEG 35kDa aqueous with operating pressures between 1‐5 bar. The rejection observed 
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for PEG 35kDa was 60% for the unmodified PAN membrane, and 80% for the membrane treated in 2M 
NaOH for 3h (tightest membrane), with an average water flux of 2 m
3
 m
‐2
 h
‐1
. Similarly to what was 
observed by Wang et al. 2006, the NaOH treatment (increasing concentration and times) was found to 
increase the solute rejection and reduce the water flux. This was due to the reduction of the pore size 
caused by the formation of the carboxylic groups. Table 11 presents a summary of the different 
modifications introduced into the PAN membranes presented in this literature review. 
Table 11. Different protocols for PAN membrane modification. 
Reference 
PAN 
(wt%)
Solvent 
mixture 
Coagulation 
bath 
Modification MWCO Test Rejections 
Linder et al.
1991 
15 PAN/DMF water 
Cross‐link with 
sodium ethoxide 
Dextran 70kDa 
at 14bar 
94% 
Wang et al.
2006 
15 
PAN/DMF + 
PVP 
(additive) 
water 
ZnCl2 treatment; 
NaOH hydrolysis 
Aqueous NaCl 
solution at 17bar 
40% 
Musale and 
Kumar 2000 
14 PAN/DMF water 
Chitosan coating; 
cross‐link with 
glutaraldehyde 
Aqueous PEG 
solutions 
600 Da 
(90%) 
Oh et al. 2001b 
10, 
15, 20 
PAN/NMP water NaOH 
PEG 35kDa 
at 1‐5bar 
80% 
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2.11. IMPLICATIONS OF THE LITERATURE REVIEW TOWARDS THE EX VIVO PRODUCTION OF HUMAN RED 
BLOOD CELLS
The literature review has allowed identifying the major gaps in the state‐of‐art technology in what concerns 
to the development of 3D platform beds for stem cell bioprocessing. Taking into consideration that the 
ultimate bioreactors are indeed the tissues and organs within our bodies, which in turn present a well‐
organized 3‐dimensional structure to support and nourish the cells they house, tackling the mass transfer 
issues that arise with the scaling up of 3D scaffolds could in principle provide better productivity to current 
bioreactor technologies. Moreover, issues of space and cost for the expansion of clinically relevant cell 
numbers have also hampered the translation of stem cell‐based technologies from the lab bench into the 
clinic, with bioreactors requiring a “multi‐step” approach being proposed as state‐of‐the‐art (Pettigrew and 
Kelley 2008), which would seriously compromise large‐scale production. On the other hand, the hurdles 
tissue engineers and biologists have been finding in the development of novel and improved bioreactors, 
have been in the minds of chemical engineers for longer (in fact, this is proven with the widely available 
fermenters, e.g. for beer production). The combination of different fields of research is hence crucial for 
the development of novel technologies. With this thesis, it is proposed to combine the selectivity 
properties of membrane technology with an in vivo mimicry of the human BM in most of its features, 
towards the development of a simpler and more cost‐effective system for the production of clinically 
relevant red blood cell numbers. 
The literature review presented has provided an indication of the engineering challenges that need to be 
overcome for the development of an artificial biomimicry of the BM as the ultimate bioreactor for the 
production of clinically‐relevant blood cell numbers. These are summarized as follows: 
1) Mass transfer limitations to nourish and renew 3D structures; 
2) The production of enucleated red blood cells in an ex vivo environment without the use of 
feeder cells; 
3) The continuous production and selective harvesting of mature functional cells; 
4) The provision of abnormally high concentrations of GFs due to the feeding strategies used, 
which triggers early differentiation of stem cells (reducing productivity) and increases the 
manufacturing costs (exogenously‐added GFs, essential to provide an animal‐derived serum‐
free environment in order to reduce the possibilities for contamination, have costs that can 
reach up to £45,000 per mg); 
The recent reviews found in literature on the large‐scale ex vivo production of RBCs highlight two major 
points (Douay and Andreu 2007; Timmins and Nielsen 2009): if on one hand the potential of tissue 
engineering to answer to blood shortage has not yet been realized, on the other hand the successful proof‐
of‐concept by many research groups around the world has been achieved, lacking only the proper 
translation into the manufacturing scale. Solving the issues of space and costs that have been overviewed 
in the literature could in principle bring this technology one step closer to the bed side. 
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CHAPTER 3 
CHAPTER 3.
MATERIALS AND METHODS
“The enormity of your problems is nothing compared with your ability to solve them. 
By overestimating them, you underestimate yourself.” 
Apoorve Dubey 
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3.1. INTRODUCTION
This chapter encompasses the materials used and the experimental methods applied to study 
3.2. MATERIALS
3.2.1. Membranes purchased 
To screen different membrane materials and test their suitability to be used in this project, the following 
membranes were used: two types of polyethersulphone (PES) with a MWCO of 5 and 10kDa, respectively, 
purchased from Sartorius, UK; two types of regenerated cellulose (RC) with MWCO of 5 and 10kDa, 
respectively, purchased from Millipore, UK; and a polycarbonate track etch flat‐sheet membrane with 2µm 
nominal pore size, purchased from GE Osmonics Labstore, USA. 
3.2.2. Materials for the preparation of ceramic hollow fibres 
Aluminium oxide powders 1µm (alpha, 99.9% metal basis, surface area 6–8m
2
/g), 0.3µm (gamma–alpha, 
99.9% metal basis, surface area 15m
2
/g), 0.05µm (gamma–alpha, 99.5% metal basis, surface area 32–
40m
2
/g) and 0.01µm (gamma–alpha, 99.98% metal basis, surface area 100m
2
/g) were purchased from Alfa 
Aesar (a Johnson Matthey company) and were used as supplied. Polyethersulfone (PES, Radal A300, Ameco 
Performance, USA), N‐methyl‐2‐pyrrolidone (HPLC grade, Rathbone) and Arlacel P135 (Polyethyleneglycol 
30‐dipolyhydroxystearate, Uniqema) were used as binder, solvent and additive, respectively, in the 
preparation of the dope solution for the alumina hollow fibres (HFs). Tap water and deionized water were 
used as the external and internal coagulants, respectively for the preparation of the alumina HFs. 
3.2.3. Manufacture of a water-filled U-tube manometer 
In order to measure the pressure difference between two streams, an artisanal manometer in the shape of 
U‐tube was built (figure 28). This is an inexpensive method for the quick measurement of pressure 
differences between two streams, particularly when they are within low values – the designed manometer, 
composed of two 1mL measuring pipettes in each side, can measure a maximum of 150mm of water 
pressure difference (or 15mbar). The pressure differential (ΔP) in a vertical water‐filler U‐tube can be 
expressed as: 
hghP ..  (2) 
where: 
ΔP = pressure difference between both sides of the u‐tube (kPa) 
γ = specific weight of the fluid in the tube (γwater= 9.81kN.m
‐3
) 
ρ = density (ρwater= 1kg.m
‐3
) 
g = acceleration of gravity (9.81 m.s
‐2
) 
h = liquid height difference between both sides of the u‐tube (m) 
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Figure 28. U-tube designed for the measurement of pressure difference between two streams. 
3.2.4. Installation of the TIPS system for production of the scaffolds 
The production of the physical 3D scaffolds (or scaffolding process) where cells can adhere onto was 
prepared by thermally induced phase separation (TIPS) with subsequent solvent sublimation, as described 
elsewhere (Safinia et al. 2005) and further detailed in section 3.6.2 (p. 99). The process involves dissolving 
the desired polymer in a solvent to achieve a 5‐8wt% solution by overnight stirring, followed by freezing of 
the solution on a temperature‐controlled cryo‐freezer at ‐86°C for 2h and then using a cryostat bath at a 
constant temperature of ‐15°C and vacuumed to 10‐2 mbar until all the solvent has been sublimated. To 
allow the production of the scaffolds in the laboratory, a TIPS system was designed and installed (figure 29 
and specifications in table 12). Taking into consideration the production steps, it required three main 
components: a temperature‐controlled cryostat bath, a vacuum pump and a solvent trap to collect the 
sublimated solvent from the scaffold. The designed system was then tailored to allow the production of 
small polyurethane scaffolds (using the lyophilisation flask depicted in figure 29) or internal scaffolds on the 
hollow fibre bioreactor (through luer‐lock tubing fitted to the vacuum pump). 
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Figure 29. Setup of the TIPS system, with the main components depicted. A- cold trap; B- lyophilisation flask; C- vacuum pump; D- 
cryostat freezer; E- polyethylene glycol (PEG) cryostat bath; F- temperature controller; G- mobile arm of the cryostat freezer in 
contact with the PEG bath.
Table 12. Specifications of the different TIPS components installed. 
Component Manufacturer 
Power 
consumption 
(W) 
Dimensions 
(WxHxL) 
(mm) 
Description 
Cold trap 
KGW Isotherm 
(SL 29GL‐Z) 
‐ ‐ 
Cold trap and Dewar type 18C to 
collect sublimated solvent 
Vacuum pump 
Leybold 
(TRIVAC D 2,5 E) 
250/300 127x225x383 
Dual‐stage oil sealed rotary vane 
vacuum pump, nom. speed of 
1400/1600rpm 
Cryostat freezer 
(dip cooler) 
Techne 
(RU‐500) 
230 370x325x430 
Consists of a refrigeration unit 
where the evaporation coil is on a 
flexible hose and placed in the 
liquid and heat is extracted as the 
coil cools 
Cryostat bath Techne ‐ 325x222x505 
B‐26 stainless steel bath, 26L 
capacity with polyethylene glycol 
Temperature 
controller 
Techne 
(TU‐10D) 
1000 124x260x237 
Heat, circulate and safely control 
the temperature of the liquid in 
the bath within precise limits; 
temperature range from ‐40°C to 
+120°C 
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3.3. HIGH-UPTAKE MEMBRANE DEVELOPMENT
3.3.1. Diffusion-driven permeability to glucose and rejection to α-lactalbumin of PES and RC flat-sheet 
membranes  
Permeability to glucose and rejection to α­lactalbumin (α­L) of the PES and RC flat­sheet membranes by 
diffusion were performed using the setup depicted in figure 30, with an effective filtration area of 7.1cm
2
. A 
more detailed description of the flow rig where the contact between both streams takes place through the 
membrane is presented in figure 31. Four different membranes were evaluated using this test: PES with 
MWCO of 5 and 10kDa, purchased from Sartorius, UK; and RC with MWCO of 5 and 10kDa, purchased from 
Millipore, UK. Membranes were preconditioned overnight in phosphate buffered saline solution (PBS, from 
Invitrogen, UK) prior to use. The setup depicted can only be used to analyse one membrane at a time, by 
inserting it between the two teflon spacers of the setup, and closing the flow chamber (figure 31) using the 
screws provided. This was then assembled as depicted in figure 30. For each experiment, side A was filled 
with 30mL of ca. 1,100mM D­glucose (Sigma­Aldrich, UK) and 16.8μg.mL
­1
 of α­L (Sigma­Aldrich, UK) in PBS 
whilst side B contained 30mL of PBS only. All experiments were performed at buffered pH 7.4, under a 
controlled temperature of 37°C and fluid recirculation in each side by peristaltic pumps at a constant 
rotational speed of 5rpm (flow rate of ca. 108mL.h
­1
). Each membrane was tested independently, by 
allowing both sides A and B to reach concentration equilibrium. For fouling experiments with serum 
proteins, only PES from Sartorius with 10kDa MW membranes were used, with the same conditions 
described above with the following changes for three different experimental conditions: i) normal filtration 
without adding bovine serum albumin (BSA, from Sigma Aldrich, UK); ii) filtration by adding BSA at a 
concentration of 10mg.mL
­1
 to both sides of the membrane for a period of 26 hours; and iii) filtration 
without adding BSA, using the membrane from the previous experiment ii). At least 7 samples from each 
side were collected during the experiments and the concentration of glucose and α­L in each side of the 
membranes measured. The concentrations of α­L were measured using a sandwich­ELISA method, as 
detailed in section 3.10.2 (p. 110). Glucose concentrations were measured using a Glucose assay kit 
(Product no. 10009582 from Universal Biologicals, UK) following the manufacturer’s instructions. Briefly, 
5μL of glucose standard (concentration range 0 to 25mg.dL
­1
) or unknown sample replicates were loaded 
into eppendorf tubes with 1.5mL volume. Afterwards, 500μL of the (1X) Enzyme Mixture was pipetted into 
each tube, tapped for a couple of times to mix thoroughly and placed into an incubator at 37°C for 10min. 
Afterwards, the tubes were removed from the incubator and 150μL from each tube was loaded into a well 
of a 96­well plate and the absorbance at 500nm read on a plate reader (ELx808, BioTek Instruments Inc., 
US). Microsoft Excel 2010 (Microsoft Co., USA) was then used to fit a linear trend line to the standard 
values by plotting the absorbance reading at 500nm for each glucose standard vs. its concentration in 
mg.dL
­1
. The standard curve was then used to determine the glucose concentration of each unknown 
sample. 
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Figure 30. Experimental setup, for the rejection studies across the tested membranes using co-current and recirculation of the liquid. 
PA and PB is where the U-tube manometer is connected to measure the pressure differential between these two points of the 
process. The shaded area of the setup is putted inside a temperature-controlled incubator at 37°C. 
Figure 31. Experimental flow rig used for the rejection studies across the flat-sheet membranes: A- overall view; B- exploded view of 
the flow chamber components, which is divided into two sides (A and B) by a centrally-positioned membrane through which the 
diffusion of molecules takes place. 
3.3.2. Development and characterization of polyacrylonitrile membranes 
3.3.2.1. Preparation of PAN flat­sheet membranes 
Polyacrylonitrile (PAN) membranes were prepared by the phase inversion method, both to produce the 
flat­sheet and the hollow fibre configurations. PAN (Scientific Polymer, USA) with CAS number 25014­41­9 
and app. MW of 150kDa was vacuum­oven dried overnight and then dissolved in anhydrous 
dimethylformamide (DMF, Sigma­Aldrich, UK) in a 100mL vessel sealed with a cap and covered with 
parafilm at 70°C overnight. Solutions of ca. 60mL with varying concentrations of PAN in DMF were 
prepared: 13wt% (7.8g of PAN + 52.2g of DMF); 15wt% (9.0g of PAN + 51.0g of DMF); and 18wt% (10.8g of 
PAN + 49.2g of DMF). Afterwards, when the solution turned from white opaque to transparent yellow, they 
were transferred into 50mL centrifuge flasks, and centrifuged at 4000rpm for 40min at 30°C. The dope 
solution was then left to de­gas for at least 5h, and then the membranes were cast using an automatic 
casting machine in polypropylene (PP) backing with a 200nm thickness casting knife. The films were then 
immediately transferred into a deionized water bath for phase inversion, and kept in deionized water 
overnight before filtration experiments or surface modification. 
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3.3.2.2. Preparation of PAN hollow fibre membranes 
A dope solution composed of either 13, 15 or 18wt% PAN in DMF was prepared as previously described 
(section 3.3.2.1). After centrifugation at 4000rpm for 40min at 30°C, the polymeric solution was fully 
degassed in a vacuum chamber for one hour, transferred into a 200mL stainless steel syringe and extruded 
through a tube­in­orifice spinneret (orifice­diameter / inner­diameter of 1.0/0.7 mm) into an external 
coagulant bath containing tap water. The internal coagulant was deionized water. The extrusion rate of the 
spinning polymeric solution and the flow rate of the internal coagulant were controlled by Harvard syringe 
pumps (Harvard Apparatus, model PHD 2000, Instech, USA) and were set to 2mL.min
­1
 and 1.5mL.min
­1
, 
respectively. The air gap was set to 20cm during the spinning. To complete solidification, fabricated hollow 
fibres were kept in a deionized water bath for at least 24 hours, before further treatment. For storage in 
water, PAN membranes were dipped in 0.5% aqueous formalin (or 0.2wt% paraformaldehyde) solution at 
4°C until further use, in order to avoid any bacterial or fungi growth on the membrane surface during 
storage (Lohokare et al. 2006). Formalin solution is prepared by adding 6g of paraformaldehyde (Sigma­
Aldrich, UK) to 3L of deionized water and immersing the membranes in this solution and stored in the fridge 
(formalin 100% is defined as an aqueous solution of formaldehyde at 40wt%). 
3.3.2.3. Annealing of PAN membranes 
To conduct experiments wherein PAN hollow fibre membranes required annealing, these were placed 
inside a temperature­controlled distilled water bath at 96°C for 10s and immediately transferred into cold 
distilled water (at 4°C), where they were left for 30min prior to proceed to the next surface modification 
step. 
3.3.2.4. Hydrolysis of PAN membranes 
For experiments wherein PAN flat­sheet or hollow fibre membranes required hydrolysis, membranes were 
placed inside 100mL of a concentrated solution of either 1M or 2M NaOH, depending on the purpose of the 
experiment. The solution was heated to the required hydrolysis temperature (55, 60 or 80°C) in a 
temperature­controlled water bath prior to immerse either the PAN flat­sheet or hollow fibre membranes 
into it and allow hydrolysis for 25 or 125min (depending on the experiment objective). After this, 
membranes were immediately transferred into cold PBS (at 4°C) and washed thoroughly with this solution 
in order to remove any excess NaOH. The membranes were then kept in PBS at 4°C overnight for complete 
removal of NaOH. 
3.3.2.5. Preservation of PAN membranes 
PAN membranes become very brittle when completely dried, and hence their pore structure was preserved 
by soaking them with glycerol (Sigma­Aldrich, UK) overnight, and then stored at 4°C in the dark until further 
use (Beder 1979). 
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3.3.2.6. Pressure­driven rejection studies of PAN flat­sheet membranes 
Pressure­driven rejection tests of PAN flat­sheet membranes were performed in a SEPA ST filtration cell 
(Osmonics/Desal, USA) (figure 32) using membrane discs with a diameter of 49mm and an effective 
filtration area of 14cm
2
, pressurized to 10bar (or lower) at room temperature. Water was used as the 
solvent and polyethylene glycol with 10kDa molecular weight (PEG 10kDa, Sigma­Aldrich, UK) as the solute. 
The SEPA cell was stirred at 300 rpm and the permeate collected into a measuring cylinder. The PEG 
concentrations in the feed (CF), permeate (CP) and retentate (CR) were determined by dry­weight 
measurements. Briefly, a sample from each phase was collected and completely dried at 40°C overnight; 
the concentrations were then determined by dividing the amount of PEG collected after drying by the 
sample volume. The rejection was determined using equation (3). 
Figure 32. Schematic of the SEPA ST filtration cell used for the rejection studies on flat-sheet membranes. The liquid volume of the 
cell is 300mL and the diameter of the membrane disc is 49mm (Luthra et al. 2002).
1001% 
R
P
C
C
R (3)
Where R is the rejection, CP the solute concentration in the permeate (passed through the membrane) and 
CR the concentration in the retentate (did not pass through the membrane). 
3.3.2.7. FTIR analysis of PAN hollow fibres 
PAN hollow fibres before and after hydrolysis treatment were analysed by Fourier­Transformed Infra­Red 
(FTIR) spectroscopy. A piece of approximately 3mm of each hollow fibre was loaded into the sample holder 
of a Spectrum 100 (PerkinElmer, Inc., USA) and the absorption spectrum of each sample was collected and 
integrated by 16 consecutive scans through a KBr crystal. The analysis of the peaks was performed using 
the software Spectrum version 6.2.0.0055 (PerkinElmer, Inc., USA). Due to the samples being preserved in 
glycerol to avoid disruption of the pore structure, a background spectrum of glycerol was also collected to 
compare with the samples. 
3.3.3. Scanning electron microscopy of flat-sheet and hollow fibre membranes 
Scanning electron microscopy (SEM) characterization was conducted for the flat­sheet PES and RC flat­
sheet membranes and the PAN hollow fibre membranes. Samples were gold coated under vacuum for 3 
min at 20mA in a sputter coater (EMITECH Model K550) and SEM images at varying magnifications were 
collected using a JEOL JSM–5610 LV (JEOL, UK).
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3.4. DEVELOPMENT OF THE LOW-UPTAKE MEMBRANE
3.4.1. Isolation of mononuclear cells and red blood cells from cord blood 
Cryopreserved human umbilical cord blood was obtained from the London Cord Blood Bank (Edgware, 
Middlesex, UK), and the studies were undertaken with regulatory and ethical approval (Harrow Research 
Ethics Committee No. 05/Q0405/20). Cryopreserved human cord blood cells were thawed in a 37°C water 
bath and gently aspirated from the blood bag using a 10mL syringe and a 16G needle. Through a standard 
density­gradient centrifugation using Ficoll­Paque PLUS (1.077g.mL
­1
; GE Healthcare, Sweden), RBCs from 
the bottom layer and mononuclear cells (MNCs) from the middle buffy coat layer were separately 
harvested using needles and counted using a haemocytometer. 
3.4.2. Analysis of the selectivity performance of polycarbonate flat-sheet membranes to RBCs / 
mononuclear cells 
The same setup employed for the flat­sheet permeability and rejection tests was also used in these 
experiments (figure 31, p. 92). Purchased polycarbonate membranes with 2µm nominal pore size, provided 
in discs of 90mm, were flushed in PBS for 1h prior to use in the experiments in order to remove any 
preservatives. The membrane was inserted between the two Teflon spacers of the setup, and the flow 
chamber (figure 31A) was closed using the screws provided, and the whole setup assembled as depicted in 
the figure. After this step, the bioreactor setup was sterilized using ethanol overnight and finally flushed 
with PBS prior to the experiments. Iscove’s Modified Dulbecco’s Medium (IMDM from Invitrogen Ltd, UK) 
was used as the conditioning media on both sides. Side A was composed of 30mL IMDM with a mixture of 
RBCs/MNCs according to the experimental plan and side B contained 30mL of IMDM only. Both sides were 
perfused in a co­current mode at a constant flow rate using a peristaltic pump of around 60mL.h­1 inside a 
fully humidified incubator at 37°C controlled temperature. The pressure differential between the two inlet 
streams to the bioreactor (sides A and B, respectively), measured using the home­made U­tube (section 
3.2.3, p. 88), was maintained at around 2mbar positive from side A to side B and the experiments lasted for 
1h. After this period, three samples were collected and analysed both by flow cytometry (to distinguish 
different cellular populations, further detailed in section 3.9.5, p. 108) and the haemocytometer (to 
determine viability of the cells): Feed – the cells used to seed side A at the beginning of the experiments; 
Retentate (side A) – the cellular population that did not cross the membrane at the end of 1h; and 
Permeate (Side B) – the cellular population that crossed the membrane during the experiments. In order to 
determine the two different cellular populations within the samples, two different antibodies conjugated to 
different fluorochromes were used: CD45­FITC to detect the population of WBCs; and CD235a­PECy5 to 
detect the population of RBCs. To assess cellular viability, cells for flow cytometry were also stained for 
Annexin V, an apoptosis marker (further explained in section 3.9.5, p. 108). 
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3.4.3. Preparation of ceramic hollow fibres 
Alumina hollow fibres are currently produced at Imperial College by Professor Kang Li’s group (Kingsbury 
and Li 2009). The current protocol was developed by Dr. Benjamin Kingsbury (Kingsbury 2010). Arlacel P135 
at 1.3wt% was dissolved in a 10% (v/v) water solution in NMP prior to the addition of aluminium oxide 
powders (58.7 wt%) at a ratio of 1:2:7 (0.01µm: 0.05µm: 1µm). The dispersion was rolled/milled with 
20mm agate milling balls with an approximate Al2O3/agate weight ratio of 2 for 48h. Milling was continued 
for a further 48h after the addition of PES (6.1wt%). The viscosity of this dope solution was measured using 
a Physica UDS­200 rheometer (Anton Paar, Austria) with a cone and plate geometry, using app. 3mL of 
sample, having found that at a shear rate of 30s
−1
 and 20°C, the viscosity of this solution was 45Pa.s. The 
suspension was then transferred to a gas tight reservoir and fully degassed in a vacuum chamber for one 
hour, transferred into a 200mL stainless steel syringe and extruded through a tube­in­orifice spinneret 
(orifice­diameter / inner­diameter of 1.0/0.7 mm) into an external coagulant bath containing tap water. The 
internal coagulant was deionized water. The extrusion rate of the spinning solution and the flow rate of the 
internal coagulant were controlled by Harvard syringe pumps (Harvard Apparatus, model PHD 2000) and 
were set to 2mL.min
­1
 and 1.5mL.min
­1
, respectively. The air gap during the spinning was set at 20cm. To 
complete the phase inversion process, fabricated hollow fibres were kept in a deionized water bath for at 
least 24h. The fibre precursors were then immersed in an excess of deionized water, which was replaced 
periodically over a period of 48h in order to remove traces of NMP. Afterwards, the prepared fibres were 
cut into around 40cm length and allowed to dry at room temperature for at least 1 day. Finally, dried fibres 
were calcined in air (ELITE furnace) to yield ceramic hollow fibre membranes (figure 33). The temperature 
was increased from room temperature to 600°C at a rate of 2°C.min­1 and held at that temperature for 2h, 
then to 1450°C (or the “sintering temperature” for experiments designed to study the influence of this 
parameter) at a rate of 5°C.min­1 and held for 4h. The temperature was finally reduced to room 
temperature at a rate of ­5°C.min­1. 
Figure 33. Sintering profile used for preparing the ceramic hollow fibres.
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3.4.4. Characterization of alumina hollow fibre membranes 
3.4.4.1. Scanning electron microscopy 
SEM characterization was conducted for the sintered ceramic hollow fibres. Samples were gold coated 
under vacuum for 3 min at 20mA in a sputter coater (EMITECH Model K550) and SEM images at varying 
magnifications were collected using a JEOL JSM–5610 LV (JEOL, UK). 
3.4.4.2. Mercury displacement porosimetry 
Mercury displacement porosimetry (MDP) allows determining the pore­size distribution of a porous 
sample, by measuring the pressure required to force mercury to enter the pores of the material. According 
to this principle, the smaller the pores the higher the pressure required to flood them, and hence the pore 
size measured is proportional to the pressure required to force the mercury through the pores, considering 
these are perfectly round. Data was collected at absolute pressures of between 1.38x10
3
 Pa and 2.28×10
8
Pa (0.2–33,000 psia) with an equilibration time of 10s using an Autopore IV 9500 apparatus (Micromeritics, 
UK). The fibres were broken into sections of approximately 4mm in length and both ends were sealed using 
epoxy resin in order to measure the pore size distribution of the outer layer alone. 
3.4.4.3. Mechanical strength 
The mechanical strength of the HFs was evaluated by the three­point bending test (Liu et al. 2001; Wei and 
Li 2008), wherein sections of approximately 30mm in length were putted into the sample holder of an 
Instron Model 5544 (Instron, USA) tensile tester provided with a load cell of 1 kN. The force was introduced 
perpendicularly to the test piece plane and the support plane. Gently, increasing force was applied into the 
fibre, until it cracked, and the last measured value was taken as the maximum bending strength supported 
by the fibre (force at fracture). The force at fracture from three different specimens was recorded and the 
bending strength (σF) was determined through the following formula (Othman et al. 2010): 
44
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where, 
σF = bending strength (Pa) 
F = force measured at fracture (N) 
L = length of the fibre (0.03m) 
DO= outer diameter of the fibre (m) 
Di= inner diameter of the fibre (m)
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3.5. MASS TRANSFER ANALYSIS
The applied model for analysis of the mass transfer properties of the membranes used is presented in more 
detail in Appendix 2 (p. 231). It is worth to note that the terminology used in the development of the model 
assumes that side A contains the solute whilst side B has no solute at the beginning of the experiments – in 
cases when the solute is added at the beginning to side B (e.g. lactate), the terminology can be inverted 
(side A becomes side B, and vice­versa). Assuming diffusion­only mass transport, the overall mass transport 
coefficients can be described by a resistance­in­series model (Emanuelsson and Livingston 2004). According 
to this model, the flux of the solute per unit transfer area (N) can be calculated as the concentration 
gradient multiplied by the local mass transfer coefficient (k) on each phase (side A, within the membrane 
and side B, respectively). However, the local mass transfer coefficients are difficult to measure, and so an 
overall mass transfer coefficient (KOV) may be defined, taking into account each of the local mass transfer 
coefficients and only based on the overall concentration difference: 
, ,A b B b OVN C C K    (5)
In equation (5), CA,b and CB,b correspond to the concentrations of solute in sides A and B of the membrane, 
respectively. To determine the concentrations profile, the following two equations can also be considered: 
dt
dC
VJ   (6) 
bBbAmOV CCAKJ ,,   (7) 
where Am is the active area of the membrane and V the volume of liquid used. Performing a mass balance 
to the solute and taking into account the concentration profile in side B of the membrane, the following 
relationship can be established: 
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 , VA and VB the volumes in sides A and B of the membrane, respectively, t is the time, CB,t
is the concentration of the solute at time t and CA,0 is the initial concentration of solute in side A. 
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 vs. t is a straight line (data not shown). The overall mass 
transfer coefficient KOV, which is equivalent to the membrane permeability (cm.s
­1) can then be estimated 
from the slope, through the following equation: 
B
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A
slopeK   (9) 
Furthermore, the diffusivity (D) of the membrane can be calculated by multiplying KOV by the thickness (δ): 
 OVKD  (10) 
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3.6. PREPARATION OF THE BIOREACTOR
3.6.1. Assembly of the shell and potting of the hollow fibres 
To assemble the bioreactor shell, three types of pieces are required: tee connectors, reducers and luer­lock 
connectors, which are assembled as depicted in figures 34 and 35 for the single­ and the dual hollow fibre 
bioreactors, respectively. The bioreactor designed allows the production of an internal scaffold in 
cylindrical shape with an internal diameter of 9.7mm and a total length of 141.5mm (total volume of 
10.5mL) for both configurations. After mounting the shell, the hollow fibres fabricated as previously 
described (section 3.3.2.2 for PAN HFs and section 3.4.3 for ceramic HFs) were potted into the bioreactor 
either using 4 ceramics (single­type HF bioreactor, figure 34) or 4 ceramics and 4 PAN HF membranes (dual 
HF bioreactor, figure 35) using epoxy resin and hardener (Araldite Rapid, Bostik Limited, UK) and allowed to 
solidify overnight prior to proceeding to the scaffolding step. 
Figure 34. Exploded view of the single-type hollow fibre bioreactor, containing 4 hollow fibres. 
Figure 35. Exploded view of the dual hollow fibre bioreactor, containing 4 ceramic (red) and 4 PAN (blue) hollow fibres. 
3.6.2. Scaffolding with Polyurethane 
Following to a previous screening by Blanco et al. 2010, it was found that polyurethane (PU) would sustain 
the best outcome in terms of cellular growth of three different acute myeloid leukaemia (AML) cell lines 
out of those highly porous scaffolds essayed (PU, poly (L­lactic­co­glycolic acid), poly (methylmethacrylate), 
poly (D, L­lactic), poly (caprolactone) and polystyrene). PU is a polymer that is known to be biocompatible 
and non­biodegradable. The inclusion of the design module with ceramic hollow fibres, which are resistant 
to most organic solvents, allows the scaffolding process to occur without major disruptions to the 
membrane structure and hence keeping its performance intact beyond this procedure, to attain functional 
membranes immersed within a porous polymeric structure. In brief, PU pellets (Noveon, Belgium) were 
dissolved in 1,4­dioxane (99.8% pure; Sigma­Aldrich, UK) to attain a final concentration of 5% (w/v) by 
overnight stirring at 80°C. Afterwards, the homogeneous solution was left to cool down to room 
temperature and 10mL inserted into a 10mL luer­lock syringe and gently inserted into the bioreactor 
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assembled according to the previous point. The whole bioreactor was then put into a freezer with 
temperature controlled at ­86°C and left for 2h for solidification of the polymer solution. After this, the 
bioreactor was removed from the freezer and its inlets connected to a vacuum pump through a setup 
prepared for that purpose, immersed within a polyethylene glycol bath at ­15°C and vacuum at 10
­2
 mbar 
was used to completely remove the solvent for a period of 3 consecutive days. The volume of solvent 
removed through this process was measured in order to ascertain that the whole solvent was removed 
during the lyophilisation process. The produced PU sponge was observed under SEM (section 3.4.4.1, p. 97) 
and analysed by MDP (section 3.4.4.2, p. 97) using the same protocols as previously described. 
3.6.3. Coating of the PU scaffold with Collagen Type I 
Collagen type I coating was performed as previously described for small PU scaffolds (Blanco et al. 2010), 
although with minor changes due to the different scaffold configurations. In brief, a stock solution 
composed of 1mg.mL
­1
 collagen type I from calf skin (Sigma­Aldrich, UK) in 0.1M acetic acid (Fisher 
Scientific, UK) was prepared and stored at ­20°C until further use. Prior to coating of the scaffold within the 
bioreactor, 10mL ethanol (70% v/v in deionized water) was inserted into the bioreactor through the cell 
seeding ports (figure 34) in order to wet it, and then perfused at a flow rate of 19mL.min­1 through the 
scaffold for 10min, after which the bioreactor was washed with PBS and perfused at the same rate for 
30min. To coat the scaffold, the collagen type I stock solution was thawed and diluted in PBS to attain a 
final concentration of 62.5μg.mL
­1
, adjusting the pH to ~7.0 with 1M NaOH. A total volume of 100mL of this 
solution was then used to perfuse the bioreactor through the cell seeding ports for a period of 1h. The 
access ports were then closed and the bioreactor was left to stand in the bench at room temperature 
overnight for coating of the PU scaffold. After this period, the scaffold was perfused with PBS for 30min in 
order to wash out any remaining protein and clear the scaffold pores. 
3.6.4. Sterilization of the bioreactor composed of HFs immersed within a PU scaffold 
Scaffold sterilization has been the subject of many studies, particularly on the influence the method may 
have towards changing the properties of the material, as observed by Shearer et al. 2006. Sterilization of 
coated PU scaffolds has been previously studied and optimized by Blanco et al. 2010, who used UV­gamma 
radiation followed by ethanol sterilization, without having observed any structural damage to the scaffold 
properties. The use of the same scaffold material in this project has allowed translating the published 
protocol to fit the purposes of the bioreactor. The sterilization was performed by UV­gamma radiation for 
15min at 230V, 50Hz and 0.14A, followed by injection of a 70% ethanol solution into the bioreactor and 
allowing it to stand overnight for complete sterilization. The bioreactor was afterwards washed with sterile 
PBS and then filled with IMDM in all compartments and putted inside an incubator at 37°C with an 
atmosphere composed of 5% CO2 (v/v), 20% O2 (v/v) and 95% relative humidity for 2 days to test for 
sterility.
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3.7. DIFFUSIVITY MEASUREMENTS IN HOLLOW FIBRE CONFIGURATION
3.7.1. Experimental setup 
Diffusivity measurements of HFs were performed in separate experiments from cell culture, in order to 
determine the diffusivity parameters of the membranes. The experimental setup used for these 
experiments is presented in figure 36, using the single­type HF bioreactor configuration. Side A (lumen of 
the HFs) was recirculated at an average flow rate of 108mL.h
­1
 for all experiments. A volume of 10mL of 
side B liquid in side B (shell space) was inserted through side B ports (figure 36) and maintained without 
flow rate throughout the experiments. 
Figure 36. Experimental setup for permeability measurements of the HU and the LU hollow fibre membranes and cellular 
transmembrane crossing tests of the LU hollow fibres. Side A (30mL) is circulated at a constant flow, controlled by a peristaltic pump, 
whilst side B (10mL) is maintained without flow.
3.7.2. Diffusion-driven permeability of PAN HFs to test resistance to the scaffolding process 
In order to perform these experiments, a bioreactor composed of 5 PAN hollow fibres (15wt% in DMF) was 
assembled as depicted in figure 34 (p. 99). For each experiment, side A contained 30mL of PBS with around 
100mM of D­glucose and was perfused through the lumen of the hollow fibres in recirculation mode at a 
constant flux of around 108mL.h
­1
. Side B was filled with 10mL of PBS containing around 30mM sodium 
lactate (Sigma­Aldrich, UK) without perfusion. Samples from both sides of the hollow fibre membranes 
were acquired over a period of around 360min. Measurements were performed in three different 
conditions: 1) unmodified membrane before the production of the scaffold around it; 2) upon hydrolysis 
with 2M NaOH at 55°C for 30min of the previous membrane; 3) upon production of the scaffold around the 
previously hydrolysed membrane. Glucose concentrations were measured using a Glucose assay kit 
(Universal Biologicals, UK) following the manufacturer’s instructions, and detailed in section 3.3.1 (p. 91). 
For lactate analysis, a Lactate Enzychrom assay kit (Universal Biologicals, UK) was used according to the 
instructions from the manufacturer. Briefly, 20μL of lactate standard (concentration range 0 to 2.0mM) or 
unknown sample replicates were loaded per well in separate wells of a 96­well plate. Afterwards, 80μL of 
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Working Reagent (prepared by mixing 60μL assay buffer, 1μL enzyme A, 1μL enzyme B, 10μL NAD and 14μL 
MTT solution) were added per well, the well plate was tapped a couple of times to mix thoroughly and then 
placed in a plate reader (ELx808, BioTek Instruments Inc., US). The optical density for time “zero” (OD0) at 
570nm was then read and the plate left to stand in the dark at room temperature for 20min, after which 
time the optical density for time 20min (OD20) at 570nm was measured. The values obtained were then 
corrected by subtracting the OD0 values to the OD20 (corrected values). Microsoft Excel 2010 (Microsoft Co., 
USA) was then used to fit a linear trend line to the standard corrected values by plotting the absorbance 
reading at 570nm for each lactate standard vs. its concentration in mM. The standard curve was then used 
to determine the lactate concentration of each unknown sample. 
3.7.3. Rejection studies of PAN hollow fibres to α-lactalbumin 
The rejection studies to the model protein α­lactalbumin of different PAN HFs prepared of 13, 15 or 18wt% 
in DMF were performed by potting 5 HFs in a bioreactor setup as depicted in figure 36 (p. 101). For each 
experiment, side A contained 30mL of PBS with around 16µg.mL
­1
 of α­L and was recirculated through the 
lumen of the HFs at a constant flux of around 108mL.h
­1
. Side B was filled with 10mL of PBS only without 
perfusion. Samples from both sides of the HF membranes were acquired over a period of up to 48h. 
Measurements were performed before and after different surface treatments of the PAN HFs. For the 
initial studies on the influence of hydrolysis, membranes were hydrolysed with 2M NaOH at 55°C for 30min, 
as described in further detail in section 3.3.2.4, p. 93. For the subsequent experiments on the optimization 
of the surface hydrolysis, all membranes were initially annealed as described in section 3.3.2.3 (p. 93) and 
then five different hydrolysis treatments were used: 1) no further modification; 2) hydrolysis at 80°C with 
1M NaOH for 25min; 3) hydrolysis at 60°C with 2M NaOH for 25min; 4) hydrolysis at 60°C with 1M NaOH 
for 25min; 5) hydrolysis at 60°C with 2M NaOH for 125min. The concentrations of α­L in each sample were 
determined by ELISA, as described in further detail in section 3.10.2 (p. 110). 
3.7.4. Diffusion-driven permeability of ceramic HFs to test resistance to the scaffolding process 
In order to perform these experiments, a bioreactor composed of 4 ceramic HFs was assembled as depicted 
in figure 34 (p. 99). For each experiment, side A contained 30mL of PBS with around 2500µg.mL
­1
 D­glucose 
and 40µg.mL
­1
 BSA and was perfused through the lumen of the hollow fibres in recirculation mode at a 
constant flux of around 102mL.h
­1
. Side B was filled with 10mL of PBS containing around 2500µg.mL
­1
sodium lactate (Sigma­Aldrich, UK) without perfusion. Samples from both sides of the hollow fibre 
membranes were acquired over a period of around 360min. Measurements were performed in three 
different conditions: 1) before the scaffolding process around the hollow fibres; 2) after the scaffolding 
process but before coating with collagen type I; 3) after scaffolding and coating with collagen type I. 
Glucose concentrations were measured using a Glucose assay kit (Universal Biologicals, UK) following the 
manufacturer’s instructions (further detailed in section 3.3.1, p. 91). For lactate analysis, a Lactate 
Enzychrom assay kit (Universal Biologicals, UK) was used according to the instructions from the 
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manufacturer (further detailed in section 3.7.2, p. 101). The concentrations of BSA were determined using a 
Micro BCA Protein assay kit (Product no. 23235 from Thermo Scientific, UK). Briefly, 150μL of albumin 
standard (concentration range 0 to 40µg.mL
­1
) or unknown sample replicates were loaded into a 96­well 
microplate (Product no. 15041). Afterwards, 150μL of the working reagent (prepared by mixing 25 parts of 
Micro BCA Reagent A with 24 parts Reagent B with 1 part of Reagent C) were added to each well, the plate 
was tapped thoroughly for a few seconds, covered with aluminium foil and incubated at 37°C for 2h. The 
plate was then cooled to room temperature and the absorbance at 560nm read on a plate reader (ELx808, 
BioTek Instruments Inc., US). Microsoft Excel 2010 (Microsoft Co., USA) was then used to fit a linear trend 
line to the standard values by plotting the absorbance reading at 565nm for each BSA standard vs. its 
concentration in μg.mL
­1
. The standard curve was then used to determine the protein concentration of each 
unknown sample. 
3.7.5. Harvesting of RBCs through the ceramic hollow fibres 
To test the ceramic hollow fibres for their feasibility in cellular harvesting, and particularly their selectivity 
to red blood cells, a single­type hollow fibre bioreactor was assembled as depicted in figure 36 using 4 
ceramic hollow fibres fabricated as described in section 3.4.3 (p. 96). RBCs and MNCs were isolated from 
umbilical cord blood as described in section 3.4.1 (p. 95). Each bioreactor setup was sterilized using ethanol 
overnight and finally flushed with PBS prior to the experiments. Iscove’s Modified Dulbecco’s Medium 
(IMDM from Invitrogen Ltd, UK) was used as the conditioning media on both sides of the hollow fibres: side 
A (composed of 30mL IMDM only circulated at a constant flow rate of 60mL.h­1 through the lumen side) 
and side B (composed of 10mL IMDM with a mixture of RBCs/MNCs maintained without flow on the shell 
side). Each experiment was performed for around 4h inside a fully humidified incubator at 37°C controlled 
temperature. After this period, three samples were collected and analysed both by flow cytometry (to 
distinguish different cellular populations, further detailed in section 3.9.5, p. 108) and the haemocytometer 
(to determine viability of the cells): Feed – the cells used to seed the bioreactor at the beginning of the 
experiments; Retentate (side B) – the cellular population that did not cross the membrane at the end of 4h; 
and Permeate (Side A) – the cellular population that crossed the membrane during the experiments. In 
order to determine the two different cellular populations within the samples, two different antibodies 
conjugated to different fluorochromes were used: CD45­FITC to detect the population of MNCs; and 
CD235a­PECy5 to detect the population of RBCs. 
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3.8. EVALUATION OF THE BIOREACTOR TO SUPPORT CELLULAR GROWTH
In order to evaluate the bioreactor developed for its feasibility in stem cell bioprocessing applications, it 
was used for the culture of MNCs isolated from human umbilical cord blood. Two different applications 
were tested: the first, using a single­type HF bioreactor, intended to grow these cells in the absence of 
cytokines to study the importance of the perfusion of media through the scaffolds; the second, using the 
dual HF bioreactor, intended to prove the principle of production of human RBCs from MNCs using two 
exogenously­added cytokines – EPO and SCF. 
3.8.1. Isolation of mononuclear cells from cord blood 
Cryopreserved human umbilical cord blood was obtained from the London Cord Blood Bank (Edgware, 
Middlesex, UK), and the studies were undertaken with regulatory and ethical approval (Harrow Research 
Ethics Committee No. 05/Q0405/20). Cryopreserved human cord blood cells were thawed in a 37°C water 
bath and gently aspirated from the blood bag using a 10mL syringe and a 16G needle. MNCs were isolated 
from the cord blood through a standard density­gradient centrifugation using Ficoll­Paque PLUS (GE 
Healthcare, Sweden). 
3.8.2. Cell culture 
For the evaluation of the single­type HF bioreactor, the setup represented in figure 37 was used. Cytokine­
free Long­term culture (LTC) medium was prepared by supplementing IMDM with 30% heat­inactivated 
foetal bovine serum (FBS from Invitrogen Ltd, UK) and 1% Penicillin/Streptomycin (Pen/Strep from Gibco, 
UK). MNCs were re­suspended in the LTC medium at a density of around 3.2x107 cells.mL­1 and 5mL of this 
cell suspension were seeded into the extra­lumen compartment of the bioreactor inside the scaffold coated 
with collagen through the cell seeding ports (figure 37). After seeding, the whole setup was put inside an 
incubator at 37°C with an atmosphere composed of 5% CO2 (v/v), 20% O2 (v/v) and 95% relative humidity 
for one hour without perfusion in order to facilitate cellular adhesion. After this lag period, 400mL of LTC 
medium were perfused in recirculation mode at a rate of 6.7mL.h­1 using an oxygenator for gas exchange 
with the incubator atmosphere and medium was fully replaced every 7 days. Cells were cultured for a 
maximum period of 22 days. 
For the evaluation of the dual HF bioreactor, the setup represented in figure 38 was used. Two different cell 
culture media were prepared for perfusion in each of the two circuits of the bioreactor: the high­uptake 
(HU) and the low­uptake (LU). Cytokine­ and serum­free LTC medium to be used in the HU circuit and 
perfused through the lumen of PAN hollow fibres was prepared by supplementing IMDM with 1% 
Pen/Strep. LTC medium to be used in the LU circuit and perfused through the lumen of ceramic hollow 
fibres was prepared by supplementing IMDM with 30% FBS, 1% Pen/Strep and a cocktail of cytokines 
composed of 2,000mU.mL­1 EPO (RnD Systems, UK) and 100ng.mL­1 SCF (RnD Systems, UK). Two bioreactors 
were prepared to be run in parallel: bioreactor A and bioreactor B. Isolated MNCs were re­suspended in the 
PhD Thesis by H. Macedo 
© Imperial College 2011 105
LTC medium for the LU circuit at a density of 22.2x10
7
 cells.mL
­1
 (for bioreactor A) and 14.8x10
7
 cells.mL
­1
(for bioreactor B) and 5mL of this cell suspension were seeded into the extra­lumen compartment of the 
respective bioreactor inside the scaffold coated with collagen through the cell seeding ports (figure 38). 
After seeding, the whole setup was putted inside an incubator at 37°C with an atmosphere composed of 5% 
CO2 (v/v), 20% O2 (v/v) and 95% relative humidity for one hour without perfusion in order to facilitate 
cellular adhesion. After this lag period, in the HU circuit 500mL of LTC medium was perfused in single­step 
at a rate of 2.5mL.h
­1
 using an oxygenator for gas exchange with the incubator atmosphere and fresh media 
was added every time the level of media was below 100mL. In the LU circuit, 110mL of LTC medium was 
perfused with 100% recirculation at a rate of 2.2mL.h
­1
 and medium was never replaced, although at the 
end of 15 days of culture 18ng.mL
­1
 (18% initial concentration) of SCF and 145mU.mL
­1
 (7% initial 
concentration) of EPO were added to this circuit in each bioreactor. Cells were cultured over a period of 31 
days. 
Figure 37. Experimental setup for the culture of cells in the single-type hollow fibre bioreactor. Media is re-circulated in the lumen of 
the ceramic hollow fibres and replaced every 7 days. 
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Figure 38. Experimental setup for the culture of cells in the dual hollow fibre bioreactor. Serum- and cytokine-free fresh media was 
perfused in the lumen of PAN hollow fibres, containing the high-uptake (HU) circuit (blue) and discarded; serum and cytokines were 
provided through perfusion in the lumen of ceramic hollow fibres, containing the low-uptake (LU) circuit (red) by re-circulating 
throughout the entire culture period. 
3.8.3. Scaffold fixation after cell culture 
After culture, the bioreactor shell was disassembled and sections of the scaffold were cut using a sterile 
scalpel and immersed into a 2% p­formaldehyde solution in PBS for 40min at room temperature. The p­
formaldehyde solution was then removed and PBS with 0.1% sodium azide was added, after which the 
scaffolds were stored in the fridge at +4°C until analysis. These cells are stable for a period of several 
months (Niu et al. 2005). For analysis requiring dry scaffold samples (e.g., SEM), the fixed scaffolds were 
frozen at ­86°C for 1h and afterwards vacuumed at 10
­2
mbar at ­15°C overnight for complete dehydration. 
Parallel experiments have shown that the structure of the scaffolds with immersed hollow fibres would 
collapse when the dehydration was performed by grading concentrations of ethanol from 0% to 100% in 
deionized water.
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3.9. BIOLOGICAL EVALUATION
3.9.1. Cell proliferation analysis in the single-type HF bioreactor 
Tetrazolium salts have been used for many years to distinguish living cells from dead ones. They are 
reduced to formazans by the cytochrome system of viable cells, and the colour developed is a direct 
measure of the viability of the culture (Baltrop et al. 1991). During this test, yellow MTS (5‐(3‐
Carboxumethoxyphenyl)‐2‐(4,5‐Dimethylthiazolyl)‐3‐(4‐Sulfophenyl)Tetrazolium, Inner Salt, a tetrazole) is 
reduced to purple formazan in the mitochondria of living cells. This reduction takes place only when 
mitochondrial reductase enzymes are active, and therefore conversion is directly related to the number of 
viable cells (Mosmann 1983). This conversion is thought to be accomplished by NADPH or NADH 
production, and the solubility of the formed product (formazan) in the media allows for a quick one‐step 
assay to determine the amount of proliferative cells in the media (Promega 2005). Cell proliferation was 
quantitatively assessed by an MTS assay (Promega, CellTiter96®Aqueous Solution Cell Proliferation Assay 
R1, UK). For each time point, the HF bioreactor was terminated and sections of about 5x5x5mm
3
 were cut 
and added the MTS according to the manufacturer, incubated for 3h at 37°C and 5% CO2 and finally the 
supernatant medium colour absorbance was measured at 490nm through an absorbance microplate reader 
(ELx808, BioTek Instruments Inc., US). 
3.9.2. Assessment of cellular growth and cellular viability 
Cellular growth and viability were evaluated every 2 days of culture. Cells were manually counted using a 
haemocytometer and cell viability was determined by a dye‐exclusion method using Erythrosine‐B stain 
solution (ATCC, UK). 
3.9.3. Morphological analysis by Scanning Electron Microscopy 
Samples of the scaffold within the bioreactor before and after coating with collagen type I and at the end of 
the cell culture were collected and prepared for morphological analysis by scanning electron microscopy 
(SEM). Samples were dehydrated as described in section 3.8.3 (p. 106). The specimens were then sectioned 
and sputter coated with gold in argon atmosphere for 2min at 20mA prior to examination by a JEOL JSM‐
840a instrument (JEOL Ltd., UK) at an acceleration voltage of 20kV. 
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3.9.4. Biochemical analysis of the culture media (Bioprofiler) 
The Bioprofiler has a number of built‐in sensors, which were used to analyse the supernatant media, 
collected from the growing cells, in order to measure the concentration of nutrients (glucose, etc.), 
metabolites (ammonia, etc.), gases (CO2 and O2) and other important parameters (pH, temperature, etc.). 
These assays are made either by direct measurement (like the concentration of oxygen or carbon dioxide) 
or by indirect measurements (e.g., glucose measurement is based on the level of H2O2 produced during the 
enzymatic reaction between glucose and oxygen molecules in the presence of the glucose oxidase enzyme). 
Medium from different points of the bioreactor, depending on the configuration, was collected through 
sterile membrane ports every 2 days and stored in syringes at ‐86°C until assays. At the end of the culture 
period, all samples were analysed using a Bioprofiler 400 instrument (Nova Biomedical, USA) for 
assessment of pH, the partial pressures of O2 and CO2 and the concentrations of glucose (Glc), glutamine 
(Gln), glutamate (Glu), Lactate, NH4
+
 , Na
+
, K
+
 and HCO3 in the culture medium. For the single‐type HF 
bioreactor, samples of the media were collected at the outlet of the bioreactor stream and each data point 
is composed of a minimum of 3 (N=3) and a maximum of 6 (N=6) samples. For the dual HF bioreactor, 
samples of the media were collected at the inlet and outlet of the bioreactor in the HU circuit and from the 
bottle in the LU circuit; for each data point, samples from both bioreactors (A and B) are represented. 
3.9.5. Flow Cytometry 
Flow cytometry (FC) was used to evaluate the surface expression markers glycophorin‐A (CD235a), CD71, 
CD45 and SYTO16. The first three clusters of differentiation (CD) stains are cell surface antigens, thus 
avoiding the membrane permeabilization step during sample preparation. On the other hand, SYTO16 is a 
nuclear dye that does not require permeabilization either since it permeates through the cellular 
membrane (regardless of its integrity) and stains DNA, showing the nuclear region in the green channel 
(fluorescein isothiocyanate or FITC); the cytoplasm is shown as dull green due to staining of the cytoplasmic 
organelles (Srinivasan et al. 2006). This would hence allow detecting enucleated RBCs: SYTO16‐/CD235a+. 
Glycophorin‐A (CD235a) conjugated with PE‐Cy5 (tandem phycoerythrin with cyanine 5 dye) (isotype 
control IgG2b) is an antigen that is expressed exclusively on basophilic normoblasts and on later stages of 
the RBC differentiation in the human BM, being very useful to identify red blood cells due to its absence on 
the lymphoid or granulocytic progenitor cells (Andersson et al. 1979). Being a well‐known RBC marker, 
CD235a is a valuable tool to assess the presence of red blood cells’ lineage (Tsuji et al. 1999). CD71 
conjugated with PE (phycoerythrin) (isotype control IgG1) is a surface marker expressed on early or 
immature erythroid cells, although the differentiation of reticulocytes into mature RBCs is followed by a 
down regulation of this transferrin receptor. Hence, the down‐regulation of CD71 combined with the up‐
regulation of CD235a can indicate the presence of red blood cells (erythrocytes = CD71‐/CD235a+) (Tsuji et 
al. 1999; Giarratana et al. 2005). CD45 conjugated with FITC (isotype control IgG1), also known as the 
leukocyte common antigen, is a transmembrane protein‐tyrosine phosphatase (PTPase) that is expressed in 
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all hematopoietic cells except mature erythrocytes and platelets (United States Biological 2007). Thus, the 
non‐expression of this marker would allow confirming the data obtained from the CD71
‐
/CD235a
+
population (mature erythrocytes = CD45
‐
/CD71
‐
/CD235a
+
) (Malik et al. 1998). 
Samples for FC were prepared through the direct immunofluorescence labelling protocol. This was 
achieved by preparing a cell pellet with a maximum cell number of 1x10
6
 cells, but sometimes as low as 
0.3x10
6
 cells due to low availability of cells in the sample, washed twice with PBS (with centrifugation at 
2000rpm for 5min between each wash) and then resuspended in 100µL of FC buffer (PBS with 0.1% sodium 
azide). Antigen staining was performed by incubating this 100µL cell suspension with the desired antibodies 
for each particular experiment (described in each experimental chapter). All CD stains used (CD235a, CD45 
and CD71) were acquired from BD Biosciences, UK and used according to the supplier by adding 10µL of 
each in the required samples. SYTO16 was acquired from Invitrogen, UK and used at a final concentration 
of 1mM. A three‐stain protocol was used each time, by combining the FITC, PE and PE‐Cy5 dyes. The 
samples were then incubated for 30min at 4°C in the dark, centrifuged and resuspended in 1mL PBS two 
times for washing the non‐binded antigens and finally resuspended in 1mL of FC buffer containing 1% p‐
formaldehyde. Analysis of the samples with the flow cytometer was performed within 1 week of staining. 
An isotype control for each sample was prepared by adding 10µL of each isotype to another 100µL cell 
suspension. Previous results, using unstained controls, have shown the inexistence of unspecific binding of 
the antibodies (data not shown), hence allowing skipping the preparation of a negative control each time. 
For positive controls and colour compensation setting, each fluorescent marker was added to a separate 
100µL cell suspension (single‐stained cells). Sample analysis was performed using an EPICS ALTRA (Beckman 
Coulter, UK), with a 488nm excitation laser and fluorescence read through different band pass filters set 
for: FITC at 525nm; PE at 575nm; PECy5 at 675nm. Flowcheck beads (Beckman Coulter, UK) were used to 
calibrate and check the optical system before each set of samples). Results were analysed with the 
software FCS Express (De Novo Software, Canada). To provide a visually better evaluation of the results, 3D 
plots were also prepared from the data collected, using the software Weasel (The Walter & Eliza Hall 
Institute, Melbourne, Australia (Battye 1992)) To calibrate the flow cytometer, every time a set of samples 
was analysed, a negative, isotype and positive controls were collected and representative data obtained is 
presented in Appendix 4 (p. 235). 
3.9.6. Confocal microscopy 
Confocal microscopy pictures were obtained by sectioning the bioreactor scaffold in slices with around 
5mm thickness, washed with PBS and then stained with 300µL of flow cytometry buffer (PBS with 0.1% 
sodium azide) and 30µL of CD235a conjugated to PE‐Cy5 for 45min at 4°C in the dark. The scaffolds were 
then thoroughly washed with cold (4°C) PBS and finally wet samples were observed on a Leica SP5 inverted 
confocal microscope (Leica, Germany) using a water‐immersed objective. 
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3.10. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
3.10.1. Introduction 
Quantification of α‐lactalbumin (from samples for rejection studies) and SCF and EPO (from biological 
samples using the dual HF bioreactor) were performed by an enzyme‐linked ImmunoSorbent assay (ELISA). 
This technique offers a high sensitivity for protein detection, for concentrations as low as 1ng.mL
‐1
. There 
are several ways to perform ELISA, but for this experiment an indirect sandwich ELISA will be used. At the 
end of the process, the amount of protein present in the sample is directly proportional to the change in 
colour of the liquid, which is measured by an absorbance plate reader. 
3.10.2. Quantification of α-lactalbumin for rejection studies 
ELISA was used to measure the concentration of α‐L in the rejection studies. Stored samples collected from 
the experiments and stored in 200µL PCR tube at ‐20°C were thawed to room temperature prior to start 
the assay. An ELISA Starter Accessory kit (catalogue #E101, Bethyl Laboratories Inc., USA) and bovine α‐L 
ELISA quantitation set (catalogue #E10‐128, Bethyl Laboratories Inc., USA) were used and the procedure 
followed according to the manufacturer’s instructions (detailed below). The detection range of the method 
is 0.78 – 50ng.ml
‐1
, specific for bovine α‐L. To perform the assay, 96‐well plates (Nunc MaxiSorp C bottom 
well Modules &Frames) were used. The coating antibody used was affinity purified bovine α‐L coating 
antibody (#A10‐128A) and the HRP conjugated used was HRP conjugated bovine α‐L detection antibody 
(#A10‐128P), diluted in sample/conjugate diluent by 1:50,000. 
The number of wells to be used per experiment was calculated in order to perform a duplicate analysis of 
each sample and standard used. In brief, 1µL coating antibody was diluted in 100 µL coating buffer (0.05M 
carbonate‐bicarbonate, pH 9.6) for each well to be coated. A volume of 100µL of the diluted coating 
antibody was then added to each well to be coated and incubated at room temperature for 1 hour. The 
plates where then aspirated and washed 5 times using the washing buffer (50mM Tris buffered saline, pH 
8.0 and 0.05% Tween 20; Sigma Chemical). After this, 200µL of Blocking Solution (50mM Tris buffered 
saline, pH 8.0; Sigma Chemical) were added to each well and incubated at room temperature for 30min. 
The plates where then aspirated and washed 5 times using the washing buffer. Following to this, standards 
and samples were diluted in sample/conjugate diluent (50 mM Tris buffered saline, pH 8.0 and 0.05% 
Tween 20; Sigma Chemical) as required to reach a concentration that would fall within the detection range. 
Then, 100µL of diluted standard or samples were added to their corresponding well and incubated at room 
temperature for 1 hour. The plates where then aspirated and washed 5 times using the washing buffer. 
Next, the HRP conjugated antibody was diluted in the sample/conjugate diluent as required, and 100µL of 
this solution was added to each well, incubated at room temperature for 1 hour and washed 5 times using 
the washing buffer. After this, 100 µL of TMB substrate solution (TMB Peroxidase Substrate & Peroxidase 
Solution B; Kirkegaard & Perry) was added to each well; the plate was covered with foil and left at room 
temperature for 15min for colour development. Finally, the reaction was stopped by adding 100µL of 
0.18M H2SO4 to each well and the absorbance at 450nm measured on a microplate reader (BioTek 
Instruments, Inc., VT, U.S.A. Model ELX 808U). 
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3.10.3. Quantification of SCF 
For quantification of the concentration of SCF in the media supernatant collected from the dual HF 
bioreactor experiments, stored samples collected from the bioreactor and stored in syringes at ‐86°C were 
thawed to room temperature. To perform ELISA, the human SCF Immunoassay Quantikine (catalogue 
#DCK00, RnD Systems, UK) was used and the procedure followed according to the manufacturer’s 
instructions. The detection range of the method is 6 – 2000pg.ml
‐1
, specific for human SCF. To perform the 
assay, a 96 well polystyrene microplate (12 strips of 8 wells) coated with a mouse monoclonal antibody 
against human SCF supplied by the kit was used. The number of wells to be used per experiment was 
calculated in order to perform a duplicate analysis of each sample and standard used. In brief, 100µL of 
RD1‐1 assay diluent (#895143, composed of a buffered protein base with preservatives) were added into 
each well to be used. Following to this, samples and standards were diluted in the calibrator diluent RD5‐5 
(#895485, composed of a buffered protein base with preservatives) as required to reach a concentration 
that would fall within the detection range. Then, 100µL of diluted standards or samples were added to their 
corresponding well, in duplicate, and incubated at room temperature for 2 hours. The plates where then 
aspirated and washed 3 times using the washing buffer (#895003, with a 25‐fold concentrated solution of 
buffered surfactant with preservatives). Next, 200µL of SCF conjugate (#890106, composed of a polyclonal 
antibody against SCF, conjugated to horseradish peroxidase with preservatives) were added to each well 
and incubated at room temperature for 2 hours. The plates where then aspirated and washed 3 times using 
the washing buffer. To prepare the substrate solution, equal volumes of colour reagent A (#895549, 
composed of 0.01N buffered hydrogen peroxide) and colour reagent B (#895550, composed of 0.35 g.L
‐1
tetramethylbenzidine). A volume of 200µL of this solution was then added per well and incubated for 
20min at room temperature protected from light. Finally, 50µL of 2N sulphuric acid was added to each well 
to stop the reaction and the absorbance at 450nm measured on a microplate reader (BioTek Instruments, 
Inc., VT, U.S.A. Model ELX 808U). 
3.10.4. Quantification of EPO 
For quantification of the concentration of EPO in the media supernatant collected from the dual HF 
bioreactor experiments, stored samples collected from the bioreactor and stored in syringes at ‐86°C were 
thawed to room temperature. To perform ELISA, the human EPO Immunoassay Quantikine IVD (catalogue 
#DEP00, RnD Systems, UK) was used and the procedure followed according to the manufacturer’s 
instructions. The detection range of the method is 2.5 – 200mU.ml‐1, specific for human EPO. To perform 
the assay, a 96‐well polystyrene microplate (12 strips of 8 wells) coated with a mouse monoclonal antibody 
against recombinant human EPO supplied by the kit was used. The number of wells to be used per 
experiment was calculated in order to perform a duplicate analysis of each sample and standard used. In 
brief, 100µL of EPO assay diluent (# 895057, composed of a buffered protein base with thimerosal and 
sodium azide) were added into each well to be used. Following to this, samples were diluted in the 
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specimen diluent (#895058, composed of a protein stabilized buffer with thimerosal) as required to reach a 
concentration that would fall within the detection range. Then, 100µL of standards or diluted samples were 
added to their corresponding well, in duplicate, and incubated at room temperature for 2 hours. The plates 
where then aspirated and blot dried on clean paper towelling, without further wash. Next, 200µL of EPO 
conjugate (#890127, composed of a rabbit polyclonal antibody against recombinant human EPO, 
conjugated to horseradish peroxidase with thimerosal) were added to each well and incubated at room 
temperature for 2 hours. The plates where then aspirated and washed 4 times using the washing buffer 
(#895059, with a 25‐fold concentrated solution of buffered surfactant containing 2‐chloroacetamide). To 
prepare the substrate solution, equal volumes of colour reagent A (#895549, composed of 0.01N buffered 
hydrogen peroxide) and colour reagent B (#895550, composed of 0.35 g.L
‐1
 tetramethylbenzidine). A 
volume of 200µL of this solution was then added per well and incubated for 25min at room temperature 
protected from light. Finally, 100µL of 2N sulphuric acid was added to each well to stop the reaction and 
the absorbance at 450nm measured on a microplate reader (BioTek Instruments, Inc., VT, U.S.A. Model ELX 
808U). 
3.11. STATISTICAL ANALYSIS
The statistical analysis of the results obtained was performed using either OriginPro7.5 (OriginLab, USA) 
software or EXCEL (Microsoft Office 2010, Microsoft, UK) and is shown as the mean ± standard deviation 
(SD) unless otherwise stated. To determine the mean and standard deviation of the pore size distribution of 
the HFs the software SigmaPlot (Jandel Scientific, San Rafael, CA) was used to fit a Gaussian curve to the 
experimental data and the values were presented as means ± 2*SD (with 95% confidence). Cell culture 
experiments using the single‐type HF bioreactor were terminated at each time point (after 7, 14 and 22 
days of culture, respectively) and MTS measurements were done in at least 8 different scaffold samples for 
each and values were averaged and expressed as mean±SD. Statistical significance of the results was 
evaluated by using single factor analysis of variance (ANOVA) with a level of significance of *p<0.05 or **p< 
0.01. The experiment using the dual HF bioreactor was only performed twice and no statistical analysis was 
performed. 
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CHAPTER 4 
CHAPTER 4.
HIGH- AND LOW-UPTAKE MEMBRANES
“Knowing is not enough; we must apply. Willing is not enough; we must do.” 
Goethe 
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4.1. INTRODUCTION
The unique properties of membranes, alongside their flexibility to be tailored for different requirements 
through surface modifications, make membrane technology an important field that could aid addressing 
some of the limitations faced nowadays by tissue engineers, particularly with scaling‐up of current 
bioreactor designs. This includes increasing the space available for cellular attachment, selective and 
continuous renewal of the cellular environment, perfusion of nutrients with low or no shear stresses to the 
cells and possible harvesting of cells from within 3D structures (Liu and Roy 2005). In fact, membranes are 
deemed to play a critical role in the next generation of biomedical devices, such as the bioartificial pancreas 
(Silva et al. 2006) and the bioartificial liver (Tzanakakis et al. 2000). Polymeric membranes are by far the 
most used type in tissue engineering, and in fact thought to play a pivotal role in this field, as many of its 
applications depend upon a core advantage: a well‐defined molecular weight cut‐off (MWCO) or size cut‐
off. These semi‐permeable membranes serve as immunoprotective barriers to support cell growth and 
function, which allow nutrients, metabolic products and wastes to diffuse through, but not immune cells or 
antibodies, with a view for implantation into patients (Silva et al. 2006). This could be an important 
advantage of membrane technology for tissue engineering applications in order to provide a suitable 
environment for the development of stem cells and their progeny. 
Cellular metabolism is affected by the environmental conditions where the cells reside, such as 
temperature, pH, dissolved oxygen (DO), and nutrient and metabolite concentrations. To promote optimal 
cellular growth, cells require the availability of nutrients such as glucose to produce energy as part of their 
metabolism, releasing metabolic by‐products such as lactate. Hence, an efficient provision of nutrients and 
removal of metabolites is paramount for cell survival. Glucose should be maintained at a concentration 
above 3mM and lactate below 22mM (Ozturk et al. 1996). The perfusion of media in the bioreactor renews 
the cellular environment, allowing maintaining the concentrations of both glucose and lactate within 
healthy levels. Metabolically, glucose is an energy source, and it can be used by either aerobic (using 
oxygen) or anaerobic (in the absence of oxygen) respiration. Through the aerobic pathway, approximately 
675kcal (2,880kJ) of food energy are produced per mole of glucose, where it undergoes glycolysis 
(producing pyruvic acid) and the citric acid cycle to produce water and CO2, yielding energy mostly in the 
form of adenosine tri‐phosphate (ATP). Through the anaerobic pathway, the energy released is around 28.1 
kcal (120kJ) per mole of glucose, which undergoes glycolysis with the production of lactic acid, through the 
following overall net reaction: 1Glucose (C6H12O6) → 2 Lac;c Acid (C3H6O3) + 2 ATP. 
Another important consideration of current stem cell cultures is related to the use of GFs. These are 
proteins or cytokines that control the self‐renewal and/or differentiation capacity of stem cells and their 
progeny (Kaushansky et al. 2010). Current protocols for stem cell culture provide nutrients and GFs through 
the same inlet. However, the consumption rate of GFs is much lower than that of nutrients, and whilst the 
media containing metabolic products must be discarded and replaced by fresh media, it inevitably contains 
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unconsumed GFs. This leads to a much higher requirement of these molecules in ex vivo cultures when 
compared to the in vivo concentrations – as an example, EPO levels in the serum of a healthy human are in 
the order of 20mU.mL
‐1
 (Kaushansky 2006), whilst common concentrations used for ex vivo expansion of 
HSCs are in the order of 2,000‐3,000mU.mL
‐1
 (Dexter et al. 1981; Mantalaris et al. 1998; Giarratana et al.
2005). This large difference could be related to difficulties in maintaining the stemness of stem cells in ex 
vivo cultures (Mohamed et al. 2006), due to the abnormally high concentrations used that can trigger 
spontaneous differentiation. Moreover, the inefficacy of state‐of‐art technology to properly separate the 
expensive GF molecules from the much lower priced cell culture media indicates a lack of optimization on 
the use of these molecules. 
An alternative to current technologies is required, to allow the provision of GFs and nutrients in separate 
streams in order to recycle the GFs that are not consumed by the cells. At the same time, and considering 
the use of these two different inlet streams inside the bioreactor (the first to refresh the cellular 
microenvironment by exchange of small molecules between the bioreactor and the supply stream and the 
second one to provide and recycle expensive growth factors) the membrane responsible for the first task 
should be designed to selectively reject large GF molecules from leaving the bioreactor, and hence wasted. 
To understand the permeability of proteins through membranes, it is important to take into account the 
isoelectric point (pI) of the protein, the pH at which it carries no net electrical charge (Zydney 1998). 
Proteins are globular molecules, usually with large molecular weights, whose structure is dependent on the 
pH of the solution where they are kept, conferring them a positive, negative or neutral molecular charge, 
depending on their characteristic pI. If the solution pH is lower than a protein pI, the protein is positively 
charged, whilst if the pH is higher, the protein is negatively charged. Because of this, the solution pH can 
alter the conformation of the proteins in solution, thus affecting their sieving effect through membranes. 
Moreover, the membrane charge has also a significant effect on protein sieving, due to the interactions 
between the protein and the membrane surface. Changing the solution pH also alters the electrical charge 
on the membrane surface due to the ionisation or deionisation of various acidic/basic groups, originating 
either attractive or repulsive interactions between the protein and the membrane surface (Zydney 1998). 
Burns and Zydney 1999 have shown that the protein‐sieving coefficient attains its maximum value near the 
protein pI and decreases at higher or lower pH values. The lowest molecular size of a GF is that of 
granulocyte‐macrophage colony stimulating factor (GM‐CSF), which has a MW of 14.6kDa. Hence, the 
filtration of these proteins falls within the range of ultrafiltration, wherein polymeric membranes have 
been mostly used. 
Apart from mass transfer limitations, another challenging aspect of growing cells in 3D structures is their 
harvesting after expansion and/or differentiation: selectivity properties of membranes could aid in 
discriminating by size the undifferentiated cells from RBCs. In vivo, RBCs are known to deform into various 
shapes on account of flow forces and the size restrictions presented by the capillaries, which they have to 
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traverse during circulation (Jayavanth et al. 2008). Within the human BM, produced blood cells are released 
into the blood stream through a rearrangement in the structure of the endothelial layer of the vascular 
system, which opens a space for the free crossing of these cells. HSCs are kept inside the marrow, and 
available for continuing haematopoiesis. On the other hand, cellular growth within static cultures currently 
used for the ex vivo expansion of HSCs reaches a plateau due to space limitations, depletion of nutrients 
and high accumulation of inhibitory metabolites (green plot in figure 39). This requires the manual 
harvesting and plating of the cells into new cultures every time cell confluency is reached, which is 
laborious and time consuming. Mimicking the release of mature blood cells observed in the BM in ex vivo
cultures could in principle increase the expansion potential of current bioreactor technologies (blue plot in 
figure 39). This would avoid the constriction of the haematopoiesis site, whilst maintaining the 
differentiation potency of the bioreactor by leaving the HSCs available for expanding and generating larger 
cellular numbers. And in fact there are studies in literature reporting the filtration of RBCs through filters 
such as polycarbonate sieves with around 3μm pores (Chien 1987). 
Figure 39. Diagram of the potential advantages in incorporating selective RBC harvesting in cell cultures – whilst static cultures 
reach a plateau in cell growth requiring stopping the culture for cellular harvesting, continuous removal of mature cells would relieve 
the cell culture space and hence provide further space for stem cells to expand and reduce the nutrient depletion and amount of 
metabolic products released. 
The study on the crossing of RBCs through a membrane could hence provide an indication on the feasibility 
of this approach. The development of the LU membrane will involve the use of a mixture of mononuclear 
cells (MNCs) and RBCs, collected from human UCB, to study the selectivity properties of a membrane to 
either cell type. The MNC fraction of human UCB (the buffy coat after Ficoll‐Paque isolation) is composed of 
several different cells, which can be distinguished by their morphology and cell surface antigen markers – a 
small percentage of which are HSCs (these compose around 0.01% – 0.05% of the UCB tissue (Placzek et al.
2009)). The majority of this cellular fraction is composed of lymphocytes, granulocytes and monocytes, 
which collectively are known as white blood cells or leukocytes (Basford et al. 2010). When analysed by 
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flow cytometry, these can be distinguished as depicted in figure 40, based on their granularity (measured in 
the side scatter (SS), it is proportional to the number of organelles in the cellular cytoplasm) and relative 
size (measured in the forward scatter (FS)). Monocytes are the larger cells from this population, and hence 
appear further to the right in the axis of the FS, whilst lymphocytes being smaller cells appear further to the 
left in the same axis (figure 40A). These cells can be further identified by their granularity alongside their 
CD45 phenotype, a common leukocyte marker (figure 41). 
Figure 40. (A) Flow cytometry analysis of the white blood cell population in human umbilical cord blood, with the three major cell 
types that compose white blood cells distinguished based on their size (forward scatter, FS) and granularity (side scatter, SS): 
lymphocytes, monocytes and granulocytes. (B) Comparison of the average cell diameter of each component of white blood cells and 
erythrocytes. Adapted from: Chow et al. 2001; Basford et al. 2010.
Figure 41. Identification of the cellular population in human umbilical cord blood by flow cytometry through morphology (side scatter, 
SS) and phenotype (CD45 expression); baso- basophils; mono- monocytes; Eo- eosinophils. Adapted from: O'Malley 2002.
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4.1.1. Aim 
The main aim of this chapter is the development of the concept towards both membrane types to be used 
within the bioreactor – the high‐ and the low‐uptake membranes. Each membrane is required to possess a 
particular set of characteristics to perform their designated task; however, common features to both are 
also required, such as: 
 High fouling resistance (with a low protein‐binding surface); 
 Biocompatibility; 
 High permeability to molecules in aqueous environments; 
 High hydrophilicity; 
More specifically, the high‐uptake membrane (HUM) should be designed in the ultraporous range to allow 
for the permeability of small molecules (such as glucose and lactate) whilst rejecting the crossing of larger 
molecules (such as cytokines) and cells, according to the schematic diagram in figure 42. In summary, apart 
from the characteristics mentioned above this membrane should also have the following design features: 
 Efficiently provide nutrients and oxygen to the cells growing in the porous scaffold and remove 
small metabolic products released by the cells and other debris, with a high permeability to 
these molecules (molecular weights smaller than 1,400Da); 
 Reject the crossing of GFs (molecular weights larger than 14,000Da), allowing the use of lower 
concentrations of these molecules to promote a closer resemblance to the in vivo conditions 
and facilitating their recycle and longer contact with the cells within the scaffold. 
Figure 42: Schematic of the high-uptake circuit. The HUM designed should present a high permeability to small molecules, such as 
nutrients and metabolites and a high rejection to large proteins (P) and growth factors (GF); dHUM – thickness of the high-uptake 
membrane; LHUM– length of a hollow fibre; FHUC – flow rate of the high-uptake circuit. 
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On the other hand, the low‐uptake membrane (LUM) should be a microporous hollow fibre capable of 
delivering growth factors (large molecules in the range of 15 to 40 kDa), serum proteins (with molecular 
weights that can be above 100 kDa) and allowing the crossing of red blood cells (which can cross pore sizes 
larger than 2µm) (schematic diagram in figure 43). In summary, this membrane should also have the 
following design characteristics: 
 High permeability to growth factors and essential proteins (molecular weights larger than 
14,000Da); 
 Allow the selective crossing of fully mature red blood cells (with an average diameter of 8µm, 
but reported to be able to cross 2‐3µm pores, due to their unique membrane properties), 
removing them from the scaffold, whilst blocking the crossing of other cells in the culture 
(particularly stem and progenitor cells); 
 This flow should be 100% recycled in order to decrease the amount of exogenously‐added 
growth factors, reducing the initial concentrations required (high concentrations have been 
linked to a reduction in the stemness of HSCs) whilst also decreasing the high costs associated 
to these molecules; 
Figure 43. Schematic of the low-uptake circuit. The LUM designed should primarily present a high permeability to large proteins (P) 
and growth factors (GF) and allow the preferential crossing of enucleated red blood cells whilst retaining stem cells within the porous 
scaffold; dLUM – thickness of the low-uptake membrane; LLUM– length of a hollow fibre; FLUC – flow rate of the low-uptake circuit. 
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4.1.2. Methodology 
The initial developments of both the high‐ and low‐uptake membranes were performed in flat‐sheet 
configuration, due to the simpler geometry of this design for the screening tests. Due to the limited number 
of solvent‐resistant materials available for tissue engineering applications, the first screening tests were 
performed using currently used membrane materials, disregarding their suitability to be used for the 
scaffolding process. The focus was given particularly to the study on the efficacy of the membranes towards 
their particular filtration requirements. Another important consideration was related with the type of 
bioreactor to be used that could integrate these features. Having established a comparison between the 
human BM and existing bioreactor designs for stem cell bioprocessing (section 2.9, p. 69), it was clear that 
the geometry of HF bioreactors would resemble better its structure, whilst allowing a higher cellular 
density within the bioreactor (as shown in table 9, p. 71) to maximize productivity, reducing costs and 
space requirements. However, HF bioreactors, due to the complexity of the geometry of the membranes, 
introduce an extra difficulty in the study of the membrane properties as required during the developmental 
stages. Hence, in this first stage of the bioreactor development, a flat‐sheet bioreactor for screening 
purposes was used. This would permit studying different membrane materials, whilst allowing a better 
comparison with existing studies, in a second stage. Nevertheless, it must be taken into account the fact 
that changing the geometry of the design, the properties of the membranes may also change, hence even 
though this relationship allows a coarse study of the membrane properties, conclusions regarding the 
overall performance of the bioreactor and the membranes in particular, should always be made using the 
chosen design, the HF system, developed in subsequent chapters. 
In order to investigate the various features required for the HUM (particularly the high permeability to 
small molecules required for cellular metabolism, the fouling resistance to proteins, and the high rejection 
to growth factors), three different types of molecules were required, each to test a different feature: 
nutrients/metabolites, culture media proteins and GFs. To perform this, an experimental model for the 
screening of different membrane materials is compared in table 13 with the most important molecules 
usually involved in these cultures. One of the important characteristics to be developed was the rejection 
of the membrane to GFs. However, considering the high price of these molecules (as seen in table 13), and 
the relatively high amounts required to perform the screening experiments, the experimental model 
incorporated alternative proteins that would be used during the first tests of the rejection performance of 
the membranes. The rejection of a membrane for proteins is not just dependent on size, but also on the 
isoelectric point (pI) of the protein (Zydney 1998). Hence, it was decided to choose a protein with a smaller 
molecular weight than the smallest growth factor commonly used – GM‐CSF with 14.6 kDa –, and with 
similar pI values. 
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Table 13. Experimental model comparison with molecules found within the BM for hematopoietic stem cell culture. Erythropoietin 
and stem cell factor will be used further on in the project, whilst the smallest cytokine normally used for HSC culture, granulocyte-
macrophage colony stimulating factor (GM-CSF), is also represented for comparison. 
Type of 
molecule 
In vivo molecules Model system 
Molecule 
MW 
(Da) 
Price 
(£.mg
­1
) 
Molecule 
MW 
(Da) 
Price 
(£.mg
­1
) 
Nutrients/ 
Metabolites 
Glucose 180 0.03 Glucose 180 0.03 
Lactate 90 0.01 Lactate 90 0.01 
Culture media 
(proteins) 
Human albumin 
(pI= 4.8) 
66,000 0.09 
Bovine serum 
albumin (BSA) 
(pI= 4.7) 
66,000 0.01 
Growth factors 
Erythropoietin 
(pI= 3.3­4.3) 
30,000 43,000 
α­lactalbumin 
(pI= 4.2­4.5) 
14,200 0.60 
GM­CSF 
(pI= 3.5­8.0) 
14,600 40,000 
Stem cell factor 
(pI= 4.8) 
21,000 25,500 
Taking this into account, the main model protein chosen was alpha­lactalbumin (α­L, figure 44). With a MW 
of 14.2 kDa and a pI between 4.2 and 4.5, it is an important whey protein in cow’s milk (at a concentration 
of ~1g.L
­1
) (Kleinberg et al. 1983). Being a protein that is present in cow’s milk, it is considerably less 
expensive to purchase than the human growth factors, and hence represents a good model to perform the 
screening tests. 
Figure 44. The protein α-lactalbumin was chosen as the model protein for the screening tests: 3D model of its globular 
structure (A) and properties of the purchased product (B). Adapted from: Pike et al. 1996.
To simplify table 13, a comparison of the price, pI and molecular weights of the two growth factors 
intended to be used later in this research (EPO and SCF) are presented in table 14 alongside the values for 
the chosen model protein. The use of small molecules in the experiments (glucose and lactate) intended to 
provide an idea of the membrane permeability characteristics. Concentration equilibrium between both 
chambers regarding these molecules was expected, and a measure of the time to reach this equilibrium 
would provide an idea of its efficiency to provide both molecules to the cells. This would also allow studying 
membrane fouling through protein adsorption, by studying the increase in the time required for this 
equilibrium to take place after contact of the membrane with bovine serum albumin (the highest 
concentrated protein in the serum used for cell cultures). On the other hand, the use of large molecules (α­
lactalbumin, replacing GFs) was intended to study the performance of the HU membrane to retain these 
molecules – in order to be efficient, a 100% rejection of the proteins was desirable.
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Table 14. Comparison of α-lactalbumin with cytokines that will be used further on in the project for the production of red blood cells. 
Protein pI 
MW
(kDa)
Price
(£.mg
­1
)
Supplier 
α-lactalbumin 4.2­4.5 14.2 0.60 Sigma­Aldrich, UK 
EPO 3.3­4.3 21.3 42,800 RnD systems, UK 
SCF 4.81 30.9 25,500 RnD systems, UK 
Mass transfer results were calculated assuming the pore diffusion model (that is, membrane pores are 
filled with water and solute diffuses through them). A mass balance to the solute in both sides of the 
membrane was made, and equation (11) was derived when considering the lower concentrated stream for 
each solute (e.g., side B for glucose and side A for lactate) and assuming the partition coefficients are equal 
to 1 (further developed in Appendix 2, p. 231): 
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Cf  vs. t  is a straight line (Appendix 2, p. 231), and the value of KOV
can be estimated. From this, the diffusivity (D) of the membrane to the solute can be calculated using 
equation (12): 
 OVKD , (12) 
where D is the diffusivity (cm
2
.s
­1
), KOV is the overall mass transfer coefficient (cm.s
­1
) and   is the 
membrane thickness (cm). 
On the other hand, this chapter will also focus on establishing the principle of the LUM using flat­sheet 
membranes: the harvesting of RBCs. Studies on the cellular transmembrane crossing were performed using 
isolated mononuclear cells (MNCs) and red blood cells (RBCs) from human UCB, using a contact cell setup 
as depicted in figure 30, p. 92. 
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4.2. RESULTS AND DISCUSSION
4.2.1. Proof-of-concept of the HUM: high glucose permeability and rejection to growth factors 
4.2.1.1. Choice of membranes for the screening tests 
The most important features of the high­uptake membrane (HUM), as a filtration barrier, were a high 
permeability to small molecules (particularly glucose and lactate) and reject the passage of proteins (with 
molecular weights larger than 14kDa). A number of companies offer a large range of off­the­shelf 
membrane materials in the ultrafiltration range required, including Microdyn­Nadir GmbH, VWR, Koch 
Membrane, Millipore, etc. Membranes used to date, for biological applications such as food processing or 
blood filtration (e.g., haemodialysis), have been composed of polymers such as cellulose (regenerated 
cellulose, chemically modified cellulose, etc.), polyacrylonitrile, polymethylmethacrylate, polysulphone, 
polyethyl vinyl alcohol, polyamide and others (Oishi and Hanai 2006). However, due to the large choice in 
terms of different materials and applications for membranes in the ultrafiltration range, the choice in terms 
of materials was narrowed down by choosing materials offering high permeability to small molecules, low 
protein binding characteristics and molecular weight cut­off in the range required to prevent the crossing 
of GFs. Particularly, a molecular weight cut­off in the range between 5kDa and 10kDa would be desirable. 
One of these materials, polyethersulphone (PES), is one of the polymers currently used with best 
hydrophilic characteristics. In fact, according to Rong et al. 2006, PES membranes present the best glucose 
diffusion coefficients within polymeric membrane materials available (5.76x10
­6
 cm
2
 s
­1
). Moreover, surface 
treatments of PES render their surface even higher hydrophilicity (hence better mass transport) and higher 
resistance for protein fouling. In order to compare the effectiveness of PES, membranes made of 
regenerated cellulose (RC), which are hydrophilic whilst offering a very low protein adsorption (Burns and 
Zydney 1999), were also chosen. Thus, four different membranes were purchased for initial evaluation: PES 
with MWCO of 5 and 10kDa, purchased from Sartorius, UK; and RC with MWCO of 5 and 10kDa, purchased 
from Millipore, UK (table 15). 
Table 15. Membranes purchased for screening purposes. MWCO=molecular weight cut-off; PES: polyethersulphone; RC: 
regenerated cellulose. 
MWCO 
(kDa)
Material Supplier 
Price 
(£.cm
­2
)
5 PES Sartorius, UK 0.21 
10 PES Sartorius, UK 0.21 
5 Ultracel RC Millipore, UK 1.31 
10 Ultracel RC Millipore, UK 1.31 
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4.2.1.2. Diffusion­driven assessment of permeability to glucose and rejection to the model 
protein 
Purchased membranes are provided preserved in glycerine and anti­microbial agents, requiring their 
cleaning prior to performing the experiments. In order to clean them from these preservatives, membranes 
were left in distilled water overnight prior to experiments. The setup represented in figure 30 (p. 92) was 
used in these experiments, with a flow rate of around 108mL.h
­1
 in each side of the membrane. The 
volumes of the each circuit of the setup (A and B) as well as that of the flow chamber depicted in figure 31 
(p. 92) were measured: each side of the circuit had a total volume of 16.8mL, of which 10mL are the volume 
inside the flow chamber and 6.8mL the volume inside the tubing used. Samples of the liquid in each side of 
the membrane were collected throughout the experiment time, and measured for the concentration of 
glucose (detected using a colorimetric assay) and α­L (detected using an ELISA kit), when required. As a rule 
of thumb, side A of the membrane contained the low molecular weight molecule (glucose), in order to 
mimic the nutrients to be fed into the bioreactor and Side B the high molecular weight molecule (α­L) 
required to remain within the bioreactor (as a model to proteins and cytokines), in order to mimic the 
environment within the cell growth chamber. 
To screen the different materials and the required molecular weight cut­off, glucose diffusivity and 
rejection to the model protein α­L were calculated for the four chosen membranes, by monitoring the 
evolution of the concentrations of both molecules with time in each side of the membrane. The 
concentration profile of glucose allowed determining the overall mass transfer coefficients, which are 
presented in figure 45 (more detailed plots are presented in Appendix 3.1, p. 234). The fitted trend line to 
the experimental data obtained for each membrane is also represented alongside its equation and the 
corresponding R
2
, in order to determine the KOV – the higher the slope of this line, the higher is the mass 
transfer coefficient of the membrane (from equation 11). To compare each membrane, their respective 
calculated KOV is plotted in figure 46. 
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Figure 45. Estimation of the mass transfer coefficient KOV of four different membranes to glucose: polyethersulphone (PES) with 
10kDa MWCO, PES with 5kDa MWCO, regenerated cellulose (RC) with 10kDa MWCO and RC with 5kDa MWCO. The higher the 
slope of the fitted trend line to the experimental data, the higher is the mass transfer coefficient of the membrane. Results for a single 
experiment. 
Figure 46. Comparison of the mass transfer coefficient KOV of four different membranes to glucose: polyethersulphone (PES) with 
10kDa MWCO, PES with 5kDa MWCO, regenerated cellulose (RC) with 10kDa MWCO and RC with 5kDa MWCO; *p<0.05; 
**p<0.01. Each value represents the average of at least 3 samples and a maximum of 8 samples. 
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In order to evaluate the thickness of the membranes (to determine the molecular diffusivity D) and observe 
their structure, SEM pictures of each membrane were obtained. Each membrane material (PES and RC) 
presented a similar structure under SEM regardless their MWCO, hence only the two membranes with 
10kDa MWCO are herein presented for comparison: PES membranes supplied by Sartorius (figure 47) and 
RC supplied by Millipore (figure 48). It is observed from the pictures, that these membranes are 
asymmetric, as expected, composed of two layers: an active layer (with the smoother surface, this is the 
tighter side of membrane, hence through which the molecular rejection of the membrane takes place); and 
a support layer (composed of larger pores, its major function is to provide mechanical stability to the active 
layer). 
Figure 47. SEM picture of the polyethersulphone flat-sheet membrane with 10kDa MWCO from Sartorius: cross section (A), active 
layer (B) and support layer (C).
Figure 48. SEM picture of the regenerated cellulose flat-sheet membrane with 10kDa MWCO from Millipore: cross section (A), active 
layer (B) and support layer (C).
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The protein rejection by each membrane was also determined by measuring the concentrations of the 
model protein in each side of the membrane at the end of the experiments. Table 16 resumes the KOV, 
calculated diffusivity (D) and rejection to the model protein α­L obtained for each membrane. It is worth to 
note that the rejection values are the minimum rejection detected based on the sensitivity of the detection 
method used. From the results shown in figures 45 and 46, it is possible to infer that, as expected, the 
membranes with higher MWCO (10kDa) have a statistically significant better permeability to glucose than 
the tighter membranes (with 5kDa MWCO). Comparing both materials screened (PES and RC), a different 
behaviour was observed depending on the MWCO of the membranes: for the tighter membranes, those 
made of RC had a better performance, whilst for the looser membranes (with 10kDa MWCO) the PES 
material had a statistically significant better permeability to the nutrient molecule. 
On the other hand, the results presented in table 16 show that all the membranes tested are good 
candidates to reject the model protein, with over 99.9% rejection of the protein throughout the time of the 
experiments. Taking these observations into account, the chosen membrane to continue further studies 
was decided based on the permeability to glucose: the PES 10kDa membrane. Comparing the behaviour of 
this membrane, which offered the best diffusivity to glucose (3.3x10
­7
 cm
2
.s
­1
), with the glucose diffusion 
coefficient within islets of Langerhans in the human pancreas (responsible to sense glucose in blood and 
produce insulin in response to reduce the concentration of this molecule), which has been measured to be 
3.8x10
­7
 cm
2
.s
­1
 (Kauri et al. 2003), it is possible to infer a great similarity. The diffusivity measured is around 
30­fold smaller than glucose free diffusion in water, mostly due to the influence of the active layer of the 
membrane, which limits the molecular mass transport. Moreover, the diffusion coefficient of this molecule 
in the human brain has been estimated to be 352x10
­7
 cm
2
.s
­1
 (Roos and Sperber 1997), nearly 12 times 
higher than the diffusivity measured. 
Table 16. Summary of the results obtained to the four membranes tested at 37°C: overall mass transfer coefficient (Kov) and 
diffusivity (D) properties to glucose and rejection to α-lactalbumin (α-L) after contact between a 16.8μg.mL-1 concentrated solution 
with distilled water only through each membrane. The diffusivity of glucose in water is also included as a mean for comparison. 
†protein rejection measured after 45h; ††protein rejection measured after 25h; †††protein rejection measured after 6h. Each value for 
KOV and D represents the average of at least 3 samples and a maximum of 8 samples. Rejection experiments for each membrane 
were performed once. 
Membrane 
Kov x10
7
(m
3
.m
­2
.s
­1
) 
D x10
7
(cm
2
.s
­1
) 
Rejection to α­L 
(%)
PES 5KDa 0.37 ± 0.05 0.52 ± 0.07 >99.99
†
PES 10kDa 2.29 ± 0.55 3.27 ± 0.78 >99.99
††
RC 5kDa 0.74 ± 0.18 1.79 ± 0.42 >99.99
†††
RC 10kDa 1,01 ± 0.17 2.86 ± 0.49 >99.96
†††
Glucose in water 
(Curcio et al. 2005) 
­ 92.4 ­ 
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4.2.1.3. Fouling studies of the PES 10kDa flat­sheet membrane 
An important parameter to take into account in this project is the resistance of the membrane materials to 
fouling by the proteins existing in solution. Ultrafiltration membranes, having a tighter structure, would 
have higher probability to have the performance reduced due to the adsorption of proteins onto their 
surface (Jung 2004). These molecules, on the other hand, generally have hydrophobic characteristics due to 
their globular structure with large molecular weights, suggesting that the surface of the membranes should 
be hydrophilic in order to reduce the probability of adsorption (Jung 2004), and hence mass transfer 
reduction. In order to assess whether the PES 10kDa membrane would be suitable to be used for cell 
culture by contacting with proteins, a fouling study using the same setup used for the permeability and 
rejection experiments was performed. Bovine serum albumin (BSA) was used in these experiments, which 
is the highest concentrated protein in cell cultures – foetal bovine serum is normally used for cell cultures 
with an average concentration of BSA of 12 – 39 mg.mL
­1
 (Stacey and Davis 2007). Figure 49 presents the 
mass transfer results for glucose through this membrane under the three different conditions used. To 
compare between the different treatments, their respective calculated KOV is plotted in figure 50. 
Figure 49. Estimation of the mass transfer coefficient of glucose through the PES 10kDa membrane under different conditions: i) no 
fouling protein used (red plot); ii) fouling protein (BSA) was added to both sides of the membrane on a concentration of 10mg.mL-1
(green plot); iii) without albumin, but using the same membrane as in experiment ii (contact with BSA for a period of 26 hours) (blue 
plot). Results for a single experiment. 
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Figure 50. Comparison of the mass transfer coefficient of glucose through the PES 10kDa membrane under different conditions: i) 
no fouling protein used (red plot); ii) fouling protein (BSA) was added to both sides of the membrane on a concentration of 10mg.mL-
1 (green plot); iii) without albumin, but using the same membrane as in experiment ii (contact with BSA for a period of 26 hours) (blue 
plot). Each value represents the average of at least 3 samples and a maximum of 8 samples. No statistical significance was found 
between the three groups. 
From figures 49 and 50, it is possible to conclude that although a slight reduction in the performance of the 
membrane, after contact with the fouling protein, is observed; this reduction is not statistically significant, 
which suggests the resistance of this membrane to fouling by high protein concentrations at least in the 
short term (26h). 
4.2.1.4. Resistance to the scaffolding process 
The proof­of­concept for the high­uptake membrane was made using a flat­sheet polyethersulphone 
membrane with 10kDa MWCO. This membrane was shown to possess a high permeability to glucose, whilst 
offering a very high rejection (over 99.9%) to the crossing of α­L, the model protein with a smaller MW size 
than common cytokines, and with similar pI values, as seen before. However, PES is not the ideal material 
for the bioreactor due to its low chemical stability, particularly in the organic solvent used for the 
scaffolding process, 1,4­dioxane. This was observed by dipping one membrane disc with 45cm
2
 surface area 
into a flask containing 50mL of the organic solvent. After overnight contact, the surface of the PES 
membrane had completely cracked showing visible signs of degradation caused by the solvent. Hence, an 
alternative material with similar flow characteristics to PES (good permeability to glucose and high rejection 
to the model protein) was desirable but also with higher chemical and thermal stability to allow for the 
scaffolding process. This will be further developed in chapter 5. 
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4.2.2. Proof-of-concept of the LUM: harvesting of RBCs 
4.2.2.1. Choice of membranes for the screening tests 
The initial studies of the low­uptake membrane were performed using a flat­sheet configuration, in order 
to prove the main concept for this membrane – the possibility for harvesting of RBCs. The main 
characteristic searched for this membrane at this stage was hence a pore size distribution that could allow 
the crossing of RBCs (as seen in the literature review in section 2.7.5 (p. 59), this would be in the range of 2 
to 3µm). A number of companies offer a large range of off­the­shelf membrane materials, including Koch 
Membrane, Millipore, Membrana, Minntech, etc. However, due to the large choice in terms of different 
materials and applications for membranes in the microfiltration range offered by GE Osmonics Labstore 
(part of General Electric, USA), this company was chosen as the preferred supplier. 
Table 17. Micro-porous membranes commercialized by GE Osmonics Labstore that are possible candidates for the low-uptake 
circuit. A polycarbonate track etch membrane with 2µm pore size (shaded) was chosen to perform the screening tests. 
Average 
pore size 
(μm) 
Material Reference Price (£.m
­2
) Remarks (according to manufacturer) 
5 μm 
Nitrocellulose 
Mixed Esters 
E50WP14225 182 
The uniform microporous structure of these filters provides the 
fastest flow rates and highest throughputs available in a 
membrane filter 
3 μm Polycarbonate K30CP04700 364 
Applications: General microfiltration and clarification, 
cytological evaluation (cerebrospinal fluid), chemotaxis, red 
blood cells (RBC), microfiltration of corrosive fluids 
3 μm 
Polycarbonate 
track etch 
K30CP00010 1813 
Absolute pore size and density provides flow control for liquids 
moving through the membrane capturing 100% of cells larger 
than pore size; low protein binding (< 5 µg/cm²) 
2 μm Polycarbonate K20CP14220 197 Applications: Chemotaxis, alkaline elution (DNA) and RBCs 
2 μm 
Polycarbonate 
track etch 
Part# 1221232 
Model# 
K20CP09030 
135 
Low protein binding (< 5 µg/cm²); precise pore size and 
density; provides flow control for liquids moving through the 
membrane and captures 100% of cells larger than pore size. 
Table 17 shows 5 different membranes that are commercially available through GE Osmonics Labstore and 
could be used for the screening tests. In order to reduce the number of materials to be tested, particularly 
for saving costs with their acquisition, one membrane was chosen based on price, availability, protein 
adsorption and also its average pore size. It was found through the literature search that RBCs are able to 
cross membranes with pore sizes as low as 2 to 3µm, and hence this was also taken into consideration in 
the selection process. The membrane that best fitted these characteristics is also presented in table 17 (in 
bold), which was chosen due to its symmetrical pore size distribution (fabricated by the track etch method, 
further explained in section 2.10.4, p. 79); pore size in the lower required range of 2µm, hence with the 
possibility for further discrimination between RBCs and the other larger cells in culture (such as white blood 
cells); low protein binding (<5µg.mL
­1
), hence less prone to fouling; and highly hydrophilic (important for 
low protein binding and efficient mass transport in aqueous environments). Moreover, polycarbonate is an 
inert material, being the most commonly used polymer for studies on RBC filtration in literature (Chien et 
al. 1967; Chien 1987; Lipowsky et al. 1993) and proven to support the development of HSCs (LaIuppa et al.
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1997). The performance characteristics of these membranes, kindly provided by the UK supplier Anachem, 
are presented in table 18. 
Table 18. Performance characteristics of the polycarbonate membranes kindly provided by Anachem (UK). 
(A) 
Pore Size
(µm) 
(B) 
Pore Density 
(pores.cm
­2
) 
Nominal Weight
(mg.cm
­
²) 
(C) 
Nominal Thickness 
(µm) 
(D) 
Minimum flow rate in 
water (mL.min
­1
.cm
­2
) 
2 2 x 10
6
1.1 10 300 
A) Tolerance + 0%, ­20%; B) Tolerance +/­ 15%; C) Tolerance +/­ 10%; D) Initial flow rates using prefiltered water at 0.7 kg.cm
­
². 
4.2.2.2. Experimental setup to test the LUM concept 
To prove the concept of RBC harvesting using a filtration membrane, the 2µm­pore size polycarbonate 
membrane from GE Osmonics Labstore was used. The experiments were performed using a membrane 
contact cell, as depicted in figure 31 (p. 92), wherein two streams (A and B) were put in contact through the 
centrally­positioned membrane and fluid was circulated in either side in a co­current mode, maintaining a 
positive pressure differential from side A to side B of around 2mbar. A mixture of RBCs and MNCs was 
inserted into side A of the membrane and circulated for 1h at a flow rate of 60mL.h­1 at 37°C. The results 
obtained in three separate independent experiments are herein reported. The fraction of human UCB 
containing red blood cells (RBCs) and mononuclear cells (MNCs) were isolated into separate containers by a 
Ficoll­Paque separation method (section 3.4.1, p. 95), and counted. Afterwards, cells from each container 
were mixed together to attain a final volume of 30mL in IMDM, in order to have different ratios of 
RBCs/MNCs per experiment, as summarized in table 19. 
Table 19. Initial cell seeding densities in each experiment to study the cellular transmembrane crossing through a 2µm 
polycarbonate flat-sheet membrane. Cells were mixed in a total volume of 30mL of IMDM, and injected in side A of the membrane. 
Parameter Experiment 1 Experiment 2 Experiment 3 
Seeded cells 
(x10
­5
 cells.mL
­1
) 
11.3 5.7 104.2 
RBCs 
(x10
­5
 cells.mL
­1
) 
5.5 5.1 101.8 
MNCs 
(x10
­5
 cells.mL
­1
) 
5.8 0.6 2.3 
Ratio RBCs/MNCs 1 9 44 
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4.2.2.3. Biological evaluation by flow cytometry 
At the end of each experiment, the cells were collected from each side of the setup and analysed by flow 
cytometry (cellular phenotype) and haemocytometer (cellular viability). The latter technique indicated a 
cellular viability of over 99% for all samples seeded into the bioreactor as well as after each experiment, 
both for the cells that did not cross the membrane (retentate) and those that crossed from stream A into 
stream B (permeate). On the other hand, flow cytometry data provided a more detailed analysis of the 
cellular distribution on both sides of the membrane. To calibrate the flow cytometer, every time a set of 
samples was analysed, negative, isotype and positive controls were also collected and representative data 
obtained is presented in Appendix 4.1 (p. 235). The results analysed by flow cytometry were performed by 
gating the cellular populations of interest in a FS vs. SS plot, which allows gating out any eventual cellular 
debris or contamination from the samples and hence the results (each gate used for each of the three 
experiments presented are plotted in figure 124 on p. 235). The morphology of the cells was very similar to 
that reported by O'Malley 2002 regarding the composition of human umbilical cord. The flow cytometry 
dot­plot presented in figure 51 was obtained for a mixture of red blood cells / mononuclear cells used 
during the experiments, wherein different white blood cells (particularly monocytes, granulocytes and 
lymphocytes) can be identified, the same way as observed in figure 40, p. 117 (Basford et al. 2010). These 
cells express the cell surface antigen CD45, which further supports this observation. Red blood cells can 
also be observed in the plot, although due to their biconcave shape their size and light scattering 
characteristics after analysis with the flow cytometry laser are very dispersed, and hence their proper 
identification is performed through the presence of the lineage­specific CD235a (or glycophorin­A) cell 
surface antigen. 
Figure 51. General identification of the cellular population in a sample of human umbilical cord blood, according to O'Malley 2002 by 
their granularity (side scatter, SS) and CD45 expression. The flow cytometry dot-plot represented corresponds to a sample 
containing both red blood cells and mononuclear cells from fresh umbilical cord blood. The five main cell types that can be identified 
are eosinophils, neutrophils, monocytes and lymphocytes (composing the white blood cell population) and precursors of RBCs (in 
red). Mature red blood cells are usually less defined, and are usually found scattered throughout the entire plot, although with higher 
concentration for low SS and FS values (red gate). 
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To have a general overview of the results obtained, the cell surface expression of CD235a (a RBC marker) 
and CD45 (a general MNC marker) antigens were plotted together for the three experiments presented 
(figure 52). The isotype and positive controls and the SS vs. FS plots for each set of data can be found in 
Appendix 4.1 (p. 235). To evaluate the influence of the membrane towards filtering the cells, the three 
phases of the experiments are represented side by side for each run performed: feed (in red), retentate 
(the cells that did not cross the membrane, in blue) and permeate (the cells that crossed the membrane, in 
green). A reduction of about 2/3 (66%) in the percentage of CD45
+
 cells can be observed on the permeate 
side of experiments 1 and 2, when compared with the population in the retentate side for each 
experiment. The percentage of cells expressing CD235a increased in the permeate of experiment 1, 
although a slight reduction was observed in experiment 2 (probably due to the presence of debris that did 
not express neither stain). Due to the low concentration of MNCs used in the feed of experiment 3 (table 
19, p. 131), this enrichment of CD235a
+
 cells compared to the CD45
+
 population of the permeate side could 
not be observed. 
Figure 52. Flow cytometry results with the expression of CD235a vs. CD45 cellular surface antigens for experiments 1 (A, B, C), 2 
(D, E, F) and 3 (G, H, I) on the transmembrane crossing of red blood cells (CD235a+) / mononuclear cells (CD45+) through a 2µm 
polycarbonate flat-sheet membrane. Three phases of the experiment are represented: fed cells (A, D and G, respectively); retentate 
side after 1h, representing the cells that did not cross the membrane (B, E and H, respectively); and permeate side after 1h, 
representing the cells that crossed through the membrane (C, F and I, respectively). Isotype controls for each experiment are also 
presented for reference. 
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In order to evaluate the membrane discrimination by size of the cells, flow cytometry data can be very 
useful. As mentioned before, the size of a cell is directly proportional to the signal on the FS channel, and 
hence a cell represented in the higher channel values (nearer 1024 bits) will be bigger in terms of 
volumetric size than a cell represented in the lower end of the axis. Figure 53 represents the relative 
expression of the cell surface antigen marker CD235a (glycophorin­A) with the relative size of the cells 
(given by the FS channel) obtained in three different experiments. In order to facilitate the interpretation of 
the results, an arbitrary vertical line divides the larger cells (to the right) from the smaller cells (to the left), 
whilst negative and positive expressions of CD235a (an RBC marker) are represented below and above, 
respectively, the horizontal line drawn (based on the isotype control). Comparing the cellular populations in 
the three samples for each experiment, two important observations could be made: 1) comparing the 
permeate with the retentate sides, the membrane selectively discriminated the cellular population by size; 
and 2) there was a depletion of the larger CD45
+
 cells fed after contact with the membrane (red circle in 
figures 53A­C). 
Figure 53. Flow cytometry results with the expression of forward scatter (FS) vs. CD235a for experiments 1 (A, B, C), 2 (D, E, F) and 
3 (G, H, I) through a 2µm polycarbonate flat-sheet membrane. Three phases of the experiment are represented: fed cells (A, D and 
G, respectively); retentate side after 1h, representing the cells that did not cross the membrane (B, E and H, respectively); and 
permeate side after 1h, representing the cells that crossed through the membrane (C, F and I, respectively). Red circle: population of 
monocytes present in the three streams of experiment 1. 
PhD Thesis by H. Macedo 
© Imperial College 2011 135
To further study this, the percentage of the cellular population appearing in the higher side of the FS 
channel (hence the percentage of larger cells present in the sample) were plotted in figure 54 for each of 
the three phases. An arbitrary threshold value in the FS channel was chosen to distinguish between “larger” 
and “smaller” cells. This threshold cannot be perfectly established, but for study purposes it was assumed 
to be around the middle value of the FS channel at 448 bits (FS=448), above which the cell population in the 
permeate side was negligible. 
Figure 54. Comparison of the percentage of cellular population with a forward scatter higher than 448 bits (larger cells) in the three 
streams of the process (from figure 53): feed, retentate (cells that did not cross the membrane, in side A) and permeate (cells that 
have crossed the membrane, in side B); *p<0.05. N=3 for each point. 
The cellular population fed to the experiment was composed of an average of (23±4)% of cells larger than 
the arbitrary value of FS=448. On the other hand, the cellular population harvested from the experimental 
setup after 1h of contact with the flat­sheet membrane from the retentate side was statistically smaller 
(composed of (11±5)% larger cells). A possible explanation could be related with the high depletion of the 
population of cells with large size but negatively expressing CD235a, more obviously observed in 
experiment 1, due to the higher concentrations of MNCs used in this experiment: comparing figures 53A 
and 53B, the cellular population marked with a red circle in the feed side is almost inexistent in the 
retentate side. These cells positively express CD45 (figure 52A), and based on their relative position in the 
FS vs. SS plot, this population is composed of monocytes and a small percentage of granulocytes (Basford et 
al. 2010). Monocytes are white blood cells and in vivo are an important part of the immune system, whose 
main function is to migrate into sites of injury and differentiate into macrophages and dendritic cells to 
elicit an immune response (Kaushansky et al. 2010). A possible explanation for their depletion after 1h of 
contact with the polycarbonate membrane could be due to their attachment as an immune response to the 
membrane surface – an observation that has been previously reported in literature (Matheson et al. 2002; 
Bieback et al. 2004). Nevertheless, the cellular population expressing the CD235a antigen remained with a 
similar size throughout the test, before (feed) and after (retentate side) contact with the polycarbonate 
membrane, as observed in the corresponding top two quadrants of the flow cytometry plots in figures 53A 
and 53B, respectively. 
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Referring to figure 54 again, it was found that the relative cell size of the population that crossed the 
membrane (permeate side) was statistically smaller than that of the cells that remained without crossing 
(retentate side). This cell size discrimination was observed for the whole cellular population harvested, i.e., 
those cells with sizes above the arbitrary threshold value of FS=448 did not appear in the samples collected 
after transmembrane crossing, regardless of their antigen expression. This could be attributed to the size 
discrimination of the membrane, which does not allow the crossing of cells larger than the established 
threshold value. 
To visually observe this difference in size, experiment 1 was used as an example. The studied plots of 
CD235a vs. CD45 were given a third dimension, by combining those results with the relative cell size in the 
FS channel (figure 55). It is possible to observe the size discrimination of the membrane, by comparing the 
cellular population in plot 55B (retentate) with that in plot 55C (permeate): the larger cells fed to the 
membrane were retained (below the red plane). 
Figure 55. Flow cytometry 3D plot of CD45 (y axis) vs. CD235a (x axis) vs. forward scatter (z axis) of experiment 1. An arbitrary 
plane on the FS channel, represented in shaded red, has been drawn in the 3D plots to observe the apparent cellular size cut-off by 
the membrane (above which cells appear to be absent from the permeate side – see text for details). Three phases of the 
experiment are represented: fed cells (A); retentate side after 1h, with the cells that did not cross the membrane (B); and permeate 
side after 1h, with the cells that crossed through the membrane (C). 
The numbers of cells crossing the membranes were also assessed. There was an average crossing rate of 
the total cellular population of (83.7±28.8)x10
4
 cells.cm
­2
.h
­1
, of which the flow rate of CD235a
+
 cells only 
(red blood cells and their progenitors) was (12.5±4.6)x10
4
 cells.cm
­2
.h
­1
 through the flat­sheet membranes.
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4.3. CONCLUSION
Two different membrane types were assessed in this chapter for their suitability to be used in the HU and 
the LU circuits, respectively, of the bioreactor under development. For the HU circuit, a membrane with a 
high permeability to small solutes but high rejection to the diffusion of proteins (herein represented by the 
model protein α­lactalbumin) was conceptualized. Polymeric materials were preferred for this application 
due to their lower brittleness, production costs and MWCO control, when compared with ceramic 
materials. Polyethersulphone is one of the best polymeric materials in terms of mass transfer for aqueous 
applications found off­the­shelf (Rong et al. 2006). The results have shown that a membrane with a 10kDa 
MWCO would have a diffusivity to glucose of (3.3x10
­7
 cm
2
.s
­1
), which is very similar to the glucose diffusion 
coefficient within islets of Langerhans in the human pancreas, of 3.8x10
­7
 cm
2
.s
­1
 (Kauri et al. 2003). This 
could be a good candidate; however, PES membranes were also shown to be ineffective when in contact 
with organic solvents, which required further developments for this membrane in subsequent chapters. 
On the other hand, the proof­of­concept for RBC harvesting using a membrane was also established using a 
polycarbonate track­etch membrane with 2µm nominal pore size in flat­sheet configuration. It was shown 
that the size cut­off provided by the membranes offered a discrimination of the cellular population by size, 
as determined by flow cytometry analysis. Nevertheless, polycarbonate is not stable in contact with organic 
solvents, particularly because of the large pore sizes produced in the membrane surface by the track­etch 
method, which render its structure a lower stability. Therefore, a more stable material, but with the 
selectivity properties of this membrane was also required. 
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CHAPTER 5 
CHAPTER 5.
DESIGN AND FABRICATION OF THE 3D DUAL-HF BIOREACTOR
"From now on we live in a world where man has walked on the Moon. 
It is not a miracle; we just decided to go." 
Tom Hanks (1969) 
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5.1. INTRODUCTION
Only in the last two decades membrane materials resistant to organic solvents started to become widely 
available (Livingston et al. 2003). These include many polymeric membranes such as polyacrylonitrile, 
poly(vinylidene fluoride), polyimide, etc. as well as ceramic membranes, such as aluminium oxide 
(Vandezande et al. 2008). The latter are often more brittle and with lower mechanical strength than 
polymeric membranes, but are chemically inert, thermally more resistant and usually offering better mass 
transport due to the larger pore sizes they can sustain. Both membrane types have thus advantages and 
disadvantages, which induces the development of an hybrid system that could take advantage from both 
types. 
Polymeric membranes, such as polyacrylonitrile (PAN), are widely used for applications particularly in the 
ultrafiltration field, such as pervaporation, water treatment, enzyme immobilization and haemodialysis 
(Wang et al. 2007). On the other hand, PAN also presents excellent properties, such as good thermal and 
mechanical stability, tolerance to most solvents and commercial availability (Zhang et al. 2010), and hence 
a very good candidate for solvent contact. This material also presents a very flexible surface for chemical 
treatment, to render it more hydrophilic and reduce the pore size distribution, to allow for a better tuning 
of the membrane molecular discrimination, as detailed in section 2.10.6 (p. 81). 
Ceramic fibres, on the other hand, are continuous fibres made of metal oxides. Their major advantages are 
the excellent thermal resistance (up to 1650°C) and high modulus and compressive strength, whilst 
presenting an outstanding chemical stability and the ability to be woven into fabrics for use in various 
reinforced plastic structures (Harper and Petrie 2003). Moreover, this high stability confer them a suitability 
to sustain much larger pore sizes than polymeric fibres while still maintaining their structure, which confers 
on them a better choice for microfiltration applications. Hence, the development of the LU circuit could 
benefit from these characteristics. Hollow fibres made of aluminium oxides are produced at Imperial 
College by Professor Kang Li’s group (Kingsbury and Li 2009). Fibres are prepared from a mixture of 
alumina, N­methyl­2­pyrrolidone and polyethersulphone resulting, upon phase inversion into a water bath, 
in the production of finger­like voids that can be controlled by the viscosity of the dope solution ((Kingsbury 
and Li 2009)). Other parameters, such as the air gap between the dope solution and the coagulation bath 
and the addition of a non­solvent (water) into the dope solution (to render it more viscous), have also been 
found to play a major role in the development of these fibres. Upon sintering, the polymeric material is 
burnt off and the alumina particles fuse together, rendering the fibres a much higher modulus strength 
than for polymeric membranes (Loeb and Sourirajan 1963; Kingsbury and Li 2009). The pore size 
distribution at the outer layer of the membranes can be slightly reduced with an increase in the sintering 
temperature (Kingsbury 2010). 
Membranes in hollow fibre configuration are particularly useful in different disciplines such as fluid 
transport and purification, optical guidance, and drug delivery. These membranes offer several advantages 
over other configurations: i) a wide surface area for the mass exchange in a small volume, ii) 
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compartmentalization in a well­defined 3­dimensional microstructure and iii) perfusion without shear 
stress. Their molecular weight cut­off (MWCO) can be tailored to allow diffusion of nutrients, waste 
products, and the external humoral factors that are beneficial to regeneration across the membrane tissue 
interface (growth factors), but e.g. exclude the transport of large immunogenic molecules. Hollow fibre 
bioreactors possess a number of advantages when compared to other designs proposed in literature, 
specially their capacity to sustain a higher cellular density whilst promoting negligible shear stresses for the 
cells being grown. However, different gaps in literature have also been found, particularly the difficulties in 
harvesting the cells produced (figure 19, p. 74). 
5.1.1. Aim 
The main aim of this chapter will be to further develop both membrane types towards achieving good 
candidates to withstand the harsh conditions required during the scaffolding process, without structural 
damage. Having established the concept for the membranes in the previous chapter, using 
polyethersulphone for the HU circuit and polycarbonate for the LU circuit, these membranes have been 
shown to be ineffective to be used within the structure of a porous scaffold, particularly due to their poor 
performance in organic solvents. The designed membranes should possess a high stability throughout the 
scaffolding process, which involves the contact with: 
 Organic solvents: 1,4­dioxane when polyurethane scaffolds are produced; 
 Low temperatures: Very low temperatures (as low as liquid N2) are usually used to solidify the 
polymer/solvent dope solution; 
 Vacuum: In order to remove the solvent from the scaffold, the membrane should withstand the 
dryness through vacuum for at least 2 to 3 consecutive days; 
Moreover, considering the advantages of hollow fibres in regards to the other bioreactor designs presented 
in the literature reviewed, the choice of materials should also easily allow the in­house fabrication of the 
membranes in this configuration. The properties of both membrane types, set in the previous chapter, 
should also be observed, towards achieving a functional membrane system that would allow the efficient 
use of GFs whilst providing a sufficient level of nutrients with the simultaneous removal of metabolites to 
the cells being grown and the continuous harvesting of mature RBCs, upon triggered differentiation using a 
cytokine cocktail. The integration of these characteristics into the design of the bioreactor proposed would 
allow the development of three novel features that could aid in tackling the challenges pointed out of 
current state­of­the­art technologies: 
 Feature 1: the first 3D hollow fibre bioreactor, composed of a porous polymeric scaffold integrated 
with hollow fibres; 
 Feature 2: the first usage of a dual hollow fibre system for the recycling of GFs whilst discarding and 
renewing cell culture media; 
 Feature 3: the first inclusion within a bioreactor design of an automated and continuous harvesting 
of mature red blood cells. 
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5.1.2. Methodology 
The design of the bioreactor was based on tackling the gaps found in the current technologies. In general 
terms, a suitable bioreactor for the production of clinically relevant RBCs should intrinsically mimic the 
human BM whilst containing the costs of such production within reasonable values, so a unit of RBCs 
produced could compete in terms of costs with current practices: blood donations cost on average around 
£135 per unit of packed RBCs (Timmins and Nielsen 2009). Having established a comparison between the 
human BM and existing bioreactor designs for stem cell bioprocessing, it was clear that the geometry of HF 
bioreactors would resemble better its structure, whilst allowing a higher cellular density within the 
bioreactor (as shown in table 9, p. 71) to maximize productivity, reducing costs and space requirements. 
This allowed conceptualizing the three important novel features mentioned above that will be further 
developed in this chapter. To achieve each of these objectives, both the high­ and the low­uptake 
membrane types, whose concept was established in chapter 4, were further developed in this chapter. 
Particularly, the materials of construction of the membranes were required to be chemically stable to 
sustain the harsh conditions of the scaffolding process and easy production into hollow fibres. 
The fabrication of the LU membrane was conducted in collaboration with Dr. Benjamin Kingsbury, a fellow 
PhD student working in Professor Kang Li’s group at Imperial College. Dr. Kingsbury’s PhD thesis, entitled 
“Morphological Study of Ceramic Hollow Fibre Membranes: A Perspective on Multifunctional Catalytic 
Membrane Reactors” (Kingsbury 2010), focused on the development of microporous ceramic hollow fibres. 
The in­house expertise on the use and optimization of these HFs was very helpful in the development of 
this membrane, particularly because it allowed performing the studies herein reported with the crossing of 
cells, hence establishing one of the key features required for the bioreactor: cellular harvesting. Studies on 
the cellular transmembrane crossing were performed using isolated mononuclear cells (MNCs) and red 
blood cells (RBCs) from human UCB (as detailed in section 3.7.5, p. 103) using the designed hollow fibre 
bioreactor setup (depicted in figure 36, p. 101). 
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5.2. RESULTS AND DISCUSSION
5.2.1. Development of a 3D HF bioreactor: a porous scaffold immersed with hollow fibres 
5.2.1.1. Design of a 3­dimensional culture 
The human BM offers a unique microenvironment wherein a complex network within the stem cell niche 
modulates self­renewal and pluripotency of resident HSCs. It is composed of a porous 3D structure, mainly 
composed of ECM tissue, which is supported by the blood vasculature. This well organized structure is also 
observed in other mammals such as the rat (figure 56), and is thought to play a very important role in the 
development of HSCs and their progeny. 
Figure 56: SEM micrograph of a rat bone marrow, with a venous sinusoid in large detail, alongside the 3D microstructure that 
characterizes the in vivo blood producing factory (Kaushansky et al. 2010).
The literature review on the integration of 3D structures with bioreactor technology (section 2.9, p. 69) has 
provided an insight into the different techniques currently being investigated to provide this growth 
geometry in a controlled environment. Designs such as the spinner flasks, rotating bioreactors and direct 
flow systems have been shown to support 3D growth (Botchwey et al. 2003) through the use of cell 
encapsulation (Song et al. 2010a), hydrogels, microcarriers (Ye et al. 2007), polymeric scaffolds (Botchwey
et al. 2003), etc. However, these designs still limit the size of the scaffolds thereby reducing the scale­up 
potential, and the microenvironment is not optimized for the culture of HSCs. It would thus be desirable to 
recreate the natural or synthetic polymeric scaffolds that have been studied in literature for potential 
tissue engineering applications (Placzek et al. 2009) without compromising mass transfer. The in vivo 3D 
architecture has also been observed to have nutrient limitations and cell hypoxia at distances greater than 
200μm from a blood vessel (Botchwey et al. 2003). These polymeric scaffolds offer several advantages over 
hydrogel­based encapsulation techniques, such as a higher mechanical stability and better physical support 
for cellular growth. On the other hand, when cells become confluent during the culture period, the cell 
mass occupies most of the available space within an hydrogel, drastically reducing mass transport; but, 
when using polymeric scaffolds, cells occupy approximately 60% of the void volume, with the rest 
comprising small cell­impermeable interconnected pores (10µm), which aids mass transport (Li et al. 1998). 
Comparing the architecture of a hollow fibre bioreactor with the highly vascularized BM, one can 
immediately establish a striking resemblance between both structures. On the other hand, the adaptation 
of the 3­dimensional structure in the bone marrow with a localized mass transport of important molecules 
to renew the HIM, using blood vessels, can definitely be seen as an evolutional advantage as it also offers 
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the possibility for the promotion of a heterogeneous microenvironment that is essential to promote 
optimal conditions to an array of different cells – with different nutrient necessities – that coexist in the 
bone marrow. From the engineering point of view, this association also offers enormous advantages, as it 
helps tackling several problems related with scaling­up designs in what concerns to localized mass 
transport and especially in the design of new and improved bioreactors for regenerative medicine: a 
synthetically “vascularized” bioreactor, or a hollow­fibre bioreactor. 
The human BM was shown to accommodate a 3­dimensional growth of cells while promoting a healthy 
level of nutrients and oxygen through its vascular network. It can also achieve very high cellular densities, 
with up to 5x10
8
 cells.mL
­1
 having been reported (Peng and Palsson 1996). A possible solution to achieve 
such high cell densities whilst continuing to provide a sufficient level of nutrients and metabolites in vitro
could be through the association of HFs made of porous materials (through which nutrients and 
metabolites can be exchanged) with a 3D structure (wherein cells can attach and grow). HF bioreactors 
have been shown to be able to accommodate at least up to 2x10
8
 cells.mL
­1
 (Chaudhuri and Al­Rubeai 
2005), a value still under the efficiency of the in vivo example, but promising in terms of future 
developments. 
5.2.1.2. Integration of the membrane concept with the 3D design – Thermal­Induced Phase 
Separation 
If the 3D growth of cells has been shown to be important for cell culture, as it better resembles the in vivo
architecture, it was also shown that vascularization is also paramount to allow using large 3D structures 
(Botchwey et al. 2003). In order to tackle the engineering challenges identified, the combination of 3D 
designs with the permeability properties of membranes appears to be a feasible approach to fulfil these 
demands. One of the methods most widely used for the production of medical­grade scaffolds that are 
biocompatible and promote growth and proliferation of cells is thermal­induced phase separation (TIPS) 
(Safinia et al. 2005). This involves the dissolution of the chosen polymer material into an organic solvent, 
such as dioxane or dimethylcarbonate (Blanco et al. 2010), followed by freezing and finally lyophilisation of 
the solvent to leave a porous polymeric scaffold in place. The liquefaction of the polymer during this 
process allows architecting the scaffold to a pre­set mould, thus establishing a defined bioreactor 
geometry. The major hurdle in combining membranes with 3D structures constructed through this method 
is that it must be present throughout every step of the scaffolding process, and hence resist the harsh 
conditions required to attain a 3D polymeric structure. Hence, the membranes used e.g. to carry nutrients 
throughout the scaffold 3D network must also possess a high chemical and physical stability to the three 
main extreme conditions required for scaffolding (figure 57): a) contact with an organic solvent (within 
which the scaffold polymeric material has been dissolved); b) low temperatures (required to freeze the 
solvent/polymer blend, which can be as low as ­198°C); and c) drying by vacuum over a period of 3 days 
(used for removing the solvent from within the polymeric structure). Because of the relatively young field 
of research into organic solvent­resistant membranes (Livingston et al. 2003), no work, up to my 
knowledge, has been published that incorporates solvent­resistant membranes into the design of 
bioreactors for tissue engineering applications with a view of producing scaffolds around them by the TIPS 
method. 
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Figure 57. Diagram depicting the scaffolding process conditions used to test the resistance of screened membrane materials. 
5.2.1.3. Cryo­temperature assessment (resistance of materials) 
The hollow fibre bioreactor being developed should be constructed of materials resistant to cryo­
temperatures due to the requirements of the scaffolding process (freezing at ­86°C for 2h). Hence, the 
different materials that compose both the bioreactor (PFA, PVDF and epoxy resin) and the hollow fibres 
(ceramic and PAN) need to be studied for their properties under low temperatures in order to realize if 
these materials would suffer any structural damage. When a material is cooled down to cryogenic 
temperatures, there is also the development of thermal stress (Kada et al. 2002). It can appear as a 
transient effect e.g. when cooling down thick walled components or it can appear as permanent load e.g. in 
piping. In both cases the stress can cause damage. As the expansion coefficient of most materials decreases 
with temperature, most contraction takes place above liquid nitrogen temperature (Scardi et al. 1996). 
Low coefficients of thermal expansion would be ideal in order to avoid cracks in the system, which would 
lead to severe leakages and loss of sterility of the bioreactor afterwards. The following terms need to be 
defined:  
i. Coefficient of expansion (COE): a measure of the change in length or volume of an object; 
ii. Coefficient of thermal expansion (CTE): a thermodynamic property of a substance that 
relates the change in a material’s linear dimensions, being defined as the fractional change 
in length per degree of temperature change; 
The linear CTE is the one­dimensional length change in temperature and can be calculated by formula (13) 
(Riemer 1989). 


  ∙ 	
, (13)
Where αL is the thermal expansion coefficient, L0 is the original length, L is the new length and ΔT the 
temperature change. 
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Table 20 summarizes some characteristics of these different materials, in order to assess their feasibility 
together when the temperature is lowered to ­86°C and afterwards increased to room temperature. 
Table 20. Characteristics of the different materials used in the construction of the hollow fibre bioreactor under development.
Material 
Melting 
point (°C) 
Low temperature 
embrittlement (°C) 
Linear CTE 
(x10
­5
 °C
­1
) 
Density at 25°C 
(g.cm
­3
) 
References 
PFA 
(Perfluoroalkoxy) 
305 ­268 13 2.15 
Row Inc. 
2008 
PAN 
(Polyacrylonitrile) 
317 N/A 6.5 1.18 
Omnexus 
2010 
PVDF 
(Polyvinylidene fluoride) 
171 ­62 4.2 1.77 TexLoc 2010 
Epoxy resin <175 ­50 1.5 ­ 10 N/A 
University of 
Bolton 2010 
Ceramic HF 
(Alumina) 
2050 N/A 0.65 3.98 
University of 
Bolton 2010 
Using formula (13) and the linear coefficients of thermal expansion for each material used in the 
construction of the bioreactor on table 20, it is possible to determine the expansion of each material from 
room temperature (25°C) to the scaffolding freezing temperature (­86°C) (table 21). It is worth to note that 
the CTE is rarely linear for all the temperature ranges, thus making a study of the material length change 
with the temperatures under study not very accurate through the use of only one value. Therefore, the 
conclusions reported on table 21 are merely illustrative and to compare the performance between the 
different materials. It is possible to observe that all the materials used to build the bioreactor have very 
similar structural changes, below 1.5% reduction. This suggests that the freezing of these materials could in 
principle be accomplished without major disruption to the bioreactor’s components. 
Table 21. Calculated changes in the length of different materials when subjected to a low temperature of -86°C. 
Material 
Linear 
CTE 
(x10
­5
 °C
­1
)
Initial length
at 25°C 
(L0, cm)
To ­86°C 
Final length 
(L, cm) 
Change (%)
PFA 
(Perfluoroalkoxy) 
13 14.0 13.80 ­1.44 
PAN 
(Polyacrylonitrile) 
6.5 14.0 13.90 ­0.72 
PVDF 
(Polyvinylidene fluoride) 
4.2 3.0 2.99 ­0.47 
Epoxy resin 
1.5 to 
10† 
2.0 
2.00 to 
1.98 
­0.17 to ­1.11 
Ceramic HF 
(Alumina) 
0.65† 14.0 13.99 ­0.07 
† having diﬀerent sources and heterogeneous composi=on, the proper=es of these materials will depend largely on the method
and materials used for their manufacture. 
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5.2.1.4. High­Uptake Membrane: resistance to the scaffolding process 
Polyacrylonitrile (PAN) (figure 58) is a polymer material with very good thermal stability, usually used in 
membrane ultrafiltration (Jung 2004), and particularly in tissue engineering applications in bioartificial 
organs (Wang et al. 2007) and haemodialysis (Silk et al. 1977; Nyberg et al. 1993). There are several reports 
in literature regarding surface modification of PAN towards more hydrophilic surfaces (Kim et al. 2002; 
Yang 2002; Jung 2004; Zhang et al. 2010), and hence less prone to fouling. At the same time, surface 
modification of the membranes also allows better controlling their MWCO. The initial experiments were 
performed to assess the permeability of this material to glucose, as well as its suitability to reject the model 
protein. 
Figure 58. Chemical structure of polyacrylonitrile: 3D molecular structure (A) and chemical formula (B). Adapted from: 
http://www.tennoji-h.oku.ed.jp.
Unmodified PAN membranes were available in the laboratory, being developed for nanofiltration 
applications, which provided a good platform bed to start working with. In fact, Linder et al. 1991 patented 
a method in which membranes prepared with this composition were cross­linked by immersion in a 1% 
(wt/v) sodium ethoxide solution (for 5 min), drained and then heated to 115 °C for 30 min, having achieved 
a solvent stable membrane that could reach nanofiltration MWCOs (~600 Da). More specifically, the 
rejections reported for this modification were 45% for raffinose (~600 Da) and 94 % for dextran 70kDa at 
14bar. Even though tighter membranes are required (offering over 90% rejection to 10kDa molecules
1
), this 
observation offered a good starting point. 
The first step in the studies of PAN membranes was to test the resistance of this material to the scaffolding 
process in HF configuration. PAN hollow fibre membranes spun from a mixture of PAN/DMF have been 
found to become very brittle after drying (Beder 1979), which was observed experimentally with a 
noticeable change of colour from transparent to white opaque immediately after removing the fibres from 
water. These fibres were easily broken with a clear reduction of the diameter. For this reason, HF 
membranes were post­treated by dipping them in glycerol prior to the experiments (particularly for the 
scaffolding process). 
Figure 60 shows the SEM pictures obtained for the PAN HFs prepared before and after the scaffolding 
treatment, composed of 15wt% in DMF. From the morphological point of view, the scaffolding process did 
not appear to influence the structure of the HFs. To further prove this, permeability and rejection studies of 
these membranes before and after the scaffolding treatment were made, in order to observe if the 
functionality of the membranes remained the same. Diffusivity measurements of the HFs were performed 
1
 This is the definition of a membrane with 10kDa molecular weight cut­off. 
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and determined as described in section 4.1.2 (p. 120). In order to assess the influence of the scaffolding 
treatment towards the functionality of the membranes, the permeability to nutrients (using glucose) and 
metabolites (using lactate) was examined in these experiments. Three different surface treatments of PAN 
(15wt% in DMF) hollow fibre membranes were investigated and compared in terms of their corresponding 
permeabilities: i) no surface treatment; ii) hydrolysed with 2M NaOH for 30min at 55°C; and iii) hydrolysed 
as sample ii) followed by scaffolding with PU around the HFs. A comparison of the overall mass transfer 
coefficients determined for both glucose and lactate for the three different surface­treated membranes can 
be found in figure 59. 
Figure 59. Effect of surface treatment of PAN hollow fibres (made of 15wt% in DMF) to the mass transfer coefficient of glucose and 
lactate. The three steps of the production of the fibres were studied: i) non-treated membranes; ii) after surface hydrolysis with 2M 
NaOH at 55°C; and iii) after scaffolding around the hollow fibres with polyurethane. Each value represents the average of at least 3 
samples and a maximum of 8 samples. No statistical significance was found between the different surface treatments for each 
molecule tested.
From the results obtained, it was possible to conclude that the hydrolysis of the membranes rendered them 
only marginally more permeable to both glucose and lactate, although this was not statistically significant. 
More importantly, the scaffolding of the HFs did not appear to influence the permeability properties of the 
membranes. To further support this observation, SEM pictures of the HFs were taken before and after 
contact for a period of at least 8h with two commonly used organic solvents to perform TIPS: 
dimethylcarbonate (DMC) and 1,4­dioxane (figure 60). It was possible to observe that, morphologically, the 
HFs remained stable after contact with these solvents. This result supports the hypothesis that this 
membrane can be used to design a membrane bioreactor with a scaffold around it. The 3D structure 
mimicked during these tests (scaffolding with polyurethane) has previously been demonstrated to support 
the growth and viability of stem cells in culture (Blanco et al. 2009). 
The average mass transfer coefficient of glucose measured after the scaffolding treatment was 
(22.4±3.0)x10
­6
 cm.s
­1
, which is higher than the same value in a healthy human’s aorta of (6.8±0.2)x10
­6
cm.s
­1
 (Ghosn et al. 2008).  
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5.2.1.5. Low­Uptake Membrane: resistance to the scaffolding process 
After being shown in the previous chapter that a membrane with a defined pore size of around 2µm could 
be used for harvesting of RBCs, it was essential to find a solvent­resistant material that could easily be 
prepared in hollow fibre configuration and have similar permeability characteristics to the polycarbonate 
flat­sheet membranes tested. Polycarbonate was already known to be soluble in a large number of organic 
solvents, and particularly 1,4­dioxane, which is used for the production of the scaffolds (Berry et al. 1967). 
This was also tested in the laboratory, by dipping a polycarbonate membrane into a glass containing 50mL 
of 1,4­dioxane, which after 24h was completely dissolved in the solvent. Considering the production of the 
scaffold around the HFs requires the sublimation of this organic solvent over a period of 3 consecutive days, 
this material is not suitable to be used for the scaffolding process. 
In order to withstand the harsh conditions of the scaffolding step, whilst presenting large pores that would 
allow the crossing of RBCs, polymeric membranes appear to be inefficient. In fact, solvent­resistant 
polymeric membranes are usually used for nano­ and ultra­filtration (Livingston et al. 2003), having very 
few applications in the micro­filtration range, due to the collapse of their structure when trying to increase 
their pore size. Ceramic membranes, on the other hand, made of continuous fibres of metal oxides have a 
high modulus and compressive strength and an outstanding chemical stability (Harper and Petrie 2003), 
which confers them a suitability to sustain much larger pores than polymeric fibres while still maintaining 
their structure. HF ceramic membranes were prepared using the protocol developed by Kingsbury 2010 
(further detailed in section 3.4.3, p. 96) and diffusivity measurements to glucose, lactate and BSA were 
performed in order to evaluate two important characteristics: 1) the influence of the scaffolding treatment 
and the coating process towards the overall mass transfer of these molecules through the membranes; and 
2) the efficiency of this membrane to deliver nutrients (e.g., glucose) and serum proteins (e.g., BSA) and 
remove metabolites (e.g., lactate). Diffusivity measurements were performed and determined as described 
in section 4.1.2 (p. 120). 
Figure 61 resumes the results obtained for the diffusivity properties of the bioreactor for the three 
different molecules tested: a nutrient (glucose), a metabolite (lactate) and a protein (BSA). The diffusivity to 
BSA is of particular importance for this membrane, as one of its features is the delivery of the GFs and 
proteins that cannot be supplied through the HU membranes, in the dual HF bioreactor. The results have 
shown that the scaffolding process does not appear to influence the behaviour of the HFs towards allowing 
the diffusion of the molecules tested, without statistically significant differences of the membrane 
permeability before or after scaffolding and coating of the scaffold with collagen. In fact, it can also be 
observed that the diffusivity of the molecules is not dependent on their size, as glucose and lactate (with 
MW of 180 and 90g.mol­1, respectively) have a similar mass transfer coefficient to BSA (MW of around 
66,000g.mol­1), of (39.5±4.3)x10­6cm.s­1. This suggests the feasibility of this membrane to be stable 
throughout the scaffolding process to allow the foaming of a porous scaffold around it and also in providing 
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proteins to the cell culture. Moreover, its high permeability to both glucose and lactate also highlight the 
possibility to use this membrane on its own for the provision of a healthy level of nutrients and removal of 
cellular metabolites from within the scaffold, for applications that may not require the use of GFs – such as 
the cytokine­free expansion of MNCs that will be assessed in chapter 6. 
Figure 61. Summary of the mass transfer coefficients measured for the ceramic hollow fibres towards nutrients (glucose), 
metabolites (lactate) and proteins (bovine serum albumin, BSA). The effect of the scaffold manufacturing process (before scaffolding, 
after scaffolding and after protein coating of the scaffold) towards the behaviour of the fibres is also represented: A) influence of each 
process towards the diffusivity of each of the molecules studied – each value represents one experiment; B) overall influence of each 
scaffolding step towards the mass transfer of the three molecules studied – each value represents the average and SD of the results 
obtained for the three molecules used (glucose, lactate and BSA).
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5.2.2. Efficient use of growth factors by a “dual hollow fibre” system 
5.2.2.1. The “dual hollow fibre” concept 
An important aspect of tissue engineering for ex vivo production of clinically relevant cell numbers is 
related with the maintenance of the stemness of the cells in culture. However, this has been quite 
challenging, particularly due to the high GF concentrations used in current ex vivo expansion systems, 
which trigger their commitment and/or differentiation towards more mature cell lineages, hence losing 
their expansion potential. In the first 2D ex vivo haematopoiesis culture established by Dexter (Dexter et al.
1977), high concentrations of EPO (2,000­3,000mU.mL
­1
) have been found to be necessary to promote 
erythropoiesis, whereas lower concentrations (200mU.mL
­1
) were unable to support the formation of 
erythroid cells (Dexter et al. 1981; Mantalaris et al. 1998). However, in a 3D packed bed perfusion 
bioreactor this lower concentration of EPO promoted erythropoiesis with 60% of the total cell number 
being erythroid cells after 4 weeks (Mantalaris et al. 1998), representing one of the lowest EPO 
concentrations reported in literature to promote erythropoiesis ex vivo. 
In vivo, EPO levels in the serum of a healthy human are in the order of 20mU.mL
­1
 (Kaushansky 2006), 
produced at an average rate of 460mU.day
­1
 per kg body weight (Coles et al. 1992). In ex vivo cultures, this 
production rate is compensated by the addition of exogenous EPO, and in some cultures with a further 
support using feeder cells (such as stromal cells), which are thought to provide a biochemical support. Fed­
batch cultures, such as the successful protocols developed by Giarratana et al. 2005, replace the media 
containing the growth factors periodically (every 3 to 5 days in this protocol). 
Due to the consumption rates of the cells as well as the ex vivo degradation rate of EPO (Schmidt et al.
2004), the levels of this molecule in culture will decline between feeding times, promoting different 
activities due to lower concentrations. Thus, in order to maintain a significant level of action by EPO, these 
cultures require the addition of high concentrations of exogenous EPO in the fresh media to compensate 
for this decline. On the other hand, in perfusion systems, which provide fresh media continuously, it was 
found that EPO was effective at lower concentrations (Mantalaris et al. 1998), suggesting that the feeding 
strategy of the culture could play an important role. This is probably due to the different molecular profiles 
observed throughout the culture period between both configurations (figure 62), wherein continuous 
perfusion maintains a more stable concentration level of the molecules in culture, whilst providing fresh 
media with higher frequency, hence requiring lower levels of EPO in the feed. The stress caused to the cells 
due to the periodic changes as well as the abnormally high concentrations of GFs that are known to trigger 
cellular differentiation, such as EPO, in fed­batch systems could be one of the causes for the loss of 
stemness of stem cells in culture. 
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Figure 62. Comparison of the concentration profile of nutrients and metabolites throughout the culture period in fed-batch and 
perfusion systems. Adapted from: Cha 2010.
The excessive use of GFs in these cultures is a limitation for large­scale applications, particularly due to the 
costs involved. The different protocols for the successful expansion of stem cells and their targeted 
differentiation towards RBCs that have been published (table 7, p. 64) claim the feasibility to be applied in a 
large­scale scenario. However, the large costs associated with the clinically relevant numbers required have 
been overviewed (Timmins and Nielsen 2009). All of these have been performed in flat 2­dimensional tissue 
culture flasks, using fed­batch cultures to feed the cells (Giarratana et al. 2005; Fujimi et al. 2008; Lu et al.
2008). Taking the target of 5 transfusable units of RBCs, and applying the protocol developed by Giarratana
et al. 2005 would require an area equivalent to two tennis courts (or 166m
2
 filled with tissue culture flasks) 
and a total cost of £41,650 for the media alone (Timmins and Nielsen 2009). Considering 5 blood units 
donated through the Red Cross or the British National Blood Service would cost overall around £670, which 
is over 60 times less (figure 63), the challenges in terms of space and costs to be overcome in order to bring 
this technology into the bedside are obvious. 
Figure 63. Comparison between traditional blood donations with the cost and space requirements to produce 5 units of RBCs in the 
laboratory using current expansion protocols. Costs of blood donations include collection, transport and storage; costs for ex vivo
production by other sources takes into account the costs for media only in the protocol developed by Giarratana et al. 2005. Data 
retrieved from Timmins and Nielsen 2009.
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Published protocols for stem cell expansion and production of RBCs provide all the required molecules 
(nutrients, proteins, cytokines, etc.) in a single feeding stream. However, the consumption rate of GFs is 
much lower than that of glucose, and whilst the media containing metabolic products must be discarded 
and replaced by fresh media, it inevitably contains unconsumed GFs. This leads to a much higher 
requirement of these expensive molecules in ex vivo cultures when compared to the in vivo consumption 
rates (as observed in table 7, p. 64). Whilst one HSC has been found to consume around 8.6x10
­3
 nmol.day
­1
of glucose in ex vivo conditions, it will only consume 8.2x10
­13
 nmol.day
­1
 of EPO in the same conditions 
(Koller et al. 1995), a 10­log difference (table 22). On the other hand, concentrations of the order of 
3,000mU.mL
­1
 (5.8x10
­3
 nmol.mL
­1
 (Douay et al. 1991)) of EPO and 3.8x10
4
 nmol.mL
­1
 of glucose (a 7­log 
difference) have been reported successful for the ex vivo generation of enucleated human RBCs from HSCs 
(CD34
+
 cells) in the presence of stromal cells (Giarratana et al. 2005). This difference in the feeding ratio of 
EPO/glucose, also observed in other culture systems such as the stirred spinner flask (Kim 1998) and the 
perfusion Aastrom Replicell (Engelhardt et al. 2001) (both with a 9­log difference) is related with the 
necessity of providing an optimal concentration of each molecule, required at a minimum concentration in 
culture in order to be effective. 
Table 22. Comparison of the ex vivo consumption rates of glucose and EPO by HSCs with the amount of these molecules provided 
in three different cell culture environments. †ex vivo consumption rates by HSCs as determined by Koller et al. 1995. 
Consumed by 
HSCs†
(x10
3
 nmol.cell
­1
.day
­1
) 
T­flask
(Giarratana et al. 2005) 
[mmol.mL
­1
.day
­1
]
Spinner Flask
(Kim 1998) 
[mmol.mL
­1
.day
­1
] 
Aastrom RepliCell
(Engelhardt et al. 2001) 
[mmol.mL
­1
.day
­1
] 
Glucose 8.6 1.0x10
4
1.3x10
4
1.8x10
4
EPO 8.2 x 10
­10
1.1x10
­3
1.3x10
­5
1.7x10
­5
Ratio x10
10
(EPO/Glucose) 
1.0 1,140.0 9.5 9.4 
It was seen in the literature review the importance of EPO to trigger erythropoiesis (section 2.8.2, p. 65), 
without which, and even in the presence of other important cytokines such as SCF, IL­3 and IL­6 in 
perfusion bioreactor systems, erythroid lineage disappears after 2 weeks of culture (Koller et al. 1993; 
Mantalaris et al. 1998). Hence, this is an essential factor that must be present in culture to achieve proper 
maturation of stem cells towards the erythroid lineage. Due to the presence of these cytokines or GFs in 
the media, this represents the largest part in the expansion costs of current protocols (Timmins and Nielsen 
2009) – in fact, cytokines alone represent 57% of the media costs used in the protocol developed by 
Giarratana et al. 2005 (figure 64). 
A problem common to both perfusion and static bioreactor configurations is the minimum concentration 
level required of these GFs. The discarded media, containing the metabolic products removed from the 
culture system, is also composed of expensive growth factors, which were not taken up by the cells. On the 
other hand, it was shown on table 7 (p. 64) that spinner flasks, which use a fed­batch system where the 
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culture media is replaced periodically, have a much lower waste of GFs than that observed in the state­of­
art Aastrom RepliCell geometry (Engelhardt et al. 2001), whose continuous perfusion of the media, hence 
continuous replacement of the whole culture molecules, leads to a much higher use of resources and hence 
a more expensive expansion. Because a continuous process is easier to operate and is more beneficial to 
the cells, it is crucial to develop a better system that could optimize the use of GFs, allowing the use of 
concentrations closer to the values that are biologically required. This would allow reducing the costs to a 
minimum to optimize the industrial process, whilst providing a more stable environment for cellular 
development and a better controlled differentiation of the stem cells. 
Figure 64. Detailed analysis of the relative costs of different media components used for the production of red blood cells in 2D 
cultures using the method developed by Giarratana et al. 2005 – costs of growth factors and other significant macromolecules used 
on the media are plotted in further detail to the right and the left of the main plot, respectively. Data retrieved from Timmins and 
Nielsen 2009.
An approach that could result in a remarkable improvement in the use of growth factors could be by 
recycling these molecules, while cleaning the cellular environment from toxic and inhibitory metabolic 
products and providing important nutrients. In order to achieve this, two different inlet/outlet streams in a 
perfusion configuration are required. Due to the mentioned benefits of membrane technology, this can be 
achieved through the use of a different membrane in each of the streams (figure 65): 1) a high­uptake 
membrane (HUM) to nourish the cells by providing the small molecules these consume abundantly but are 
relatively inexpensive (e.g., glucose); and 2) a low­uptake membrane (LUM) to provide the large molecules 
that cells consume in a lesser amount (e.g., growth factors such as EPO). This strategy would then allow 
recycling the stream containing the growth factors (through the LUM) whilst discarding the stream 
containing the metabolites produced and other cell debris. In order for this dual membrane configuration 
to be functional, the HUM should be designed to prevent growth factors to enter the stream being 
discarded, in a function similar e.g. to that of the human kidneys, which are responsible to filter the blood 
by removing the metabolic products, whilst preventing the waste of blood cells (figure 20, p. 75). 
Figure 65. The dual membrane concept. The low-uptake membrane would allow recycling GFs whilst the high-uptake membrane 
would clear the system from toxic metabolic products and provide nutrients that are highly required by the cells.
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5.2.2.2. Design of the dual HF Bioreactor 
Common HF designs incorporate a single inlet and outlet to the bioreactor, facilitating its construction. 
Different configurations, however, have been presented. This includes the design of the Multicoaxial 
bioreactor developed by Wolfe et al. 2002, composed of four concentric tubes disposed one inside the 
other to provide two parallel streams supported by a third for gas exchange, which are used specially with 
the aim to promote a constant flow of nutrients through the cellular compartment and efficient 
oxygenation (figure 66). The most outer tube is the housing and is made of polycarbonate 6cm long with 
13mm outer diameter (OD), around a Silastic (Kivisaari and Niinikoski 1973) tube 9cm long (aeration fibre, 
AF) with 7.9mm OD for aeration; the next tube is a polysulphone HF with 0.1µm pore size, 3mm OD and 
11cm in length (middle fibre); and finally the most inner tube is a polysulphone HF with 0.65µm pore size, 
1.2mm OD and 15cm in length (inner fibre). The cell compartment is located in the space created between 
both polysulphone membranes, and the higher pressure promoted in the middle fibre compared to that in 
the inner fibre promotes flow convection through the cell compartment. 
Figure 66. Multicoaxial bioreactor, with an overall view of the design (A) and a more detailed description of the system of concentric 
fibres (B). IF- inner fibre; MF- middle fibre; AF- aeration fibre; M1- manifold 1 for provision of the extracapillary space with nutrients 
through the IF; M2- manifold 2 for provision of the extracapillary space with nutrients through the MF; M3- manifold 3 for oxygenation 
through the AF. Adapted from: Wolfe et al. 2002. 
The interesting feature in this design is the method disclosed to provide the HF bioreactor with multi­inlets. 
This is created by a concentric disposition of the hollow fibres, which are potted to the bioreactor in turns: 
the most outer fibre is potted in first place using epoxy (the AF, potted to manifold 3 in figure 66), followed 
by the middle fibre (potted to manifold 2) and finally the inner fibre (potted to manifold 1). This provides an 
interesting observation for a method to dispose different HF types into the bioreactor being developed in 
this project. 
The materials of construction for the bioreactor shell were chosen in order to resist low temperatures and 
solvent contact, due to the conditions required by the scaffolding process. Perfluoroalkoxy (PFA) is resistant 
to cryo­temperatures with a good chemical stability, while also offering the added advantages of allowing a 
visual inspection of the scaffold produced due to its relative transparency, a high robustness to be reused 
and a biocompatible material. Hence, it was decided to build the bioreactor shell using this material.
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5.2.2.3. High­Uptake Membrane development and characterization 
5.2.2.3.1. Shrinkage of PAN membranes after hydrolysis 
The studies on the surface modification of PAN membranes started by first potting the HFs into the 
bioreactor, and then perform hydrolysis of the membranes in situ. This would allow studying the influence 
of the surface treatment towards the behaviour of the membranes in a more reproducible way, since the 
same membrane could be used for comparison, hence reducing the batch­to­batch error in the results. It 
would also allow an easier fabrication method, without having to manipulate the fibres after hydrolysis. 
However, it was found that the rejection to the model protein of the hollow fibres before and after in situ
hydrolysis remained apparently unchanged, which was counter­intuitive in comparison to the observations 
made before using flat­sheet membranes. To observe any structural changes in the hollow fibres due to 
hydrolysis, two sets of membranes were prepared and observed under SEM (figure 67): PAN hollow fibres 
before (67A, 67B and 67C) and after (67D, 67E and 67F) hydrolysis treatment with 2M NaOH for 30min at 
55°C. 
Figure 67. Representative SEM pictures of hollow fibre PAN membranes prepared of 15wt% in DMF, before (A, B and C) and after 
(D, E and F) hydrolysis treatment with 2M NaOH for 30min at 55°C. Magnifications of 100x (A, B, D and E) and 350x (C and F). 
Observing the SEM pictures of the PAN membranes before and after hydrolysis, it was possible to observe 
that this surface treatment leads to a slight change in the morphology of the membranes. More specifically, 
it was possible to perceive that the diameter of the hollow fibres reduced around 33% in size after 
hydrolysis (from 1.2mm to 0.8mm). The fact that up to this point the hydrolysis of these fibres was being 
made in situ, i.e., after having cured the bioreactor inlets with epoxy, the diameter reduction after 
hydrolysis of the fibres might have been the cause of having found poor rejection performances by the HFs 
to the model protein α­lactalbumin. For this reason, all subsequent bioreactors were prepared by treating 
the surface of the PAN membranes before potting the bioreactor. 
A Novel 3D Dual Hollow Fibre Bioreactor for the Production of Human Red Blood Cells 
© Imperial College 2011 158
5.2.2.3.2. Studies on the surface hydrolysis of PAN hollow fibres 
Due to their chemical structure, PAN membranes are ideal candidates for ultrafiltration applications that 
require contact with organic solvents, whilst allowing the exchange of nutrients and metabolites with the 
feeding stream and preventing the crossing of large protein molecules. In order to take advantage of its 
chemical structure, surface hydrolysis has been identified in literature as a good method to render higher 
hydrophilicity to these membranes, which could in principle increase permeability to small molecules and a 
higher resistance to protein adsorption (Jung 2004). This experiment intended to assess two different 
parameters: 
1. The percentage of PAN in the dope solution with DMF – 13, 15 or 18wt%; 
2. The effect of surface treatment by hydrolysis with NaOH; 
PAN hollow fibre membranes with three different compositions (13, 15 or 18wt%) in DMF were prepared 
according to the protocol in section 3.3.2.2 (p. 93) and the hydrolysis of the membranes was performed as 
described in section 3.3.2.4 (p. 93), by using 2M NaOH at 55°C for 30min as suggested by Yang and Tong 
1997. Figure 68 summarizes the results obtained for the protein adsorption of each membrane (through a 
mass balance to the protein) as well as for the rejection of the membranes with time. It is worth of note 
that a statistical analysis was not performed on this data due to the number of samples collected per 
experiment (N=2) – nevertheless, both experiments performed for each data point were in agreement, with 
their average values presented in figure 68. 
From the results obtained, it was observed that in the experiments using the membranes without surface 
treatment, the model protein α­L was not detected in solution at least after 20h on average of the start of 
the experiments. This was due to the protein being adsorbed onto the surface of the unmodified 
membranes (Valette et al. 1999). On the other hand, the hydrolys of the membranes allowed maintaining 
the mass balance of α­L within steady levels throughout the 48h that the experiments lasted. In terms of 
their capacity to prevent the crossing of α­L, it was observed that after 20h of experiment, the protein 
started to diffuse through the membranes, resulting in very low rejection values after 48h. Even though the 
tightest membrane tested (18wt% in DMF) presented a higher rejection than the other two looser 
membranes, as expected, this was considered a very low performance as only 42% of the protein could be 
retained. 
Hence, surface modification of the PAN HFs required further developments, although these experiments 
allowed identifying that the high concentration of 18wt% PAN in DMF would achieve the best results in 
terms of protein rejection. It is worth to note that even though higher concentrations of polymer could in 
principle further increase the rejection properties of fabricated membranes, the solubility of PAN in DMF 
limited a further increase of this percentage (higher concentrations of polymer were tried but proven to be 
very difficult to achieve). This required searching for other methods to improve this feature.
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5.2.2.3.3. Membrane annealing 
Experiments using PAN flat­sheet membranes and tested using a dead­end filtration cell at 10bar pressure 
(setup depicted in figure 32, p. 94) for their rejection to polyethylene glycol (PEG) with a molecular weight 
(MW) of 10kDa were previously performed. Due to the need to retain proteins with a molecular weight 
larger than 14kDa, the rejection of this solute by the membrane under pressure would provide an idea of 
its performance when used in the diffusion­driven experiments. Analysis of the solute in the three phases 
(feed, permeate and retentate) after dead­end filtration by dry­weight measurements provided 
information regarding the rejection properties. In order to assess a feasible surface treatment to further 
increase the MWCO of these membranes, filtrations before and after surface treatment by hydrolysis with 
2M NaOH for 30min at 55°C were performed. 
A comparison of the results obtained for the membranes before (unmodified) and after hydrolysis is 
presented in table 23. It was possible to observe that the surface treatment of the membranes rendered 
them a tighter structure, observed by the increase of the rejection to PEG 10kDa from (51.3±1.1)% (on the 
unmodified membrane) to (95.3±1.3)% (after hydrolysis). This observation confirmed the feasibility of 
modifying the surface of PAN membranes with a tighter structure, and hence a higher rejection to solutes 
in the MW range of 10kDa (herein represented by the PEG molecule) – observed by a remarkable decrease 
in the fluxes of pure water and concentrated PEG solution by nearly 98% and increase of the rejection to 
the solute to over 95%. However, these experiments were performed using a dead­end filtration cell at 
10bar pressure, conditions very different from those required for the bioreactor: hollow fibre configuration 
and without applying any pressure, with molecular exchange by diffusion only.
Table 23. Rejection and flux results of either pure water or a 20g.L-1 PEG 10kDa solution for two different surface-treated PAN 
membranes (15wt% in DMF), after dead-end cell filtration at 10bar. Hydrolysis protocol was performed using 2M NaOH at 55°C for 
30min. N=3 for the unmodified membrane and N=2 for the hydrolysed membrane. 
PAN surface 
treatment 
Rejection to PEG 
10kDa (%) 
Water Flux 
(L.m
­2
.h
­1
) 
PEG10kDa Flux 
(L.m
­2
.h
­1
) 
Unmodified 51.3±1.1 705.1±57.4 350.5±8.9 
Hydrolysis with 
NaOH 
95.3±1.3 16.4±7.8 4.6±0.4 
Having observed that by applying a pressure of 10bar to the flat­sheet membranes had allowed obtaining a 
membrane system that could reject the model protein, whilst without applying such pressure in the hollow 
fibre configuration that was not observed, an important conclusion could be made. The collapse of the PAN 
structural matrix due to the high pressure applied in the flat sheet configuration could be responsible for 
the increase of the rejection to the model protein. Hence, it could be worth trying to do the same, or 
similar, procedure to the hollow fibre configuration. Since the hollow fibre configuration is not supported 
by a backing material, unlike wise the flat sheet membranes, applying pressure to collapse the matrix 
structure would be quite challenging, and hence it was decided to try to anneal the hollow fibre 
membranes by boiling them at high temperatures, such as suggested by some papers (Kim et al. 2002; Jung
et al. 2005). This process would promote a higher staibility to the PAN matrix structure, and could in fact 
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mimic the behaviour observed when high pressure is applied in the flat­sheet configuration – reducing its 
pore size or matrix structure to prevent the crossing of large molecules, in the size range of the model 
protein α­lactalbumin. Moreover, annealing of PAN membranes has been found to be a very fast process: 
non­annealed membranes would have 0% rejection to polyethylene glycol (PEG) molecules with 10kDa 
MW, which was increased to over 90% after 10s of annealing at 96°C and remained unchanged even after 
30s of annealing (Kim et al. 2002). Hence, the lowest annealing time, of 10s at 96°C, was chosen to perform 
the experiments. 
5.2.2.3.4. Optimization of the surface hydrolysis procedure 
The next step was to optimize the surface hydrolysis of PAN HFs, by treating their surface with different 
conditions, and study if membrane annealing followed by surface hydrolysis could aid increasing their 
rejection performance to proteins. In order to maintain the standardization of the samples, all membranes 
were made of 18wt% PAN in DMF and annealed in water at 96°C for 10s prior to hydrolysis surface 
treatment, as described in the previous section. To perform these experiments, four bioreactors in parallel 
were used – each composed of a different surface treatment of the PAN hollow fibres (as detailed in 
section 3.3.2.4, p. 93): 1) annealing only at 96°C; 2) annealing at 96°C followed by hydrolysis at 60°C with 
2M NaOH for 25min; 3) annealing at 96°C followed by hydrolysis at 60°C with 1M NaOH for 25min; 4) 
annealing at 96°C followed by hydrolysis at 80°C with 1M NaOH for 25min; 5) annealing at 96°C followed by 
hydrolysis at 60°C with 2M NaOH for 125min. A summary of the mass transfer coefficients and the 
corresponding diffusivities to a nutrient (glucose) and a metabolite (lactate) as well as the rejection 
performance to the model protein α­lactalbumin are presented in table 24 and figure 69. Measurements 
for the membranes hydrolysed at 60°C with 2M NaOH for 125min were not presented as the hydrolysis 
procedure was too violent and resulted in the dissolution of the membranes. 
Table 24. Permeability results of the PAN hollow fibres to both glucose (nutrient) and lactate (metabolite) molecules (all PAN 
membranes are 18wt% in DMF and annealed in water at 96°C for 10s). KOV- overall mass transfer coefficient; D- diffusion coefficient 
through the membrane. †lactate diffusion coefficient in water (at 37°C)= 480x10-8 cm2.s-1 (McNee et al. 1982);††glucose diffusion 
coefficient in water (at 37°C)= 924x10-8 cm2.s-1 (Curcio et al. 2005); N=3 for all experiments. 
Surface 
treatment
Property 
Only annealing 
Annealing and 
hydrolysis at 60°C 
with 2M NaOH. 
Annealing and 
hydrolysis at 60°C 
with 1M NaOH. 
Annealing and 
hydrolysis at 80°C 
with 1M NaOH 
Thickness (µm) 195.7±18.8 206.7±6.1 225.8±4.0 217.7±15.6 
KOV for Lactate 
(x10
6
 cm.s
­1
)
13.8±2.3 15.3±2.8 28.5±4.5 31.4±2.8 
D for Lactate
†
(x10
8
 cm
2
.s
­1
)
24.9±4.1 30.7±5.6 64.4±10.1 64.7±5.8 
KOV for Glucose 
(x10
6
 cm.s
­1
)
16.3±5.5 19.5±10.2 31.6±0.1 50.6±4.3 
D for Glucose
††
(x10
8
 cm
2
.s
­1
)
29.4±10.0 38.9±20.4 71.3±0.2 104.2±8.9 
Protein adsorbed after 
2x75h (μg.cm
­2
)
292.4 113.2 190.1 146.8 
Rejection to α­L 
(% after 75h)
80.3 93.9 88.8 92.5 
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Figure 69. Comparison of the influence of four different surface treatments of the PAN hollow fibres towards their performance in 
terms of high permeability to nutrients (glucose) and metabolites (lactate) and high protein rejection (results plotted from table 24). 
N=3 for the experiments measuring KOV and N=1 for the protein rejection values. ** p<0,01 when compared to the other three measurements for 
glucose; * p<0,05 when compared to the other two measurements for lactate; all other differences are not statistically significant. 
From the results obtained, it was possible to observe the influence of both the temperature of hydrolysis 
and the concentration of NaOH towards the efficiency of the membranes in terms of permeability to 
glucose and lactate and the rejection to α­L. For the same temperature, hydrolysis at 1M NaOH provided 
better permeability than at 2M for both molecules, although the difference was only statistically significant 
for glucose; on the other hand, the rejection to α­L was increased from 1M to 2M – this could be related to 
the tighter membranes that resulted from the hydrolysis at 2M NaOH. When increasing the temperature of 
hydrolysis from 60°C to 80°C with hydrolysis at 1M NaOH, a further improvement of the membranes was 
observed, although only the permeability to glucose this time was statistically significant. This was probably 
due to a more completed hydrolysis reaction that rendered the membrane with a higher hydrophilicity, and 
hence better permeability in an aqueous environment. Moreover, this increase in the temperature has also 
impaired the membrane with a slightly better rejection to α­L. 
In order to compare the different surface treatments of PAN HFs studied in these experiments, the 
rejections to the model protein α­L obtained for each membrane treated with time are presented in figure 
70. As observed before, the membranes without any surface treatment add a very high protein adsorption, 
which reduced the rejection to 0% (due to the absence of protein in solution). The use of annealing only has 
allowed increasing the resistance of the membrane to protein adsorption, probably due to the 
condensation of the polymer matrix that resulted in a lower surface area of contact between the solution 
and the membrane. To further observe this effect, SEM pictures of each of the surface­treated HFs were 
taken and presented in figure 71. In fact, annealing of the HFs decreased their diameter, due to the 
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compression of the PAN matrix as referred; this could directly influence the increase in protein rejection 
(due to a tighter membrane) and decrease in protein adsorption as observed on table 24. Increase of time 
of hydrolysis rendered the membranes with increasing diameters, which was better observed on the 
membranes hydrolysed for 125min, which after the treatment had become jelly and very difficult to 
handle. This observation had already been reported in literature (Yang and Tong 1997). 
Figure 70. Influence of the surface treatment of PAN (18wt% in DMF) hollow fibres towards rejection to the protein α-lactalbumin. 
N=1 for all experiments. 
The annealing of the membranes followed by the hydrolysis of their surface with NaOH was thus shown to 
be effective in achieving membranes with high protein rejection (up to 94% after 75h of contact between 
two streams) and high permeability to glucose and lactate. Even though surface hydrolysis with 2M NaOH 
for 25min at 60°C resulted in the best rejections to α­L (figure 70) out of the conditions tested, the 
membranes hydrolysed with 1M NaOH at 80°C offered the best permeabilities to glucose and lactate 
(figure 69). Hence, the best compromise in terms of high rejections to α­L / high permeabilities to glucose 
and lactate was considered to be that for the latter treatment. The mass transfer coefficients measured to 
glucose was (50.6±4.3)x10­6cm.s­1 and to lactate was (31.4±2.8)x10­6cm.s­1, which is a very good 
improvement on the permeability to both molecules tested in regards to previous results, without 
annealing (section 5.2.2.3.2, p. 158). The permeability to glucose of this membrane has over 7 times better 
permeability to the same molecule than an healthy human’s aorta, which is (6.8±0.2)x10
­6
 cm.s
­1
 (Ghosn et 
al. 2008). It is also worth of note that the permeability to glucose by this membrane is higher than the 
permeability measured for the ceramic hollow fibres [(39.5±4.3)x10
­6
cm.s
­1
], even though ceramic 
membranes have a looser structure than the polymeric PAN membranes. This could suggest a higher 
hydrophilicity of the PAN membranes when compared to the ceramic ones, which allows for a more 
efficient mass transport of water molecules. 
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Figure 71. SEM pictures of PAN (18wt% in DMF) hollow fibre membranes with different surface treatments: unmodified, annealed at 
96°C for 10s only, annealed and hydrolysed (1M NaOH) at 80°C for 25min, annealed and hydrolysed (2M NaOH) at 60°C for 25min, 
annealed and hydrolysed (1M NaOH) at 60°C for 25min, annealed and hydrolysed (2M NaOH) at 60°C for 125min. 
PAN annealed at 96°C for 10s and 
hydrolysis (1M NaOH) at 80°C for 
25min 
PAN unmodified PAN annealed at 96°C for 10s 
PAN annealed at 96°C for 10s and 
hydrolysis (2M NaOH) at 60°C for 125min 
PAN annealed at 96°C for 10s and 
hydrolysis (1M NaOH) at 60°C for 25min 
PAN annealed at 96°C for 10s and 
hydrolysis (2M NaOH) at 60°C for 
25min 
PhD Thesis by H. Macedo 
© Imperial College 2011 165
5.2.2.3.5. FTIR analysis of hydrolysed PAN hollow fibres 
Fourier­transformed infra­red (FTIR) spectroscopy analysis was performed on the surface­treated PAN HFs 
to study the chemical composition at the surface of the membranes, as well as the efficiency of the method 
used to hydrolyse the membranes. From the hydrolysis mechanism of PAN hollow fibres in basic conditions 
(25, p. 82), it was seen that three major species can be present at the surface of the membranes: the non­
reacted species (with a CH­CN terminal bond), a semi­reacted species (polyacrylamide with a CH­CONH2
terminal bond) and a fully­reacted species (polyacrylic acid with a CH­COOH terminal bond). This means 
that the full reaction can be followed through the amount of –COOH and –CONH2 groups present in the 
hollow fibres through an FTIR analysis (Yang and Tong 1997). Figure 72 presents the FTIR spectra obtained 
for the different treated membranes, alongside the identification of some peaks related to the functional 
groups involved in the reaction of PAN with NaOH. 
Figure 72. FTIR spectrum analysis of different surface-treated PAN (18wt% in DMF) hollow fibres: unmodified, annealed at 96°C for 
10s only, annealed and hydrolysed (1M NaOH) at 60°C, annealed and hydrolysed (2M NaOH) at 60°C, annealed and hydrolysed 
(1M NaOH) at 80°C. All hydrolysis treatments were performed for 25min followed by thorough washing in cold (4°C) PBS. Blue 
shaded areas represent the peaks corresponding to unmodified PAN; red shaded areas represent the peaks corresponding to the 
products of hydrolysed PAN. 
Moharram et al. 2002 proposed a method to study the interaction between both of the most important 
products resulting from the hydrolysis of PAN (polyacrylamide and polyacrylic acid). By analysing the 
absorbance ratios of A(1700 cm
−1
)/A(1450 cm
−1
) and A(1650 cm
−1
)/A(1450 cm
−1
) they have found a 
correlation in terms of the decrease/increase of the concentration of each molecule in solution – this was 
done to observe the influence of ­irradiation on the structure of both polymers, independently, and even 
though very small changes were found during their study, a correlation of both these ratios with the 
intensity of radiation was found. These ratios were also used to observe the influence of the different 
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hydrolysis treatments towards the modification of the surface of PAN hollow fibres, and presented in table 
25. The peak at around 1700cm
−1
 in the spectrum corresponds to the stretching absorption band of the 
carbonyl group C=O (corresponding to polyacrylic acid) (Moharram et al. 2002); the peak at 1650cm
−1
corresponds to the C=O bond of polyacrylamide (Murugan et al. 1998; Moharram et al. 2002); and at 
1450cm
−1
 corresponds to the aliphatic nitrile group C≡N of the unreacted species. Hence, an increase of the 
ratios of A(1700 cm
−1
)/A(1450 cm
−1
) and A(1650 cm
−1
)/A(1450 cm
−1
) would indicate a modification of the 
surface of the PAN membranes. 
Table 25. Influence of different PAN surface treatments towards three different reference peaks as suggested by Moharram et al.
2002. 
Surface treatment 
A(1700cm
­1
)/ 
A(1450cm­1) 
A(1650cm
­1
)/ 
A(1450cm­1) 
Non­treated 0.15 0.28 
Annealed only 0.12 0.24 
Hydrolysis (1M) at 60°C 0.27 0.32 
Hydrolysis (2M) at 60°C 0.31 0.39 
Hydrolysis (1M) at 80°C 0.51 0.61 
Used in bioreactor 
(hydrolysis with 1M 
NaOH at 80°C) 
0.52 0.57 
From table 25 it is possible to observe that the hydrolysis of the PAN hollow fibres does enhance the peaks 
corresponding to the two species identified as products for the hydrolysis reaction (polyacrylic acid and 
polyacrylamide). Both these molecules are hydrophilic, and hence an increase of their presence at the 
surface of the membranes would indicate a consequent increase in the hydrophilicity of the membranes. As 
expected, membrane annealing does not influence this ratio: by comparing the annealed only membranes 
with the non­treated membranes, the ratios of the reacted and unreacted species remain very similar. 
The large peak correspondent to the aliphatic nitrile group on the PAN unmodified membrane is reduced 
with an increasing hydrolysis reaction, being replaced by the increase in the peaks corresponding to the 
carbonyl groups in the reacted species. This increase in the reaction rate, followed by the increase of the 
peak ratios represented in table 25, is also directly linked to the increase of the permeability of the 
membranes to both glucose and lactate, as discussed before. Comparing in terms of the influence of NaOH 
concentration towards the hydrolysis of the membranes, the reactions at 60°C have shown a similar 
concentration of reacted species, although a concentration of 2M achieved a slightly higher reaction rate 
than 1M. Nevertheless, the data suggests that this is a process highly governed by the temperature of the 
reaction: increasing the temperature to 80°C has increased substantially the concentration of reacted 
species, which was also observed in the permeability experiments. Comparing the effectiveness of the 
hydrolysis between the sample hydrolysed at 80°C and the one used in the bioreactor (hydrolysis 
performed with the same conditions), it is also possible to conclude that this procedure is reproducible.
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5.2.2.4. Low­Uptake Membrane development and characterization 
An available method for production of precursor fibres that would attain a pore­size distribution in the 
range required (2 to 3µm) after sintering (Kingsbury 2010) was further studied by changing the maximum 
sintering temperature of these fibres. Three different sintering temperatures were studied initially: at 1450 
1500 and 1600°C. The lower temperature to be studied was chosen for having been shown to have a pore­
size distribution in the upper range of the required value (of around 3µm) – lower sintering temperatures 
would attain larger pore sizes (Kingsbury 2010) –, and the higher temperatures were chosen in order to 
study the influence of increasing the sintering temperature towards the overall structure of the HFs. SEM 
pictures of the fibres were acquired and are presented in figure 73. Table 26 presents some physical 
properties measured for these membranes, particularly their mechanical bending strength and the outer 
diameter. 
Comparing the membranes presented in figure 73 and table 26, it is possible to observe that the sintering 
of the fibres at higher temperatures leads to a reduction in the fibre diameter (around 6.7% reduction for 
an increase of 50°C in the sintering temperature from 1450 to 1500°C and only a further 1.9% reduction 
when increasing to 1600°C). This is followed by morphological changes in the structure of the HFs: those 
sintered at the lower temperature (1450°C) have a higher number of large finger­like pores traversing the 
membrane than those sintered at 1500°C or 1600°C. The increase in the sintering temperature leads to a 
tighter membrane (with a lower pore­size distribution) that are also mechanically more stable (table 26). It 
is also important to notice the size decrease of the finger­like pores with an increase of the sintering 
temperature – whilst for the membranes sintered at 1450°C (figure 73A) these are seen traversing the 
whole thickness of the membrane, connecting the inner to the outer surface, these large pores are almost 
entirely blocked for the membranes sintered at 1600°C (figure 73C). Taking these observations into 
account, and even though the fibres sintered at 1450°C are mechanically weaker than the other tested 
fibres, the larger number of pores would in principle provide a better flux of RBCs through the membranes, 
due to the greater void space available. Therefore, the compromise between cellular flux/mechanical 
stability led to choose the ceramic hollow fibres sintered at 1450°C as the preferred protocol to continue 
the investigation. In fact, handling of the HFs proved to be a challenge due to their relative brittleness, 
increasing the difficulty in potting them on the bioreactor shell. However, the gentle handle of the hollow 
fibres together with the use of araldite epoxy for potting have shown to be successful in allowing the 
assembly of the bioreactor using these fibres. 
Table 26. Comparison of the characteristics of the hollow fibres after different sintering temperatures (N=3 for each point). 
Sintering temperature 
(°C) 
Mechanical 
strength (MPa) 
Outer diameter 
(μm) 
1450 130.6 ± 8.7 770.5 ± 14.4 
1500 210.5 ± 8.8 718.8 ± 22.4 
1600 355.5 ± 26.4 705.2±8.6 
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Figure 73. SEM pictures of hollow fibres sintered at different temperatures: 1450°C (A), 1500°C (B) and 1600°C (C). Three different 
magnifications were used for each membrane, in order to observe the finger-like pores and the inner surface pore density. The outer 
(ØO) and inner (Øi) diameters of the fibres are also represented in the figure alongside the corresponding sintering temperatures. 
Further SEM pictures were taken from the ceramic HFs sintered at 1450°C for a closer morphological 
evaluation (figure 74). The pore­size distribution of these membranes is asymmetric, as visible in the SEM 
pictures, with different pore­size distributions in the inner and outer layers. Moreover, from figure 74B it 
can be seen that the finger­like pores, which traverse the membrane from the outer to the inner surface, 
have a smaller diameter in the outer surface that increases with the proximity to the inner surface. This is a 
significant observation for the function of the HFs, since the preferential selectivity of the membranes 
should be in the outer layer – in contact with the scaffold where cells are growing and RBCs harvested. 
Having a smaller pore­size distribution in this layer allows better controlling the selectivity properties of the 
membrane, and preventing clothing due to funnelling of the cells. 
Figure 74. Scanning electron micrographs of a home-made ceramic hollow fibre membrane: (A) inner surface and (B) detail of the 
cross section of a ceramic membrane sintered at 1450°C. 
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To further study the pore­size distribution in the outer surface of these membranes, a mercury 
displacement porosimetry (MDP) analysis was performed. However, due to the higher pore­size 
distribution on the inner surface of the hollow fibres, it was necessary to block the ends of the fibres using 
epoxy resin to prevent intrusion of the mercury preferentially through the inner side (as seen in figure 74). 
Figure 75 presents the results obtained for the MDP analysis of the fibres. The calculated pore sizes are 
plotted against the differential mercury intrusion into the pores, as explained in section 2.10.2 (p. 76). From 
this analysis, it can be seen the fibres have a bimodal pore size distribution, which is in accordance with 
literature and corresponds to the finger­like pores (the larger pores through which the majority of the mass 
transport takes place) and the sponge­like pores (the smaller pores observed that provide mechanical 
stability to the fibres), respectively (Kingsbury and Li 2009). The larger pores of (3.1±0.7)µm characterize 
the membrane outer surface pore­size distribution and the smaller pores, with a wider distribution and a 
peak at around 0.35µm, correspond to the sponge­like region of the ceramic HFs. Having an average pore­
size distribution of 3.1µm in its surface, these membranes could allow the crossing of RBCs (as proven using 
the polycarbonate flat­sheet membranes). However, and even though the large finger­like pores appear to 
be connecting the outer surface of the HF with its inner surface (figure 74B), it was still required to prove if 
these pores are effectively linked to the inner surface of the membrane to allow the complete traverse of 
RBCs through the membrane. This was studied in the next section. 
Figure 75. Mercury displacement porosimetry analysis of the outer surface of the ceramic hollow fibres sintered at 1450°C. The 
larger plot shows no pores in the range above 4μm on the outer layer of the membrane, whilst the magnification in the smaller pore-
size ranges shows the larger pore-size distribution on the outer surface of the membrane to be 3.1±0.7μm.
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5.2.2.5. Scaffold characterization 
In order to determine the quality of the scaffold material and porosity for tissue engineering applications, 
its morphological characteristics were determined by MDP. In order to study the pore size distribution 
inside the scaffold, alongside the distribution of pores when ceramic hollow fibres are present, two samples 
were analysed: 1) scaffold obtained from a bioreactor without fibres; and 2) scaffold obtained from a HF 
bioreactor having 2 ceramic hollow fibres immersed. Measures of porosity and total pore area were 
collected (table 27) as well as the pore size distribution (figure 76). The pore size distribution of the PU 
scaffold produced ranged from 20­200μm, with a pore distribution peak at around 100μm. It was also 
observed that the presence of the HFs originated an extra peak from the scaffold itself, at around 0.3µm, 
which corresponds to the mercury intrusion into the sponge­like structure of the ceramic HFs (as it is 
absent from the sample without HFs). This corresponds to about 3.5% of the scaffold total void volume as 
calculated from the plots in figure 76 and is responsible for the perfusion of nutrients throughout its 3D 
network. This is not the actual pore distribution of the ceramic hollow fibres in the outer layer, as seen 
from figure 74 (p. 168), which is overlapped by the pore­size distribution of the scaffold itself. 
Table 27. Mercury displacement porosimetry analysis of the bioreactor PU scaffold with and without ceramic hollow fibres immersed. 
Sample Porosity 
BET surface 
area (m
2
.g
­1
) 
PU without fibres 79.1 230.0 
PU with ceramic hollow fibres 
immersed 
81.7 230.0 
Figure 76. Mercury displacement porosimetry of PU scaffolds produced with (darker line) and without (lighter line) ceramic hollow 
fibres immersed. 
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On the other hand, for both cases, with and without HFs immersed within the scaffold, 29.7% of the void 
volume of the scaffold is composed of pores smaller than 11µm (calculated from figure 76). According to Li 
and colleagues, a large percentage of the void volume of scaffolds usually used for tissue engineering 
applications (up to 40%) is composed of pores smaller than 10µm. This is essential to maintain the mass 
transport properties of the scaffold itself after cells reach confluency, since this void volume cannot be 
filled by the cells due to their small size and can thus maintain the interconnectivity between the pores for 
mass transport (Li et al. 1998). Around 60% of the scaffold void volume is composed of pores ranging from 
14­180μm, with a peak at around 90μm. This renders the scaffold suitable for tissue engineering 
applications since there is enough space for cells to disperse and grow, whilst allowing the establishment of 
niches within the protection of the scaffold pores. 
The coating with collagen type I of the scaffold was also analysed. In order to observe the differences in the 
scaffold morphology, SEM pictures of the scaffold before and after coating with this protein were obtained 
(figure 77). It can be observed that the coating procedure of the scaffold with collagen was successful, and 
also that it properly connects the scaffold 3D matrix to the hollow fibres (figure 77D). This protein is one of 
the main components of the human bone marrow ECM, responsible for promoting a strong mechanical 
contact between the scaffold material and the cells (Blanco et al. 2010), providing a further step towards 
mimicking the human bone marrow microenvironment. 
Figure 77. SEM pictures of hollow fibre membranes immersed within PU scaffolds before (A and C) and after (B and D) collagen 
type I coating. 
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5.2.3. Continuous cellular harvest by transmembrane crossing 
5.2.3.1. Learning from nature: the endothelial layer 
Up to my knowledge, the idea of using a membrane to selectively allow the crossing of mature cells to be 
harvested from within a cell culture system has not yet been proposed. It is intended to incorporate the 
design of the bioreactor with such feature, in a way to separate the growing undifferentiated HSCs from the 
differentiated RBCs. The use of membrane technology to achieve this purpose is another advantage of this 
field, especially if one considers that this process in vivo is accomplished by a membrane (Grant et al. 1981; 
Inoue and Osmond 2001; Ribatti et al. 2007). In order to determine and highlight the differences between 
immature stem cells and definitive blood cells, and therefore being capable of separating them, the study 
of the in vivo BM is essential. The complex vascular network that composes the BM (figure 78) has been 
shown to be responsible for harvesting the differentiated blood cells from the marrow and injecting them 
into the blood stream, while limiting the passage to the other undifferentiated cells (Inoue and Osmond 
2001). 
Figure 78. (A) Simplified schematic diagram of the external architecture of the bone marrow and its trabeculae protected within the 
bone cavity. (B) Schematic drawing of the BM cellular environment indicating the stem cell niche and maturational niches towards 
the sinusoid. OB, osteoblast; HSC, hematopoietic stem cell; Gr, granulocyte; AD, adipocytes; MK, megakaryocyte; MΦ, 
macrophage; T, T cells; B, B cells; E, erythroid progenitors; RE, reticular endothelial cells. Adapted from: Panoskaltsis et al. 2005. 
It is known that in vivo RBCs have to cross through 3µm diameter capillaries and 2 to 3µm slits in the 
reticuloendothelial sinusoids. Being 7 to 8 µm sized, an erythrocyte is able to accomplish this task by 
elongating, tank treading, and otherwise deforming to pass through (as already shown in figure 16, p. 59). 
Thus, during its 120­day life span, the erythrocyte must undergo extensive passive deformation and must 
be stable to resist fragmentation (Narla 2006). The use of membrane technology, in order to achieve this 
purpose, appears to be one of the best solutions to tackle this problem, especially if one considers that this 
process in vivo is accomplished by a membrane (Grant et al. 1981; Inoue and Osmond 2001; Ribatti et al.
2007). Considering the results obtained using a polycarbonate flat­sheet membrane in section 4.2.2 (p. 
130), a membrane with 2µm pore size could be a good starting point for the design of the low­uptake 
membrane.  
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5.2.3.2. Harvesting of RBCs through ceramic hollow fibres 
In order to observe the functionality of the ceramic HFs to harvest RBCs from within the 3D scaffold porous 
structure, a single­type hollow fibre bioreactor was assembled and used to filter RBCs, isolated from 
umbilical cord­blood. The setup used is depicted in figure 31 (p. 92), wherein two streams (A and B) were 
putted in contact through the centrally­positioned membrane and fluid was circulated in either side in a co­
current mode, maintaining a positive pressure differential from side A to side B of around 2mbar. A mixture 
of RBCs and MNCs was inserted into side A of the membrane and circulated for 1h at a flow rate of 60mL.h
­
1
 at 37°C. The results obtained in three separate independent experiments are herein reported. The 
fraction of human UCB containing red blood cells (RBCs) and mononuclear cells (MNCs) were isolated into 
separate containers by a Ficoll­Paque separation method (section 3.4.1, p. 95), and counted. Afterwards, 
cells from each container were mixed together to attain a final volume of 30mL in IMDM, in order to have 
different ratios of RBCs/MNCs per experiment, as summarized in table 28. 
Table 28. Initial cell seeding densities in each experiment to study the cellular transmembrane crossing through a 2µm 
polycarbonate flat-sheet membrane. Cells were mixed in a total volume of 30mL of IMDM, and injected in side A of the membrane. 
Parameter Experiment 1 Experiment 2 Experiment 3 
Seeded cells
(x10­5 cells.mL­1) 
100.1 84.6 100.1 
RBCs
(x10
­5
 cells.mL
­1
) 
50.0 59.7 50.1 
MNCs
(x10
­5
 cells.mL
­1
) 
50.1 25.0 50.0 
Ratio RBCs/MNCs 1.0 2.4 1.0 
In order to observe the transmembrane crossing of RBCs, SEM pictures of the ceramic HFs upon completion 
of the experiments were taken (figures 79 and 80). The pictures proved the concept of RBC harvesting 
through these membranes, which they can traverse by squeezing through, as more closely observed in 
figure 79B. In fact, this figure represents the concept idealized for this membrane – a normal RBC at rest 
with a diameter of around 7µm can be observed in figure 79B (i), whilst another RBC is just emerging from 
within the membrane into the lumen of the HFs in figure 79B (ii). A number of other cells with a 
morphology similar to that of RBCs can also be seen emerging into the HFs, as depicted in fake colour red in 
figure 79C. 
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Figure 79. Red blood cells crossing the ceramic hollow fibre with magnification of 500x (A) and 2,500x magnified from the shaded 
area in A (B). For an easier identification of the red blood cells in the picture, Photoshop was used to colour these cells in fake colour 
red (C). In the picture, two different status of red blood cells are found: i) a red blood cell that has fully passed through the membrane 
and ii) a red blood cell that is just emerging from within the membrane. White arrow: direction of the flow of the red blood cells, from 
the shell side to the lumen side of the hollow fibre. 
Figure 80. Red blood cells populating the ceramic hollow fibre: cross-section (A) and inner surface (B). Several cells are seen on the 
outer surface of the hollow fibre trying to enter the membrane, with some of them squeezing through to enter the membrane (red 
arrows) and squeezing out to leave the membrane (orange arrows). White arrows: direction of the flow of the red blood cells, from 
the shell side to the lumen side of the hollow fibre. 
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At the end of each experiment, the cells were collected from both sides of the setup and analysed by flow 
cytometry (cellular phenotype) and haemocytometer (cellular viability). The latter technique indicated a 
cellular viability of over 99% for all samples seeded into the bioreactor as well as after each experiment. On 
the other hand, flow cytometry provided a more detailed analysis of the cellular populations. Figure 81 
presents the isotype control used for the samples analysed, which were identified based on their surface 
antigen markers CD45 (FITC channel) and CD235a (PE­Cy5 channel). 
Figure 81. Isotype control for the samples analysed by flow cytometry from the three experiments in analysis to study the 
transmembrane crossing of red blood cells (CD235a+) / mononuclear cells (CD45+) through ceramic hollow fibres sintered at 
1450°C.
Figure 82 shows an overview of the results obtained for the three experiments analysed, from the feed 
(cells injected into the shell side of the bioreactor), the retentate (cells after filtration that did not cross the 
membrane) and the permeate (cells that have crossed the membrane). It was observed that the 
membranes allowed the crossing of cells, as observed previously for the flat­sheet polycarbonate 
membranes. The phenotype of the cells that have crossed was very distinct from that of the cells that were 
retained by the membrane. Particularly, the region corresponding to CD235a
­
/CD45
­
 (3
rd
 quadrant of the 
plots) increased substantially for the samples collected from the permeate side of the HFs (figures 82C, 82F 
and 82I), which could be attributed to the presence of non­cellular events and debris. 
Seeded cord blood cells were found to be characterized by a double­positive population in the CD235a vs. 
CD45 plots (figures 82A, 82D and 82G), which appear in the CD235a
+
/CD45
+
 quadrant. However, after 
contact with the membranes, particularly in the cells collected from the shell side of the bioreactor 
(without crossing the membrane), it appears that a great portion of these cells lose their CD45 phenotype 
(more obvious in figures 82B and 82H due to the higher percentage of MNCs present in the feed). As a 
consequence, the cellular population was observed deviated towards the left of the plot. The glycophorin­A 
antigen used to stain the cells was conjugated to the tandem fluorochrome PE­Cy5, which has been 
reported to bind some classes of human macrophages and granulocytes (BD Pharmigen 2008). This binding 
is done via their fragment crystallisable (Fc) receptors, which are proteins that exist on the surface of these 
cells that contribute to the protective function of the immune system. An immune reaction of the cells 
towards the materials in the system could further enhance the binding of the CD235a­PE­Cy5 dye to the 
surface Fc receptors, which due to the higher brightness of this dye in respect to FITC (used conjugated 
with CD45), could create this artefact in the data. 
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Figure 82. Flow cytometry results with the expression of CD235a vs. CD45 cellular surface antigens for experiments 1 (A, B, C), 2 
(D, E, F) and 3 (G, H, I) on the transmembrane crossing of red blood cells (CD235a+) / mononuclear cells (CD45+) through ceramic 
hollow fibres sintered at 1450°C. Three phases of the experiment are represented: fed cells (A, D and G, respectively); cells that did 
not cross the membrane (collected from the shell side – retentate) after 4h (B, E and H, respectively); and permeate side after 1h, 
representing the cells that crossed through the membrane (C, F and I, respectively). 
This evidence is further supported by the maintenance of the cellular morphology before (figures 83A, 83D 
and 83G) and after (figures 83B, 83E and 83H, respectively) contact with the membrane, with the only 
exception being the reduction of the monocytes’ population (red circles in figure 83), as already observed 
for the polycarbonate membranes in chapter 4. However, this shift in the CD45 expression of leukocytes 
was not observed in the experiments using the polycarbonate membranes, wherein only the population of 
monocytes was depleted, but the Fc receptors of the white blood cells were not further activated. This was 
observed by the maintenance of the CD235a and CD45 expressions in the retentate side after contact with 
the membrane for 1h, when compared to that of the cells fed to the system (figure 52, p. 133). The data 
suggests that neutrophils are the major cell type involved in this apparent loss of CD45 expression (based 
on their relative position in the FS vs. SS plots). These are the most abundant circulating white blood cells, 
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representing around half of the entire population of leukocytes. In response to infections, their major role 
in blood, they adhere onto the endothelial cells lining the blood vasculature through selectins (sugar 
binding proteins) and begin to roll along the vascular endothelium (Karlsson 2004). Interaction of these 
cells with aluminium oxide membranes has already been shown (Karlsson et al. 2004), and could be the 
main reason for this observation. 
Figure 83. Flow cytometry results with the expression of forward scatter (FS) vs. side scatter (SS) for experiments 1 (A, B, C), 2 (D, 
E, F) and 3 (G, H, I) through ceramic hollow fibres sintered at 1450°C. Three phases of the experiment are represented: fed cells (A, 
D and G, respectively); cells that did not cross the membrane (collected from the shell side – retentate) after 4h (B, E and H, 
respectively); and permeate side after 1h, representing the cells that crossed through the membrane (C, F and I, respectively). Red 
circle: population of monocytes present in the three streams of each experiment. 
The numbers of cells crossing the membrane were also assessed. There was an average crossing rate of the 
total cellular population of (240±105)x10
4
 cells.cm
­2
.h
­1
, of which the flow rate of CD235a
+
 cells only (red 
blood cells and their progenitors) was (12.5±4.6)x10
4
 cells.cm
­2
.h
­1
 through the ceramic hollow fibre 
membranes. This was nearly 3­fold increase of the cell flux obtained for the flat­sheet membranes 
(assessed in section 4.2.2.3, p. 132).  
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5.3. CONCLUSION
To produce hollow fibres immersed within a polymeric scaffold, a defined set of characteristics of the 
membranes used are required. These membranes should be biocompatible and capable of providing a high 
mass transport of molecules in aqueous environments, but should also maintain these characteristics after 
being subjected to the harsh conditions required during the scaffolding process. Two different types of 
membranes were therefore desirable, as determined in chapter 4: one in the ultrafiltration range (with 
10kDa MWCO) and another in the microfiltration range (pore size of around 2­3μm). 
In this chapter, the development of the high­uptake membrane was assessed. Employing a membrane that 
allows the exchange of small molecules for the renewal of the culture medium (e.g., by providing nutrients 
and removing metabolites), whilst preventing the crossing of large molecules, which are also much more 
expensive, could aid in heavily reducing the costs associated with the culture media for the expansion of 
stem cells (growth factor costs represent over 50% of the costs associated with the culture of stem cells in 
current technologies, as seen in figure 64, p. 155). Polyacrylonitrile was identified as a good candidate to 
replace the PES membranes studied in chapter 4, particularly due to its history in tissue engineering 
applications. This polymer, made of aliphatic nitrile groups (­C≡N), offers a good basis for surface 
modification. In fact, hydrolysis of the surface of PAN membranes resulted in the reduction of the 
membrane molecular cut­off, with an increase of the rejection to the model protein, and a decrease of 
protein adsorption. However, hydrolysis alone was not sufficient to attain membranes with the required 
high rejection to proteins and hence a further surface modification technique was required. By annealing 
the matrix of the membranes followed by surface hydrolysis, it was possible to fine tune the structure of 
the HFs within the ultrafiltration range required, achieving a membrane with good permeability to nutrients 
(such as glucose) and metabolites (such as lactate) but highly impervious to large molecules, such as growth 
factors and other proteins. Being also a thermal and chemically stable material, PAN HFs could be used to 
design a membrane bioreactor with a scaffold around it. 
On the other hand, the low­uptake membrane was also further developed in this chapter. A ceramic 
material was preferred for this application due to the large pore sizes required for an organic solvent­stable 
membrane, wherein polymeric materials due to their softer structure would have more difficulties in 
performing. It was shown that these membranes could in fact allow the crossing of RBCs, which in turn 
would aid in the harvesting of cells from within the bioreactor. 
The observations made in regards to the possible interactions of the white blood cells with the materials 
used during the filtration tests (the ceramic hollow fibre membranes, polyfluoroalkoxy bioreactor shell, 
glass and silicone tubing) have highlighted the complexity in the development of this system. By attaching 
to the membrane, through an immune response, these cells could be increasing the mass transfer 
resistance to the flow of the erythroid cells as well as the macromolecules provided by the LU circuit, by 
blocking the pores responsible for the transport. It is thus desirable to prevent this. Taking into account the 
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main aim of this project is the production of mature enucleated RBCs, controlling the differentiation 
pathway of HSCs exclusively towards the erythroid lineage, without the production of white blood cells, 
could alleviate this problem. It was seen in literature that a number of cytokines control this pathway 
differentiation (section 2.8.2, p. 65) (Neildez­Nguyen et al. 2002; Douay and Andreu 2007), and thus an 
optimization of the cocktail of proteins that would in one hand maintain and augment the proliferation of 
haematopoietic stem cells (such as stem cell factor) and in the other hand direct their differentiation 
towards the erythroid lineage (such as erythropoietin) could help preventing the production of undesirable 
mature cell lineages. 
In summary, each of the three bioreactor features conceptualized have been assessed to render both 
membrane types proposed the required characteristics. The next step of the project was hence to combine 
these features and test the bioreactor for its performance and suitability for stem cell bioprocessing. 
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CHAPTER 6 
CHAPTER 6.
EVALUATION OF THE BIOREACTOR TO SUPPORT CYTOKINE-FREE 
EXPANSION OF HUMAN CORD BLOOD MONONUCLEAR CELLS
"Aerodynamically, the bumble bee shouldn’t be able to fly, but the bumble 
bee does not know it so it goes on flying anyway." 
Mary Kay Ash 
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6.1. INTRODUCTION
The 3D porous structure of in vivo systems, such as that of the human BM, is thought to play a pivotal role 
in the success of in vivo expansion and differentiation of stem cells. Within the BM, a close and intricate net 
of different molecules and accessory cells (Mantalaris et al. 1998; Li et al. 2001; Pathi et al. 2004; Pathi 
2005), such as stromal cells, the ECM proteins and an array of soluble and ECM­bound growth factors, also 
known as the Haematopoietic Inductive Microenvironment (HIM) (Mantalaris et al. 2004c), promote the 
necessary biochemical support for stem cell development. On the other hand, an intricate 3D architecture 
provides the physical support, allowing a higher surface for cellular adhesion while promoting closer 
contact between cells, not only to exchange biochemical signals between each other but also with the 
surrounding microenvironment (Mantalaris et al. 2004c). The ECM is the skeleton of the in vivo niche that 
protects and supplies all the cells residing within it, being secreted by virtually every cell in the body and 
responsible for a number of important tasks related to cell survival and differentiation (Ambrosio et al.
2007). 
Mimicking this 3D architecture in an ex vivo environment, however, is an engineering challenge due to the 
consequent increase in the mass transfer resistance required to renew the microenvironment. To have an 
idea of this, a cylinder with 1cm diameter composed of material similar to a frog’s nerve, if suddenly placed 
in oxygen, would take 185min to attain 90 per cent of its full saturation with that gas. However, the 
vascularization of this structure in vivo is responsible to promote a faster intake, and an actual nerve 
0.7mm thick would in fact take only 54 seconds to reach the same saturation level (Hill 1928). The same 
adaptation is found in the BM (Ma et al. 2005), being the blood vessels responsible for an in situ delivery of 
important metabolic reagents and removal of its products. This also offers the possibility for the promotion 
of a heterogeneous microenvironment that is essential to promote optimal conditions to an array of 
different cells – with different nutrient necessities – that coexist in the bone marrow. From an engineering 
point of view, this association is also of great importance, as it helps tackling several problems related with 
scaling­up designs due to localized mass transport and especially in the design of new and improved 
bioreactors for tissue engineering. An in fact, whereas thin scaffolds (<100µm) are feasible without an 
internal blood/nutrient supply, thicker scaffolds (>100µm) need to be engineered to contain a “capillary 
network” as part of the structure (Placzek et al. 2009). 
Even though several attempts to tackle the mass transport issues in 3D structures have been presented 
through the use of bioreactor designs such as spinner flask bioreactors, rotating bioreactors and direct flow 
systems (Botchwey et al. 2003), these still limited the size of the scaffolds used and the microenvironment 
provided was not adequate for HSCs. HF bioreactors, on the other hand, incorporating selectively 
permeable membranes, present a great resemblance with the bone marrow vasculature. As an example, 
Cui and colleagues have developed a HF membrane which is seeded with a mixture of collagen gel and 
Cytodex 1 microcarriers containing cells, resulting in a 3D structure that can be fed by the HFs (Ye et al.
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2007). Moreover, the study has also shown a significant advantage of including perfusion through HFs 
when compared to static controls (without perfusion), when culturing rat bone marrow fibroblastic cells (Ye
et al. 2007). However, it would be desirable to be able to use the natural or synthetic polymeric scaffolds 
that have been studied in literature for potential tissue engineering applications (Placzek et al. 2009) within 
HF bioreactors, which up to my knowledge has not yet been reported successfully. These offer several 
advantages over hydrogel­based encapsulation techniques, such as a higher mechanical stability and better 
physical support for cellular growth. On the other hand, when cells become confluent during the culture 
period, the cellular tissue occupies most of the available space within a hydrogel, drastically reducing mass 
transport; but, when using polymeric scaffolds, cells occupy only about 60% of the void volume, since in 
average the other 40% is comprised of cell­impermeable interconnected pores, with pore sizes lower than 
10µm, which in turn can be used for mass transport (Li et al. 1998). 
The fundamental principle underlying the concept of tissue engineering lays in the ability to inoculate 
functional cells into a 3D scaffold/ECM substitute to render it a specific performance (depending on the 
intention of the scaffold), and then use it to replace or repair injured tissue in human recipients that require 
cell therapies (Song et al. 2006; Tanzi and Farè 2009; Song et al. 2010b). These 3D scaffolds are mainly 
classified into two categories: porous (or “hard”) and injectable (or “soft”) scaffolds (Hutmacher et al.
2007). The latter type has been the focus of an increasing attention for in vivo cell therapies due to the 
advantages for in situ gelation, such as the ease of operation, moulding pattern, lower trauma and avoid 
surgeries (Bonzani et al. 2007; Hutmacher et al. 2007). These are made of a wide variety of materials such 
as chitosan (Chen et al. 2004), collagen (Li et al. 2005), mixtures of chitosan, β­glycerophosphate and/or 
collagen (Hoemann et al. 2005; Song et al. 2010b), etc. 
To further enhance the surface properties of the porous scaffolds used, which provide the physical 
structure onto which cells can proliferate, coating of its structure with proteins that promote cellular 
adhesion has been described (Blanco et al. 2010). This would further enhance the mimicry of the in vivo
systems by combining the benefits of the physical 3D structure with the biological signals that exist in the 
bone marrow. Being one of the most ideal matrices to support cellular growth known up to now and the 
first natural biological material applied in cell culture (Gu 2006), collagen has the advantages of having low 
immunogenicity, good biocompatibility and biological degradability. It has an unique molecular identifying 
signal system that can improve cellular adhesion, proliferation and differentiation, hence providing a 
suitable bed for cellular expansion and differentiation (Li et al. 2005). Moreover, this protein can 
decompose into several types of amino acids in vivo, being nontoxic, non­irritant and neutrally 
immunoreactive. Some of the disadvantages on the use of this protein are related with its fast degradation 
rate and relatively low mechanical strength (which can be strengthened by using a hard scaffold, such as 
polyurethane). 
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My research group at Imperial College London (Biological Systems Engineering Laboratory) has been 
working towards the development of an ex vivo mimicry of the bone marrow 3D structure to study the 
development of acute myeloid leukaemia (AML), by coating different polymeric scaffolds with ECM 
proteins, such as collagen type I and fibronectin (Blanco et al. 2010). It was found that out of those 
conditions tested, polyurethane (PU) scaffolds coated with 62.5µg.mL
­1
 of collagen type I provided the best 
growth to the three AML cell lines tested, over a period of 6 weeks and in the absence of exogenous growth 
factors (section 5.2.1.1, p. 143). The limitation of this design, however, is its scale­up. Whilst the 5x5x5mm
3
scaffolds used could in fact accommodate the expansion of cells, allowing the development of a laboratory­
scale ex vivo model of AML, increasing its size towards the expansion of clinically relevant cell numbers 
would originate the development of necrotic centres within the scaffolds, due to limited nutrient supply to 
those cells located further away from the periphery of the scaffold (Li et al. 1998). This would hence 
decrease the productivity of such system, hence requiring the inclusion of a faster and more efficient 
transport mechanism, such as hollow fibres. And in fact, the idea of growing cells in HF bioreactors was 
already introduced over thirty years ago (Knazek et al. 2008). Nowadays, this design has been widely used 
in the production of several different proteins from mammalian cells (Williams et al. 1997), for the 
production of cells and in tissue engineering applications, such as bioartificial organs (Gramer et al. 1999). 
One of the methods most widely used for the production of medical­grade scaffolds that are biocompatible 
and promote growth and proliferation of cells is thermal­induced phase separation (TIPS) (Safinia et al.
2005). This involves the dissolution of the chosen polymer material into an organic solvent, such as dioxane 
or dimethylcarbonate (Blanco et al. 2010), followed by freezing and finally lyophilisation of the solvent to 
leave a porous polymeric scaffold in place. The liquefaction of the polymer during this process allows 
moulding the scaffold to a previously established structure. However, this requires a high chemical stability 
of the membranes that will be used to carry nutrients throughout the scaffold 3D network, but only in the 
last two decades membrane materials resistant to organic solvents started to become widely available 
(Livingston et al. 2003). These include many polymeric membranes such as polyacrylonitrile, poly(vinylidene 
fluoride), polyimide, etc. as well as ceramic membranes, such as aluminium oxide (Vandezande et al. 2008). 
The latter are often more brittle and with lower mechanical strength than polymeric membranes, but are 
chemically inert, thermally more resistant and usually offering better mass transport due to the larger pore 
sizes they can sustain. A number of companies have developed ceramic membranes for ultrafiltration and 
microfiltration applications, which are usually prepared by the sol­gel process (Baker 2001). The inclusion of 
these membranes in the design of bioreactors provides a number of advantages: increase of the space 
available for cellular attachment, selectively and continuously renew the cellular environment, perfusion of 
nutrients with low or none shear stresses to the cells and possible harvesting of cells from within 3D 
structures (Liu and Roy 2005). 
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6.1.1. Aim 
Upon the design and development of the bioreactor concept and the membranes required to achieve the 
purposes of this project, the main aim of this chapter was to assess the potential of the bioreactor in 
supporting cellular growth. The integration of the membranes with the 3D structure was expected to 
require further optimization of the bioreactor construction techniques, due to the processes involved, 
which are herein described. In order to study the potential of the bioreactor to support cellular growth, this 
chapter also includes the results obtained for the culture of the mononuclear cell fraction of human UCB 
cells within a single­type HFB, composed of ceramic HFs only. 
6.1.2. Methodology 
The initial trials using the novel 3D HF bioreactor (HFB) concept were performed by using one single type of 
hollow fibres, made of alumina. The injection of the cells in the bioreactors that I produced was performed 
by Dr. Maria Rende, a post­doctoral fellow working in the Biological Systems Engineering Laboratory (BSEL), 
Imperial College. Dr Rende measured the cellular growth of the cells with time and took SEM pictures of the 
single­type hollow fibre bioreactor. Her work is acknowledged in the text. With the cells collected, I have 
performed flow cytometry analysis which is also presented in the results and discussion section. With the 
culture of these cells using the 3D HF bioreactor, its performance could be evaluated, particularly in what 
concerned to design problems and the compatibility to support cellular growth. Human UCB cells, which 
were used during the trials, usually require the presence of serum, although recent studies have suggested 
that when these cells were cultured in the 3D environment recreated by the HFB (polyurethane coated 
with collagen type I) they have survived and proliferated (Blanco et al. 2009). The provision of serum into 
the bioreactor can only be achieved through the LU membrane, which was designed for that purpose. 
Hence, the so­called “single­type 3D HFB” was composed of 4 ceramic hollow fibres per bioreactor only, 
which provided all the nutrients and serum to the cell culture, whilst removing cellular debris and 
metabolic products. Moreover, by incorporating this membrane type alone into the design, could provide 
further insights into cellular harvesting from the bioreactor. Being the main purpose of this chapter to 
observe the capacity of the bioreactor to sustain cellular growth, the culture was performed in the absence 
of any exogenously­added cytokines – in fact, the use of a single type of HFs would not allow recycling 
these molecules either. This system was used as the control bioreactor culture for this project, whose study 
in the final experimental chapter 7 for the production of red blood cells involved the inclusion of two 
important cytokines. A comparison of the outcome from both cultures would allow understanding the 
importance of the expensive but essential exogenously­added cytokines. 
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6.2. RESULTS AND DISCUSSION
6.2.1. Mimicking the human Bone Marrow 
The ceramic HFs immersed within the 3D polyurethane scaffold was observed under SEM. The design of the 
bioreactor was based on the structure of the bone marrow – composed of i) a 3D extracellular matrix 
supported by ii) an intricate network of blood vessels for delivery of nutrients and other important 
molecules essential to renew the cellular microenvironment. Figure 84 presents a morphological 
comparison between the rat bone marrow and the scaffold produced within the HF bioreactor. The two key 
features of the bone marrow are mimicked in the bioreactor through the use of i) a porous polyurethane 
scaffold, mimicking the 3D matrix and ii) a membrane system made of hollow fibres, mimicking the vascular 
system. To further observe the 2
nd
 feature of the developed bioreactor (section 5.2.1, p. 143), i.e. hollow 
fibres immersed within a polymeric scaffold, the overall cross section of the bioreactor’s scaffold was 
observed by SEM; a total of 33 photos from different locations around the cross section were taken and 
these were then merged using Photoshop, in order to obtain figure 85. 
Figure 84. The human bone marrow has been used as the inspiration for the development of the 3D hollow fibre bioreactor. In the 
picture, the two main physical components of a rat bone marrow (A) (adapted from: Kaushansky et al. 2010) are compared with 
those recreated in the bioreactor (B) – the vascular system (mimicked through the use of hollow fibres [C]) and the extracellular 
matrix (mimicked through the use of polyurethane scaffolds [D]). 
Figure 85 presents an assembly picture of several photos taken by SEM in different regions of the scaffold 
cross­section. The porous PU scaffold is visible with four ceramic hollow fibre immersed; it is worth of note 
that one of the represented fibres appears broken, which was due to the cut of the cross­section using a 
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scissors to take the photo. The diameter of the scaffold, as observed by SEM, is 8mm (figure 85). The inner 
diameter of the bioreactor wherein the scaffold is produced is 9.7mm, and the difference in the size is two­
fold: i) the dope solution containing PU and 1,4­dioxane will shrink in volume due to the behaviour of the 
organic solvent, hence producing a scaffold with a volume smaller than the liquid phase; and ii) due to the 
preparation of the scaffold samples for SEM, which are required dried, the PU structure further contracts 
before being observed under SEM. For this reason, different drying processes have been tried for preparing 
the samples for SEM in order to maintain the scaffold structure as intact as possible; the chosen method 
(found in the materials and methods in Chapter 3) involves freezing the scaffolds and removal of the water 
by lyophilisation, which nevertheless still slightly changes the scaffold morphology. 
Figure 85. Scanning electron micrograph of the total cross section of the single-type 3D hollow fibre bioreactor, depicting the 
permeable hollow fibres immersed within the polyurethane 3D porous structure (obtained by the combination of a total of 33 photos 
taken by SEM, and using Photoshop to merge them).
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6.2.2. Scaffold intrusion into the ceramic hollow fibres 
6.2.2.1. Introduction 
During the development stage of the bioreactor, it was found that the ceramic hollow fibres were being 
blocked by the infiltration of polyurethane during the scaffolding process. Due to the large pores that 
populate the surface of these hollow fibres (in the range of (3.1±0.7)µm pore­size distribution), the 
polyurethane, with a MW of 150kDa, can easily permeate through these pores when the liquid dope 
solution is injected into the bioreactor. In fact, this infiltration has been observed in SEM pictures (figure 
86). The scaffold within the lumen of the hollow fibres increases the resistance to molecular transport and 
the pressure drop across the bioreactor. This is detrimental to mass transport, as well as to the flow path 
through the bioreactor – the two separate streams in the dual HF bioreactor require that the flow path 
throughout both circuits are not obstructed in order to maintain a steady laminar flow. Hence, it was 
required to develop a method that would allow the scaffolding process around the hollow fibres, but 
preventing the PU from entering the pores of the HFs. The solution should allow the protection of the 
lumen of the HFs during the scaffolding and afterwards relieve the space for media perfusion. 
Figure 86. SEM pictures of a ceramic hollow fibre blocked by the infiltration of polyurethane during the scaffolding process: 
magnifications of 100x (A) and 300x (B). 
PhD Thesis by H. Macedo 
© Imperial College 2011 191
6.2.2.2. SOLUTION 1: Fill the lumen of the ceramic fibres with pure solvent 
In order to prevent the blockage of the ceramic HFs during the scaffolding of the bioreactor, the first 
solution tried was to inject pure dioxane into the lumen of the ceramic HFs (through ports LU in figure 87) 
prior to injecting the scaffold dope solution (PU + dioxane) around the fibres (through ports C in figure 87). 
Having the lumen of the HFs filled with the same liquid in the dope solution could in principle reduce the 
permeation rate of the PU through the pores, until the whole liquid freezes at ­86°C. The injected dioxane 
could then be removed through the TIPS system alongside the dioxane present in the dope solution, hence 
reducing the number of steps required in the fabrication process. Ports LU and HU were closed during the 
scaffolding process and vacuum used through ports C for 3 consecutive days. 
Figure 87. Dual hollow fibre design, with both hollow fibre types depicted: blue (side A) – ultraporous polyacrylonitrile hollow fibre; 
red (side B) – microporous ceramic hollow fibre. Also depicted in the figure are the access ports that are used for producing vacuum 
within the bioreactor to remove the solvent during the scaffolding treatment (green arrows), while the port connecting to the inside of 
PAN hollow fibres is closed. 
At the end of the scaffolding, the bioreactor was observed for the efficiency of this technique. However, it 
was observed that polyurethane had crossed through the lumen of the ceramic HFs, as observed after 
careful examination of the bioreactor. This had not been observed in the bioreactors made without 
protecting the fibres with pure dioxane. This was probably due to the high concentration gradient created 
with the addition of pure solvent within the lumen of the HFs, increasing the permeability of PU through 
the pores of the fibres. On the other hand, injecting a liquid within the ceramic hollow fibres that would 
change in volume upon freezing (dioxane contracts below its freezing point), could cause stress to the 
ceramic hollow fibres, increasing the likelihood of cracks in the structure. For this reason, a non­solvent to 
dioxane, such as water, could not be used. 
6.2.2.3. SOLUTION 2: Use of guitar strings to protect the lumen of the ceramic fibres 
The next solution attempted was to use a material that would maintain its volume and structure even at 
very low temperatures (scaffolding involves the freezing of the bioreactor at ­86°C). This was done by 
protecting the lumen of the fibres using electrical guitar strings (Kensington Chimes Music Shop, UK) gauge 
13 (330µm diameter), which are made of stainless steel, a material highly resistant to not only organic 
solvents but also very low temperatures – the fact that this is a stable solid material, the changes in volume 
for low temperatures are negligible, thus also reducing the stresses to which the hollow fibres would be 
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subjected to. After inserting the guitar strings into the lumen of the fibres, the scaffolding process was 
undertaken as previously described (figure 87), and at the end the strings were removed to leave the lumen 
of the ceramic hollow fibres clear of any obstructions by the PU scaffold. 
In order to further assess the advantage on using this technique to prevent the blockage of the fibres, the 
inlet pressure of liquid being introduced into the bioreactor was measured in two different bioreactors: 
A. 3D ceramic HF bioreactor produced without using the guitar strings; 
B. 3D ceramic HF bioreactor produced using the guitar strings to protect the lumen of the fibres; 
Using an U­tube manometer, constructed as depicted in section 3.2.3 (p. 88), the inlet pressures were 
measured for both bioreactors, at a constant flow rate of 1.7mL.min
­1
 (peristaltic pump at a speed rate of 
10rpm). These are shown in table 30. It was observed that the inlet pressure measured in the bioreactor 
was the same before and after scaffolding with protection of the guitar strings, but much higher for when 
the fibres were not protected. Moreover, this was further confirmed by the SEM pictures shown in figure 
88, wherein the intrusion of PU was obvious for the membranes observed after the scaffolding process 
(figures 88B and C), but the removal of the guitar strings at the end of the scaffolding process allowed 
relieving the lumen of the fibres from the scaffold. This hence proved to be an efficient method to protect 
the lumen of the ceramic hollow fibres during the scaffolding procedure. 
Table 30. Inlet pressures measured for the bioreactors produced by scaffolding with and without the use of guitar strings within the 
lumen of the ceramic hollow fibres. †relative to atmospheric pressure; each value was repeated three times. 
Scaffolding treatment 
Inlet pressure at 
1.7mL.min
­1
 ﬂow rate (mbar)† 
No scaffolding 6.7 
Scaffolding without guitar 
strings 
> 19.6 
Scaffolding with guitar 
strings 
6.7 
Figure 88. SEM pictures of ceramic hollow fibres before (A) and after the scaffolding process without (B) and with (C) the protection 
of the HFs using guitar strings. It is shown that the use of the guitar strings have helped protecting the lumen of the hollow fibres free 
from the polymeric foam.
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6.2.3. Support of cellular growth in the single-type HF bioreactor 
6.2.3.1. Experimental setup 
As proof of concept, hollow fibre bioreactors composed of ceramic hollow fibres only were evaluated for 
their capacity to support cellular growth. The intended purpose was to study the expansion of mononuclear 
cells (MNCs) isolated from the umbilical cord­blood (UCB) in the single­type HF bioreactor, cultured in the 
absence of any exogenously­added cytokines, in order to study the importance of the 3D scaffold and 
continuous perfusion of nutrients. The designed bioreactor was composed of 4 ceramic hollow fibres 
immersed within a polyurethane scaffold coated with collagen type I (figure 89). It was shown previously 
that these hollow fibres have a good permeability to both nutrients and proteins, and taking into account 
the intended purpose was to culture the cells without adding cytokines, the use of the HU membranes was 
redundant for these experiments. Figure 90 schematically represents the cell culture setup used 
throughout these experiments, which were performed with the help of Dr. Maria Rende. 
Figure 89. Picture of the single-type hollow fibre bioreactor. Cells are inoculated through the cell seeding ports, which are then 
closed and maintained sealed throughout the experiment time, whilst media is continuously fed to the bioreactor through the lumen 
of the fibres (depicted by the blue arrows). The polyurethane scaffold, foamed around the ceramic hollow fibres, and post-coated 
with collagen type I, provides the physical structure where cells can attach and proliferate, while the hollow fibres continuously renew 
the micro-environmental niche by providing nutrients and other important molecules and removing metabolites. 
Figure 90. Schematic picture of the experimental setup for the culture of cells in the single-type hollow fibre bioreactor. Media is re-
circulated in the lumen of the ceramic hollow fibres and fully replaced every 7 days. 
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A volume of 5mL of cell culture medium containing UCB­MNCs were seeded onto the PU­coated scaffold at 
a final density of 1.6x10
7
 cells.mL
­1
. A total volume of 400mL of medium composed of IMDM with 30% FBS 
and 1% pen/strep was perfused through the lumen of the ceramic hollow fibres in recirculation mode and 
fully replaced every 7 days of culture (figure 91). The cells were cultured over a maximum period of 22 days 
in a cytokine­free environment. 
Figure 91. Initial conditions and flow rate used during the 22 days of cell culture within the single-type hollow fibre bioreactor. 
6.2.3.2. Cellular growth evaluation 
In order to evaluate the growth profile of the cells, samples at days 7, 14 and 22 were collected from the 
scaffold (each time point required the sacrifice of a bioreactor) and analysed for their metabolism by an 
MTS assay (figure 92). The light absorbance measured at each time point, proportional to the number of 
viable cells, was corrected by subtracting the absorbance measured for samples at day 0 (collected after 
seeding the scaffold, waiting 1h in the incubator, and immediately terminating the bioreactor). From the 
MTS analysis performed on the scaffold samples a steady increase in cellular activity was observed, which 
correlates to an increase of the cellular population within the bioreactor throughout the 22 days of culture 
(achieving a final 4­fold expansion of the initial cell number). This not only suggests the biocompatibility of 
the bioreactor, but also its efficiency in providing a suitable environment for the cells. Taking into account 
the culture was performed in the absence of any exogenously­added cytokines, which are usually required 
for the maintenance of cellular activity in ex vivo cultures (Blanco et al. 2010), these results suggest the high 
importance of the 3D structure provided by the PU scaffold as well as the perfusion provided by the HFs. 
The concentration profile of glucose and lactate in the culture media with time at the outlet of the 
bioreactor were also measured and plotted in figure 93. The results have provided an indication of active 
cellular metabolism, with the production of lactate and consumption of glucose. Throughout the culture 
period, the requirements of the cell culture microenvironment in terms of the flow of these molecules were 
efficiently managed by the membranes in terms of removal of metabolites and provision of nutrients. The 
high increase of lactate concentration observed towards the end of the culture period (at day 22), 
highlights the need for a continuous supply of fresh media containing glucose and without lactate, instead 
of recycling the cell culture media (the main point for adapting the HU membrane into this system). 
Nevertheless, the concentration of glucose throughout the culture time is above its low limit for cell growth 
(1mM) and lactate is below its maximum level (22mM) for cell growth inhibition (Ozturk et al. 1996). 
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Figure 92. Evaluation of the capacity of the single-type 3D HF bioreactor to sustain cellular growth by culturing MNCs: cellular 
growth profile as measured by MTS. (**p<0.01). Note: data obtained as a result of collaboration with Dr. Maria Rende. 
In order to observe the morphology of the cells growing within the bioreactor, sections of the PU scaffold 
after 22 days of culture were observed under SEM (figure 94). It was possible to observe a large number of 
cellular agglomerates growing within the protection of the PU scaffold pores and covering a large portion of 
the scaffold. These spaces within the pores of the scaffolds have hence provided the conditions necessary 
for the development of stem cell 3D niches, which in vivo characterize the human bone marrow 
microenvironment and are essential for the successful expansion of hematopoietic stem cells (Wilson and 
Trumpp 2006). Morphologically, the cells observed are also round in shape, suggesting a high viability, 
which is in contrast to the morphological observation previously made by our group when culturing these 
cells without the provision of the 3D scaffolds, in flat 2D surfaces (Blanco et al. 2009). 
Figure 93. Evaluation of the capacity of the single-type 3D HF bioreactor to sustain cellular growth by culturing MNCs: cell culture 
medium profile of glucose and lactate with time, measured on the outlet from the bioreactor. Note: data obtained as a result of 
collaboration with Dr. Maria Rende.
A Novel 3D Dual Hollow Fibre Bioreactor for the Production of Human Red Blood Cells 
© Imperial College 2011 196
PhD Thesis by H. Macedo 
© Imperial College 2011 197
6.2.3.3. Flow cytometry analysis 
The phenotype of the cells harvested from within the single­type HF bioreactor was also evaluated. Figure 
95 presents the evolution of the cellular population in terms of the morphology of the cells (SS vs. FS plots) 
and their expression of the surface markers CD45 and CD235a. Cells flowing into the harvesting bottle were 
monitored at days 6, 15 and 22 of culture, whereas at the end of the culture, by day 22, the cells remaining 
on the scaffold were also analysed, to investigate the feasibility of the membrane in terms of selectivity to 
the cells. 
Figure 95. Flow cytometry dot plots following the phenotype progression of the cellular population throughout the 22 days of culture 
of MNCs within the single-type HF bioreactor, in terms of the expression of CD45 (FICT channel) and CD235a (PE-Cy5 channel): 
seeded cells at day 0 (A and B); cells that crossed the HFs and moved into the LU circuit bottle after 6 days (C and D), 15 days (E 
and F) and 22 days (G and H); and cells that did not cross the HFs having remained in the scaffold after 22 days (I and J). 
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Red blood cells can be identified by their high expression of CD235a but negative expression of CD45 
(CD235a
+
/CD45
­
). A population of about 55% RBCs was seeded into the bioreactor (figure 95B), which 
started to flow into the bottle, as observed at days 6 (figure 95D) and 15 (figure 95F). After this period, a 
decay on this population was observed towards the end of the culture (figure 95H). In fact, it is observed 
that the cells start losing their CD235a expression, and RBCs, characteristically with high expressions of this 
antigen are not observed by the end of the culture. Analysing the cells that remained within the scaffold 
(figure 95J), and comparing with those that have crossed the HFs into the bottle (figure 95H), it is possible 
to observe that this population is characterized by a higher percentage of CD45
+
 cells (56.7% compared 
with 10.6%, respectively). In contrast, the cells that have remained in the scaffold were characterized by a 
lower CD235a cell population (3.9%) when compared with those that have crossed the HFs (11.9%). 
To further observe the influence of the bioreactor towards the phenotype of cultured cells, figure 96 
presents the CD71/CD45/CD235a antigen expression of the seeded cells at day 0 and the cells that have 
crossed the HFs into the harvesting bottle. It is possible to observe that whereas seeded cells had a high 
percentage of CD45
+
/CD71
­
/CD235a
­
 population (green population in the plots), the produced cells had lost 
most of the expression in this marker, as observed before. Instead, these cells presented an early erythroid 
population (red in the plot from figure 96B), characterized by a CD235alow/CD71+ phenotype. This indicates 
the feasibility of the bioreactor in triggering erythropoiesis, even in the absence of exogenously­added EPO, 
but also its inefficiency in promoting terminal enucleation of the cells. 
Figure 96. Comparison of the cellular population of day 0 (A) with the cells that crossed the HFs and migrated to the collection bottle 
after 22 days of culture (B) in terms of their surface expression in CD45 (x axis), CD71 (y axis) and CD235a (z axis). 
On the other hand, the cellular viability of the harvested cells was also evaluated by flow cytometry, 
through the relative expression of Annexin­V, an apoptotic marker. From figure 97, it is possible to observe 
the decrease in the cellular viability with time within the single­type HF bioreactor, throughout the 22 days 
of culture. Nevertheless, the cellular viability was maintained at values above 87% during the culture time 
period, proving the feasibility of the bioreactor in maintaining and growing the cells even in the absence of 
cytokines. Only recently Blanco et al. 2009 have reported for the first time the successful expansion of 
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MNCs from UCB in a serum­ and cytokine­free environment, using the 3D PU scaffolds applied in this 
process, in contrast with complete cell death verified after 1 week in 2D cultures. The obtained results are 
thus concurrent with the published results. 
Figure 97. Evolution of the cellular viability with time of culture of MNCs within the single-type HF bioreactor, as measured by the 
expression of Annexin V (solid line) when compared to the unstained control (shaded plot). Seeded cells (A) were cultured in the 
bioreactor and those that had crossed the HFs and moved into the LU circuit bottle after 6 (B), 15 (C) and 22 (D) days of culture 
were measured. Percentage of viable cells is reported in the right-hand side of each corresponding sample.
6.3. CONCLUSION
A novel 3­dimensional hollow­fibre bioreactor mimicking the function of the BM and capable of delivering 
cell culture media and serum proteins to a chamber where HSCs can be grown in a 3D environment was 
developed. It was shown that MNCs collected from umbilical cord blood can be grown within this system 
over a period of at least 3 weeks, under cytokine­free conditions. The method used for the combination of 
3D porous scaffolds that can be coated with ECM proteins with hollow fibres immersed within their 
structure allows the production of a structure that intimately mimics two of the most important features of 
the BM: the 3D extracellular matrix and its vasculature. This system can also be used as an ex vivo model of 
the human bone marrow, which allows the design of experiments to study e.g. the influence of drugs to 
treat malignancies such as anaemia or leukaemia.  
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CHAPTER 7 
CHAPTER 7.
FEASIBILITY OF RED BLOOD CELL PRODUCTION
“It is difficult to say what is impossible, for the dream of yesterday is the hope of 
today and the reality of tomorrow." 
Robert Goddard 
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7.1. INTRODUCTION
The title of the paper by David Kaplan and colleagues “It takes a village to grow a tissue” (Kaplan et al.
2005) is quite descriptive of the major hurdle to circumvent in the field of tissue engineering if one is to 
consider its widespread benefits: the replacement of lost or damaged tissues (Langer and Vacanti 1993). In 
fact, producing a single tissue on the lab bench has already been successfully achieved with e.g. skin grafts 
(Bilodeau and Mantovani 2006); however, the biological developments have not been followed by their 
engineering counterpart to allow these approaches to be available for the wider public. And that starts by 
the hindrance of current technologies to address the challenges of producing large numbers of cells. In a 
review by Timmins and Nielsen, the possibility of manufacturing red blood cells (RBCs) for large­scale 
transfusions and use is discussed (Timmins and Nielsen 2009). The establishment of a system that could 
sustain a cellular output that would be clinically relevant, according to the US Defence Advanced Research 
Programs Agency (USDARPA), would require the development of a system with a production capacity of at 
least 100 units of RBCs per week (or 2x10
14
 RBCs/week). Considering the human BM of an adult has a 
cellular output of only 0.7 units per week (1.4x10
12
 RBCs/week) under normal conditions (Palsson et al.
1993b; Timmins and Nielsen 2009) it is possible to realize the hurdles to surpass nature itself. At the same 
time, in chapter 5 the resources and space required to achieve such goal were highlighted: the production 
of 5 units of RBCs from a single cord blood using one of the best known protocols for the expansion and 
differentiation of RBCs (Giarratana et al. 2005) would require an area equivalent to two tennis courts (or 
166m
2
) and a cost of £41,650 for the media alone (Timmins and Nielsen 2009), whilst 5 donors would cost 
only around £670 to the Red Cross, over 60 times less (figure 63, p. 153). 
This highlights the need for the design of new and improved bioreactors for stem cell bioprocessing. In 
chapters 4 and 5, two membranes tailored to be fitted within 3D porous scaffolds were conceptualized and 
developed. This association takes advantage in one hand of the benefits of growing cells in 3D tissues 
(Sullenbarger et al. 2009) and on the other hand apply the permeability and selectivity properties of 
membrane technology (Silva et al. 2006). The feasibility of this bioreactor in supporting the expansion of 
MNCs from cord blood in a cytokine­free environment as well as the biocompatibility of the elements used 
and the benefits of combining 3D structures with perfusion through hollow fibres were proven in chapter 6. 
On the other hand, a study by Lim 2008, wherein different cytokines such as SCF, IL­3, IL­6, FL, TPO, GM­CSF 
and EPO were investigated for their influence towards the expansion and maturation of UCB CD34+ cells 
into the erythroid lineage, has allowed perceiving that SCF and EPO had the most influential effect, 
respectively. The study involved using a mathematical approach, known as design of experiments (DOE), to 
identify and optimize the parameters that would provide the best expansion rates and differentiation 
potential. Moreover, the protocol developed by Giarratana et al. 2005 used amongst other cytokines a 
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cocktail composed of 100ng.mL
­1
 SCF and 3,000mU.mL
­1
 EPO to expand UCB­CD34
+
 stem cells towards 
erythroid cells (the cells were co­cultured in 2D tissue­culture flasks with accessory stromal cells that have 
promoted the production of enucleated RBCs at the end of 21 days). 
In order to prove the principle that it is possible to expand UCB MNCs within the novel designed 3D dual HF 
bioreactor, and trigger cellular differentiation towards the erythroid lineage, the two essential GFs that 
were identified, SCF and EPO, will be used in the initial trials. This would allow studying on one hand the 
efficiency of the membrane system in preventing the waste of these molecules whilst renewing the cellular 
microenvironment and on the other hand the capacity of the bioreactor in producing enucleated RBCs in 
the absence of feeder layers. 
7.1.1. Aim 
The main aim of this chapter is to prove the concept of integrating the three bioreactor features studied in 
chapter 5 to produce human enucleated RBCs, using two GFs: SCF (important for HSC self­renewal) and EPO 
(important in the differentiation of HSCs towards red blood cells). In chapter 6 the concept of growing cells 
within the bioreactor was successfully proven, with the expansion of mononuclear cells. The main aim of 
this chapter was to “flex” the closed­loop automated dual HF bioreactor with the addition of SCF and EPO 
at the beginning of the culture in order to expand and mature erythrocytes and attempt the selective 
harvesting of the cells. 
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7.1.2. Methodology 
The designed 3D dual HF bioreactor incorporates two different hollow fibre types, for the delivery and use 
of two different streams of molecules. Figure 98 presents the schematic of this bioreactor, alongside the 
proposed method of integrating two different streams for feeding this bioreactor (whose function is further 
detailed in figure 99). The inclusion of a PU scaffold surrounding the HFs at the centre of the bioreactor, 
wherein cells are injected through the two central ports in the diagram, allows the provision of a porous 3D 
structure where cells can reside, proliferate and differentiate towards RBCs, which in turn can be 
continuously harvested through the LU circuit of the design. MNCs isolated from UCB were seeded into the 
novel bioreactor and a cocktail of 100ng.mL
­1
 SCF and 3,000mU.mL
­1
 EPO were used to further potentiate 
the expansion of these cells (when compared to the cytokine­free environment provided in chapter 6) and 
drive the differentiation of the cells towards the enucleated RBCs. 
Figure 98. Dual hollow fibre design, with both hollow fibre types depicted: blue (HU side) – ultraporous polyacrylonitrile hollow fibre 
for exchange of small metabolic molecules; red (LU side) – microporous ceramic hollow fibre for delivery of large molecules such as 
cytokines and harvesting of red blood cells. Also depicted in the figure are the access ports for each hollow fibre stream that enters 
the bioreactor, which in the centre are surrounded by a porous structure made of polyurethane (PU) to support the adhesion and 
growth of HSCs and their progeny. 
Figure 99. The two different types of hollow fibres used in the bioreactor, alongside a brief description of their major role.
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7.2. RESULTS AND DISCUSSIONS
7.2.1. RBC sedimentation rate in the design of the bioreactor 
The main function of the bioreactor was to harvest RBCs from within the scaffold and transport them into 
the LU circuit bottle. For this reason, the bioreactor design in the dual configuration required a special 
attention for assembly. Due to the relatively high density of red blood cells (1.1g.mL
­1
 on average 
(Linderkamp et al. 1993)) compared to water (1g.mL
­1
), RBCs have a high tendency for sedimentation – due 
to the low flow rate of the media, the cells would probably not ascend in the tubing, which could be an 
issue for cell harvesting. The erythrocyte sedimentation rate (ESR) or Biernacki reaction, is a simple method 
used to determine the rate at which RBCs sediment in a period of 1h (Plebani and Piva 2002). The average 
ESR measured for 20 people was found to be 26.57mm (Plebani and Piva 2002) – meaning that a RBC would 
fall 26.57mm in a vertical tube at 37°C per hour, considering the tube liquid is not agitated. In the 
bioreactor, on exit from the scaffold after harvesting, the RBCs would have to rise through the LU circuit 
exit port (figure 98), with a height of 4,7cm and 1cm diameter. Taking into account the 2.2mL.h
­1
 flow rate 
used in this circuit, for the volume of 3.7mL of media this represents, the residence time required for a 
molecule to exit from the top of the outlet port would be 1.7h. This results in a maximum velocity of rising 
of the RBCs through the tube of 28mm.h
­1
, a value that is too close to the 26.57mm.h
­1
 sedimentation rate. 
Hence, RBCs would not be able to rise through the tubing to leave the outlet port of the bioreactor and 
enter the collection bottle. In order to minimize this effect, the inlet and outlet ports of the LU circuit were 
designed to be perpendicular to the cell seeding ports (figure 100), which in turn have to be maintained in 
the upright (vertical) position to facilitate cell seeding at the beginning of the experiments and maintain the 
level of liquid within the scaffold throughout the culture period. On the other hand, by maintaining the LU 
outlet port in a horizontal position, perpendicular to the cell seeding ports, would provide an easier flow of 
the RBCs after leaving the scaffold, without having to rise through the outlet port. This could in principle aid 
in the cellular collection from within the bioreactor. 
Figure 100. Detail of the dual hollow fibre bioreactor ready for cell culture. The PU scaffold is notorious in the picture through the 
PFA shell, as well as the high-uptake membrane that extends from the scaffold; the low-uptake membrane is not visible in the picture 
because it is immersed within the PU scaffold only. 
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7.2.2. Experimental setup 
An experimental setup for the culture of mononuclear cells within the dual HF bioreactor was designed and 
assembled as depicted in figure 101. The different components and streams are represented, particularly 
the oxygenation of the HU circuit (represented in blue) and the recirculation of the LU circuit without 
oxygenation (represented in red). Two bioreactors were built and used in parallel as shown in figure 102. 
Both bioreactors are represented, alongside the tubing, media bottles (for the LU and the HU circuits), 
peristaltic pumps and oxygenators. 
Figure 101. Experimental setup for the production of human red blood cells using the 3D dual hollow fibre bioreactor. Serum- and 
cytokine-free fresh media was perfused in the lumen of PAN hollow fibres, containing the high-uptake (HU) circuit (blue) and 
discarded; serum and cytokines were provided through perfusion in the lumen of ceramic hollow fibres, containing the low-uptake 
(LU) circuit (red) by re-circulating throughout the entire culture period.
Figure 102. Experimental setup used for both dual-hollow-fibre bioreactors used in parallel (bioreactor A and bioreactor B). LU: low-
uptake circuit; HU: high-uptake circuit. 
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7.2.3. Observation of the bioreactors after 31 days of culture 
After the culture of MNCs within the dual HF bioreactors over a period of 31 days, the cultures were 
stopped and several analyses were performed on the cells. Figure 103 shows the cell pellets recovered 
from each bioreactor. Even though this is not a quantitative nor qualitative method, the visual observation 
of the cellular pellet provided a clear indication of the presence of cells coloured red, only typical of RBCs, 
better observed in figure 103ii. Due to cord blood heterogeneity, and the variability inherent to biological 
processes, bioreactor A resulted in better cell expansions than bioreactor B (as observed from the relative 
pellet size of the cells collected from both bioreactors, in figure 103i). Taking into account the objective of 
this trial was to assess the feasibility of the bioreactor in supporting RBC production, and to facilitate the 
discussion of the results, bioreactor A was chosen to continue further analysis. 
Figure 103. Visible morphology of the blood cells (red arrows) produced in the dual hollow fibre bioreactors after 31 days of culture 
of mononuclear cells (i) and a more detailed view of the cells collected from Bioreactor A (ii). 
Figure 104 presents a general overview of Bioreactor A, wherein the different flow streams are depicted. 
Upon de­encapsulation of the scaffold from within the bioreactor shell, it was possible to remove the 3D 
PU structure intact, which can be observed in figure 105. The cylindrical shape of the scaffold is obvious on 
the picture, as well as both of the membrane types used (the HU and the LU HFs) immersed within it. 
Figure 104. View of the bottom of Bioreactor A, turned upside down. The different flow parts of the bioreactor are depicted: the HU 
circuit (in blue), the LU circuit (in red), the media flow direction through the lumen of both membrane types (in red) and the cell 
seeding ports (in black). 
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Figure 105. Internal PU scaffold after de-encapsulation from the bioreactor shell – the immersed hollow fibres are also visible.
Before dismantling the bioreactor, however, a high deposition of cells was observed outside the scaffold at 
the bottom of the bioreactor (black arrows in figure 106). The sedimentation rate of the cells was 
calculated in section 7.2.1 (p. 205), and for that reason the configuration of the outlet port from the LU 
circuit was changed to reduce the likelihood of RBC deposition. However, and as observed through the 
bioreactor’s shell, the sedimentation rate of the cells was still faster than the flow rate of the media, and 
this region of the bioreactor became populated with cells that did not flow into the harvesting bottle 
(which represented 99.5% of the harvested cells). This is obviously a design problem, which will require 
either the increase of the flow rate to promote a faster flow to compensate for the sedimentation rate 
and/or further rotating the LU outlet port to prevent the need for the cells rising in the tubing after 
harvesting to flow into the collection bottle. 
Figure 106. Bottom of the Bioreactor A (i), with a higher detail of the outlet side from the low-uptake membrane (ii), where a 
deposition of cells with red coloration (typical of red blood cells) is observed throughout the whole bottom surface of the flow (black 
arrows) – due to the slow flow rate there is a high deposition of cells in this area, after exiting from the scaffold. 
Nevertheless, this can also be seen as an advantage of the design, as it allowed separating the more dense 
cells (that sedimented) from the less dense (that flown into the collection bottle). The cells harvested from 
the scaffold but that sedimented on the bioreactor shell just before the outlet port from the LU circuit were 
also examined alongside the cells that were harvested but flown into the collection bottle and the cells that 
remained within the scaffold.
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7.2.4. SEM pictures of the dual hollow fibre bioreactor with a PU scaffold 
In order to observe the internal structure of the 3D HF bioreactor, SEM pictures were taken from the 
different scaffold components. Figure 107 presents an overall view of the scaffold cross­section, wherein 
the two different HF types can be observed immersed within the PU 3D scaffold. Further detailed pictures 
of the scaffold and the HFs are presented in figure 108 (showing the intimate contact between both 
structures) and the lumen of the ceramic HFs in figure 109, wherein a dividing cell (shaded blue), fibroblast­
like cells (white arrows) and biconcave­shaped cells, typical of RBCs (red arrows) can be observed. 
Figure 107. SEM picture of the total cross-section of the bioreactor scaffold immersed with both types of hollow fibre membranes, 
alongside the diameter of the fibres and the bioreactor. OD: outer diameter; ID: inner diameter.
A Novel 3D Dual Hollow Fibre Bioreactor for the Production of Human Red Blood Cells 
© Imperial College 2011 210
PhD Thesis by H. Macedo 
© Imperial College 2011 211
A Novel 3D Dual Hollow Fibre Bioreactor for the Production of Human Red Blood Cells 
© Imperial College 2011 212
Figure 110 shows a detail of the 3D PU scaffold populated with cells. A closer observation of their 
morphology (figure 110B) has shown a high cellular density within the bioreactor, even after 31 days of 
culture, with the cells presenting a round and healthy morphology, typical of viable cells. The two different 
membranes used within the bioreactor can be observed in further detail in figure 111: ceramic HF 
membrane for harvesting of red blood cells and delivery of growth factors and/or serum (A and B); 
polyacrylonitrile HF membrane for delivery of nutrients and removal of metabolites (C and D). Red blood 
cells were observed crossing the ceramic HFs, but not the PAN HFs, as expected. 
Figure 110. Detail of the porous PU scaffold within bioreactor A, with several cells dispersed, magnified 200x (A) and 500x (B).
Figure 111. Detail of the microporous ceramic (A and B) and ultraporous polyacrylonitrile (C and D) HFs immersed within the PU 
scaffold, magnified 100x (A and C) and 350x (B and D). Red blood cells (black arrows) were observed within the ceramic but not 
within the PAN membranes. 
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To better observe the efficiency of the ceramic HFs in allowing the crossing of RBCs, sections of the scaffold 
containing these membranes were collected and stained with CD235a (or glycophorin­A) and observed 
under a confocal microscope (as detailed in section 3.9.6, p. 109). A 3­dimensional stack picture was 
acquired for a cross­section of a ceramic HF (figure 112), wherein the green region corresponds to the 
presence of CD235a
+
 cells and the red region to the PU scaffold; being a typical marker of RBCs, the picture 
has shown that the cells, as observed before by SEM, actually cross the HF from the scaffold through the HF 
wall and into the lumen region, wherein the flow of the LU circuit finishes the harvesting process from 
within the 3D scaffold by transporting the cells to the outlet port of this circuit. 
Figure 112. Confocal microscopy of a ceramic hollow fibre after staining with CD235a conjugated with PE-Cy5 (green colour in the 
picture; red colour represents the scaffold in the PE channel). This is a cell surface marker of late erythroid cells, including mature 
red blood cells, and was observed throughout the interior of the hollow fibres, indicating their crossing from the scaffold into the 
lumen of the fibres. 
7.2.5. Flow cytometry analysis of produced cells 
Flow cytometry analysis was performed on the harvested cells that were flowing into the collection bottle 
with time of culture (at days 7, 22 and 31) and at the end of the culture period from within the scaffold, the 
collection bottle and also from the area at the outlet port of the LU circuit wherein cells were observed 
depositing. Figure 113 presents a 3D plot analysis of the evolution of the cellular population harvested from 
within the dual HF bioreactor, in terms of surface expression in CD71 and CD235a (both erythroid markers) 
and SYTO16 (a marker that indicates the presence of a nucleus). The main objective of this analysis was to 
study the feasibility of the bioreactors in producing enucleated RBCs, which are characterized for the 
absence of a nucleus (SYTO16­) and surface expression of CD71 (CD71­) but high expression of CD235a 
(CD235a+). As immature stem and progenitor cells mature into erythroid lineages, their phenotype 
progresses from CD71­/CD235a­ to CD71+/CD235a­, then  to CD71+/CD235a+ and finally to CD71­/CD235a+
(Miharada et al. 2006). A colour code was used to allow identifying the regions in the 3D plots: CD235a 
(Red), CD71 (Blue) and SYTO16 (Green). Cells appearing in the plots with red colour only would hence 
express the same phenotype as enucleated RBCs: SYTO16
­
/CD71
­
/CD235a
+
 (red arrows in figure 113).
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Analysing these results, it was possible to observe that the cells flowing into the bottle of each bioreactor 
had a fast decay in enucleated RBCs with time. This important observation indicated in one hand that the 
RBCs present at day 7 in the harvesting bottles (plot B in both figures), which most likely resulted of the 
crossing of seeded cells (plot A), could not survive under the suspension conditions provided by the media 
in the bottle, having disappeared by the end of the 31 days of the experiment (plot D). This lack of survival 
of cells in 2D cultures was already known in literature (Blanco et al. 2009). Produced enucleated RBCs 
started instead to sediment outside the HFs, at the outlet of the LU circuit, as observed before. The 
presence of these cells in the samples collected from within the scaffold and those that sedimented outside 
the HFs at the end of the culture period provided an indication that the 3D scaffold offered a better 
environment, wherein enucleated RBCs could be produced and maintained viable for longer periods of 
time. 
Figure 114 compares the cellular phenotype collected after 31 days of culture from the three different 
locations in the bioreactor in terms of the expression in CD71, CD235a and SYTO16. It is possible to observe 
that the cells that flowed into the bottle were less mature than the cells that sedimented outside the HFs. 
This can be seen by the relative expression of CD235a in either sample: the cells collected from the bottle 
(figure 114G) have a lower CD235a (CD235alow) intensity than the cells sedimented outside the HFs (figure 
114K). Moreover, the CD235a
+
 cells in the group collected from the bottle also express SYTO16
+
, confirming 
the lack of proper maturation of these cells. On the other hand, the cells with CD235a
+(high)
 and CD71
­
observed in the population that sedimented outside the HFs is also SYTO16
­
 (shaded area in red on the 
plots), which confirms their higher level of maturation – in fact this phenotype is associated with mature 
enucleated RBCs (Tsuji et al. 1999; Srinivasan et al. 2006). Since CD235a is absent from erythroid colony 
forming cells but increases in expression during maturation from pro­erythroid blast cells and CD71 is an 
early erythroblast marker (Lu et al. 2008), the population of CD235a
­
/CD71
+
 cells that were generated 
represent early erythroid cells. These cells would mature into RBCs by losing their expression in CD71 and 
increasing in CD235a. 
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Figure 114. Study of the erythroid lineage development after 31 days of culture of MNCs within the dual HF bioreactor A, in terms of 
the expression of SYTO16, CD71 and CD235a: seeded cells at day 0 (A, B, C and D); cells that crossed the HFs and moved into the 
LU circuit bottle after 31 days (E, F, G and H); cells that crossed the HFs but sedimented without flowing to the bottle (I, J, K and L); 
and cells that did not cross the HFs (M, N, O and P). Shaded box in red: phenotype of enucleated RBCs (SYTo16neg/CD235apos). 
Figure 115 presents in further detail the evolution of CD45, CD34 and CD235a expressions of the cell 
samples. Cells collected from the scaffolds after 31 days appeared to be more homogeneous than the cells 
that crossed the HFs, both into the bottle and that sedimented. As an example, comparing figures 115P and 
115T (cells that crossed the HFs) with figure 115X (cells that remained inside the scaffold) it was possible to 
observe that the latter cells were richer in the erythroid lineage (CD235a) and presented a lower 
percentage of leukocytes (CD45) than the other two cell populations. The fact that the media containing 
the cells being harvested from within the bioreactor was never replaced throughout the culture period, it 
could be possible that this “contamination” of cells was due to the initial settling of the bioreactor. This 
suggests that towards the end of the culture, by day 31, the cells within the scaffold were becoming more 
committed to the erythroid lineage. Moreover, a small but detectable percentage of CD34
+
 cells (around 
1.5%) were found inside the scaffold, suggesting the maintenance of stem cells after 1 month of culture. 
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Figure 115. Flow cytometry dot plots following the phenotype progression of the cellular population throughout the 31 days of culture 
of MNCs within the dual HF bioreactor A, in terms of the expression of CD45 (FICT channel), CD34 (PE channel) and CD235a (PE-
Cy5 channel): seeded cells at day 0 (A, B, C and D); cells that crossed the HFs and moved into the LU circuit bottle after 7 days (E, 
F, G and H), 22 days (I, J, K and L) and 31 days (M, N, O and P); cells that crossed the HFs but sedimented without flowing to the 
bottle after 31 days (Q, R, S and T); and cells that did not cross the HFs after 31 days (U, V, W and X). 
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7.2.6. Quantification of red blood cell production 
Cellular viability throughout the culture period was assessed by haemocytometer. It was observed that all 
samples were composed of cells over 95% viable. Table 31 resumes the efficiency the 3D dual HF bioreactor 
in the expansion of total cell numbers and also of the expansion of enucleated RBCs, when compared to the 
initial seeding numbers. A 33.5­fold expansion of the total cell number was obtained after 31 days, which is 
in contrast with the 4­fold expansion after 22 days observed for the cytokine­free culture studied in chapter 
6. This observation highlights the advantage on the use of cytokines in increasing the productivity of these 
systems, as well as in influencing the differentiation pathway of the cells – the addition of EPO in the 
culture has allowed producing RBCs, which were not observed in the absence of this GF. This resulted in a 
13.9­fold expansion of the numbers of enucleated RBCs that were seeded (alongside the MNCs from the 
UCB), with the production of 15.3x10
8
 RBCs with over 99% viability. 
Table 31. Summary of the cell numbers produced and harvested in the 3D dual HF bioreactor after culture of MNCs for 31 days in 
an initial cytokine cocktail composed of 100ng.mL-1 SCF and 2,000mU.mL-1 EPO.
3D Dual HF 
Bioreactor 
Day 0 
Seeded (x10
8
 cells) 11.1 
Enucleated RBCs (x10
8
 cells) 1.1 
Day 31 
Crossed the ceramic HF 
after 31 days (x10
8
 cells) 
297.8 
Collected from the PU 
scaffold (x10
8
 cells) 
73.8 
Total enucleated RBCs (x10
8
cells) 
15.3 
Total cells fold-expansion 33.5 
RBCs fold-expansion 13.9 
7.2.7. Evaluation of the performance of the HU membrane to renew the microenvironment 
In order to study the efficiency of the HU hollow fibres to renew the microenvironment, providing a healthy 
level of nutrients and reducing the concentration of metabolites, a molecular profile analysis of the culture 
media throughout the culture period was performed. The profile in both HU and LU sides of the 
membranes were evaluated by a Bioprofiler analysis and representative molecular profiles of the HU and 
the LU sides of the bioreactor throughout the culture time period are presented in figures 116 and 117, 
respectively. A more detailed comparison between the molecular profiles in each membrane side is 
presented in Appendix 5 (p. 238), regarding the following parameters: glucose, lactate, pH, pO2, pCO2, 
glutamine, glutamate, NH4
+
, K
+
, Na
+
 and HCO3. 
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The information on the concentrations of the different analysed solutes (glucose, lactate, glutamine, 
glutamate, NH4
+
, K
+
, Na
+
 and HCO3) in the HU side at the inlet and outlet to the bioreactor, have also 
allowed determining the flux of these molecules through the HU hollow fibres with time, using the 
following parameters: 
 Number of PAN hollow fibres per bioreactor: 4
 Fibre outer diameter= 890µm
 Fibre thickness= 210µm
 Fibre inner diameter= 520µm
 Length of each fibre= 15cm
 Contact Area of PAN HFs (A) = 15.7cm
2
 Total internal volume of PAN HFs (V) = 0.097cm
3
 Flow rate (F)= 2.5mL.h
­1
 Residence time = V/F = 0.039h
The flux of molecules through the membrane in the LU circuit was not calculated because this stream is 
completely recycled, and hence the concentration of molecules is cumulative. 
The results have provided an indication of active cellular metabolism, with the production of lactate and 
consumption of glucose. Throughout the culture period, the requirements of the cell culture 
microenvironment in terms of the flow of these molecules were efficiently managed by the membranes in 
terms of removal of metabolites and provision of nutrients. Moreover, it is also possible to conclude that 
the concentration of glucose was maintained above its low limit for cell growth (3mM) and lactate below its 
maximum level (22mM) for cell growth inhibition (Ozturk et al. 1996) throughout the entire culture period.  
Taking into account that the media flowing in the LU circuit was never changed nor replaced during the 31 
days of culture (apart from the injection of SCF and EPO at day 15), the concentration profile of molecules 
within this stream is very similar to that within the 3D scaffold wherein cells are growing. This allows 
following the efficiency of the HU circuit in renewing the cellular microenvironment. In fact, the stable 
concentration profile in the LU circuit towards the end of the culture period in terms of glucose and lactate 
as well as the pH and other important parameters measured, has provided an indication that the HU circuit 
was efficient in accomplishing this task. 
Moreover, the cellular growth within the bioreactor can be correlated with the accumulation of 
metabolites, particularly lactate. It is observed that bioreactor A has a higher initial production of lactate 
than bioreactor B – which resulted in a much higher cellular expansion of the cells within bioreactor A (as 
observed in table 31, p. 218). Nevertheless, both bioreactors reached a similar concentration level towards 
the end of the culture – at about 15mM, a value below the inhibitory level of this molecule. This lactate 
profile was followed also by the glucose profile, which decreased more rapidly for Bioreactor A, although 
reaching a steady concentration level in both bioreactors towards the end of the culture.
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7.2.8. Concentration profile of the growth factors 
Figure 118 shows the concentration profile of SCF and EPO with time in both the HU and the LU sides of 
bioreactors A and B. GFs were added only at the beginning (day 0) of the culture, and hence it was 
important to monitor the evolution of the concentration of both molecules within the bioreactor. 
Moreover, this would also allow assessing the feasibility of the HU membrane in preventing the waste of 
GFs. The concentration profile of the GFs with time has shown that, as expected, both molecules are 
reduced with time, which can be attributed to both the degradation of the proteins and consumption by 
the cells, as highlighted before. Whilst at the end of the culture period (day 31), SCF had disappeared 
almost completely in both bioreactors, EPO levels were at around 500mU.mL­1. This suggests a feeding 
strategy of addition of SCF more frequently than EPO should be used, in order to compensate for the 
different degradation/consumption rates of each protein. Another important observation made was 
related with the concentration of GFs in the HU side. SCF and EPO were not fed to this circuit stream of the 
bioreactor for the whole culture period, and hence presence of these molecules would indicate their 
diffusion through the HU membrane from within the bioreactor. Apart from day 1, wherein bioreactor A 
presented a rejection of 98% to SCF and EPO, all other measurements did not reveal a trace of GFs in the 
waste stream (rejection >99.99%). This proved that the HU membrane was able to prevent the waste of 
GFs, a very important feature conceptualized for the bioreactor. 
Figure 118. Concentration profile of SCF (A, B) and EPO (C, D) used in the cell culture with time for both HU (A, C) and LU (B, D) 
circuits of the bioreactor.
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7.3. CONCLUSION
Using a cocktail composed of 100ng.mL
­1
 SCF and 2,000mU.mL
­1
 EPO, mature enucleated RBCs were 
observed exiting the scaffold through the selectively permeable membranes. Even though this is an under­
optimized process, with the addition of cytokines at the beginning of the experiment and only a small 
percentage at the end of 2 weeks of culture (as represented in figure 118), it has provided valuable 
information regarding possible feeding strategies to further enhance the productivity of this system. By 
supplying fresh cytokines at time points when their concentration levels are reduced, due to degradation 
and consumption by the cells, the expansion of the cells towards achieving higher cell numbers could be 
incremented and result in fold­expansions comparable to those reported in literature of over 200,000 times 
within the same time frame (Neildez­Nguyen et al. 2002; Giarratana et al. 2005; Miharada et al. 2006; 
Fujimi et al. 2008). Even though this feeding strategy has not been optimized, it represents a novel feeding 
approach to that of currently used in bioreactor technologies, with beneficial effects. Particularly, with the 
possibility to culture cells in a 3D environment that can be perfused with nutrients due to the hollow fibre 
membranes, as well as to continuously harvest cells as these mature and cross the ceramic HFs. 
Even though only “small” amounts of enucleated RBCs were produced in this system (1.5x10
9
 RBCs), 
particularly when compared to the required numbers (1 unit of transfusable RBCs contains 2x10
12
 cells, 
over 3 log difference), the productivity of the system is much higher than that of current technologies. 
Table 32 presents a comparison between the results obtained in this system with those obtained by state­
of­art technologies in literature. A number of features that the 3D dual HF bioreactor offers in comparison 
with these technologies are expressed in this table. First, the reduction of the number of culture steps 
required to obtain enucleated RBCs, and hence the reduction in the culture complexity – whilst the HF 
bioreactor allows the culture in a single step with continuous cell harvesting, other technologies either 
require periodic harvesting (Engelhardt et al. 2001) or a three­step manual culture (Giarratana et al. 2005; 
Neildez­Nguyen et al. 2002). Moreover, this system allowed the enucleation of cells in a 3D culture system 
without the use of feeder cells, in contrast to other technologies (Engelhardt et al. 2001; Giarratana et al.
2005). Both these features allow the use of a much smaller culture volume (10mL) in comparison with 
other technologies (the static cellular production would require a bioreactor with over 40,000mL volume to 
produce a single unit of RBCs). This is related to the increase of cellular productivity of the bioreactor 
through the inclusion of cellular harvesting: after 31 days, a cell output of 37.2x10
8
 cells.mL
­1
 was achieved, 
which is 18­fold superior to current HF bioreactors that can accommodate only up to 2x10
8
 cells.mL
­1
(Chaudhuri and Al­Rubeai 2005). This also represents a higher cell density than the in vivo BM, which has 
been found to be 5x10
8
 cells.mL
­1
 (Peng and Palsson 1996). 
Finally, the recycle of GFs allowed the use of low amounts of these proteins, comparable to the quantity of 
EPO used in the system by Giarratana et al. 2005 (0.6U of EPO per 108 produced cells), considering this 
expansion protocol also uses feeder cells to provide additional amounts of GFs. This allowed the production 
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of cells at 90% lower costs of GFs than the commercially available Aastrom Replicell (perfusion bioreactor in 
table 32), and 67% lower than the feeder­free system reported by Neildez­Nguyen et al. 2002. The 
optimization of the culture conditions herein described could in principle provide a further reduction of 
these costs, particularly with the targeted differentiation of the cells towards mature RBCs, through a more 
intimate control of the GF concentration profile and/or the use of other cytokines (as observed for the 
other cultures). 
Table 32. Comparison of the results obtained with this work regarding the production of enucleated RBCs with other results reported 
in literature. †1 unit of RBCs contains around 2x1012 cells.
Parameter 
3D Perfusion 
Dual Hollow 
Fibre Bioreactor 
Perfusion 
bioreactor 
Feeder 2D 
expansion 
Feeder­free 2D 
expansion 
Reference This work 
Engelhardt et al.
2001
Giarratana et al.
2005
Neildez­Nguyen et 
al. 2002
Seeded cell type
UCB mononuclear 
cells 
BM mononuclear 
cells 
UCB CD34
+
UCB CD34
+
Feeder Layer NO YES YES NO 
Culture steps One One Three Three 
3D Structure YES NO NO NO 
% enucleated RBCs 3.2 0 (7% erythroid) 98 4 
Bioreactor volume to 
produce 1 unit RBCs
†
 (mL)
10 (with automated 
harvesting) 
280 (with periodic 
harvesting) 
40,000 40,000 
Growth Factor costs 
(£ per 10
8
 produced cells)
0.8 8.0 0.6 2.3 
Growth Factor costs 
(£ per 10
8
 produced RBCs)
19.0 
NO RBCs 
PRODUCED 
0.6 57.7 
EPO used 
(U per 10
8
 produced cells)
0.6 4.0 0.6 3.0 
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CHAPTER 8 
CHAPTER 8.
OVERALL CONCLUSIONS AND FUTURE DIRECTIONS
“This is the greatest week in the history of the world since the Creation, 
because as a result of what happened in this week, the world is bigger, 
infinitely.” 
Richard M. Nixon 
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8.1. OVERALL CONCLUSIONS
Herein it is proposed a novel 3­dimensional HF bioreactor with the following features: 1) a 3D hollow fibre 
bioreactor incorporating a polymeric porous scaffold surrounding the hollow fibres; 2) a bioreactor 
designed for the continuous harvesting of mature cells from within 3D scaffolds; 3) a design that provides 
two different inlet streams for nutrients and growth factors, respectively, with a view to reduce the costs of 
large­scale production of red blood cells (growth factors can cost up to £43,000 per mg). To protect the IP 
of this design, a Patent Cooperation Treaty (PCT) application has been filled in December 2010. 
It was shown that the integrated hollow fibre membranes allow the selective mass transport of nutrients 
(glucose), metabolites (lactate), proteins (albumin) as well as RBCs. The “dual hollow fibre” concept 
introduced allows the recycling of GFs, maintaining them for longer periods in the culture, which in 
principle can allow the use of lower concentrations in the media. The system allowed the differentiation of 
cord blood stem cells into mature enucleated RBCs, as proven morphologically by SEM and phenotypically 
by flow cytometry, under a cocktail composed of 100ng.mL
­1
 SCF and 2,000mU.mL
­1
 EPO. It is important to 
note that, unlike wise any other culture systems, these GFs were added only at day 0, being adjusted only 
at day 15 with a further 18ng.mL
­1
 SCF and 145mU.mL
­1
 EPO, without any further additions. Some of the 
produced cells were successfully harvested from within the growing space with time of culture, which 
provided further space within the 3D scaffold for stem cells to grow, having achieved a 33.5­fold expansion 
of the initial cells after 31 days of culture. 
In summary, using the BM as a model, a novel 3D HF bioreactor that is capable of delivering cell culture 
media and serum proteins to a chamber where HSCs can be grown in a 3D environment was developed. It 
was shown that MNCs collected from umbilical cord blood remain viable within this system over a period of 
at least 4 weeks, under cytokine­free conditions. Moreover, it was also shown the feasibility for the 
production of enucleated RBCs in a feeder­free 3D system after 31 days. This was achieved with the large 
savings of costs with GFs and space requirements to produce the same number of cells by other proposed 
ex vivo methods (as summarized in table 32, p. 224), even though the proof­of­concept was performed in 
an under­optimized culture. The method herein introduced for the combination of 3D porous scaffolds that 
can be coated with ECM proteins with hollow fibres immersed within their structure allows the production 
of a system that intimately mimics two of the most important features of the BM: the ECM and its 
vasculature. 
This highly flexible platform technology enables a functional BM biomimicry, with the potential to allow 
studying the hematopoietic microenvironment in 3D ex vivo and to deliver a cost­effective production of 
clinically­relevant haematopoietic cell components for therapeutic use.
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8.2. FUTURE DIRECTIONS
The development of a device that could alleviate blood shortage around the world, particularly in the so­
called third world countries, wherein the scarcity of this fluid is obvious, or use in war theatres, would 
indeed be very helpful. To achieve such aim, the bioreactor herein developed requires further 
improvements. From the translation of the techniques herein described into Good Manufacturing Practice 
(GMP) to the quality control of the RBCs produced, there are also design flaws which need careful 
attention. Some of these have already been identified. As an example, the LU membrane requires further 
studies to achieve a more stable structure: brittleness is usually described as one of the hurdles in the use 
of ceramic hollow fibre membranes, with the production of large pore­sizes further exacerbating this 
problem. This was found to be a constant problem in the assembly of the bioreactors described, usually 
delaying the quicker assembly of the systems for analysis. However, these membranes do have a high 
potential for development, since many parameters can be tuned in order to attain stronger and more 
effective membranes: as an example, the effect of the sintering temperature towards the mechanical 
strength of these membranes was tested (figure 26, p. 167), showing that higher sintering temperatures 
could render better stability in handling the fibres. This, however, will reduce the pore­sizes of the HFs; 
hence, the increase in the strength of the fibres will come at the expense of the cellular permeability. 
On the other hand, this bioreactor can be used as a platform study that could be adapted towards different 
applications, by changing the scaffold material and its coating (considering both membrane materials used 
are stable in the great majority of available organic solvents used for TIPS) and/or by changing the 
properties of the HFs to provide e.g. different molecular transport mechanisms. An interesting field of 
study could be angiogenesis. This is the process of capillary formation, which can be induced by specific 
GFs, such as vascular endothelial growth factor (VEGF) that is known to promote vascularization (Soker et 
al. 2000). In fact, the regeneration of capillary networks has been shown to be possible ex vivo. This has 
been demonstrated using collagen gels to support the growth of capillaries differentiating from mouse BM 
cells. It was found that using an in vitro model of capillarogenesis (aorta/collagen type I gel), capillaries 
grown ex vivo would closely resemble those in vivo, having shown a high degree of differentiation (Akita et 
al. 1997). The vascularization of HF membranes could provide a further mimicry of the in vivo conditions. A 
possible method to achieve such goal could be by designing materials that induce vascularization even 
without the use of growth factors; some examples include the use of expanded PTFE (Boswell and Williams 
1999), porous polyvinyl alcohol (Sharkawy et al. 1998) and polyacrylate containing traces of methacrylic 
acid (Gorbet M. B. 2003). 
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APPENDIX 
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Appendix 1. STANDARD CURVES
Appendix 1.1. Calibration of ELISA for detection of α-lactalbumin 
Figure 119 presents the experimental data points obtained for the calibration of this method for α­
lactalbumin quantification, as well as the curve fitting, generated through SigmaPlot as a four parameter 
logistic (4­PL), typical of ligand­binding reactions. 
Figure 119. Calibration curve for ELISA detection of the protein α-lactalbumin in the high-uptake membrane rejection studies.
Appendix 1.2. Calibration curve for BSA analysis in the flat-sheet experiments 
Figure 120. Calibration curve for determining the concentration of BSA in flat-sheet experiments.
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Appendix 2. MASS TRANSFER EQUATIONS
Figure 121 depicts the concentration profile of a solute diffusing from side A into side B, through a 
membrane, which is considered to be porous and permeable to the molecule. The resistance­in­series 
model will be considered to model the experimental data (Emanuelsson and Livingston 2004), and hence 
determine the mass transfer coefficients of the membranes studied. In these equations, side A relates to 
the side containing the highest solute concentration. 
Figure 121: Concentration profile through a porous membrane, using the pore diffusion model and considering partition coefficients 
equal to 1 (pores are filled with water, which is the same fluid in both sides A and B).CA,b- concentration in side A on the bulk; CA,A-m- 
concentration in side A on the interface with the membrane; C*m,A-m- concentration in the membrane on the interface with side A; CB,b- 
concentration in side B on the bulk; C*B,B-m- concentration in side B on the interface with the membrane; Cm,B-m- concentration in the 
membrane on the interface with side B. 
The flux of the solute per unit transfer area (N) can be calculated as the concentration gradient multiplied 
by the local mass transfer coefficient (k) on each phase (side A, within the membrane and side B, 
respectively): 
, ,A A b A A m A
N C C k   , (14) 
, ,m m A m m B m m
N C C k    , (15) 
, ,B B B m B b B
N C C k   , (16) 
Wherein: CA,b­ solute concentration in side A on the bulk; CA,A­m­ solute concentration in side A on the 
interface with the membrane; C*m,A­m­ solute concentration in the membrane on the interface with side A; 
CB,b­ solute concentration in side B on the bulk; C*B,B­m­ solute concentration in side B on the interface with 
the membrane; Cm,B­m­ solute concentration in the membrane on the interface with side B. 
Equations (14), (15) and (16) can be rearranged: 
, ,
A
A b A A m
A
N
C C
k
  , (17) 
, ,
m
m A m m B m
m
N
C C
k
   , (18) 
, ,
B
B B m B b
B
N
C C
k
  , (19) 
Membrane
C*B,B­m = Cm,B­m
CA,A­m = C*m,A­m
CB,b
CA,b
Side A
Side B
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The local mass transfer coefficients are difficult to measure (unless an experiment is designed where the 
concentration on one of the sides can be neglected), and so an overall mass transfer coefficient (KOV) may 
be defined, taking into account each of the local mass transfer coefficients and only based on the overall 
concentration difference. Moreover, the overall flux of the solvent per unit transfer area (N) is the same on 
each phase (
A m B
N N N  ), and thus the following overall equation can be considered: 
, ,A b B b OV
N C C K   (20) 
Grouping equations (17), (18) and (19) to arise into equation (20): 
, ,
mA B
A b B b
A m B
NN N
C C
k k k
    (21) 
Or: 
, ,
1 1 1
A b B b
A m B
N C C
k k k
 
     
	 

(22) 
Comparing equation (22) with equation (20) it is possible to conclude that: 
BmAOV
kkkK
1111
 (23) 
To determine the concentrations profile, the following two equations, describing the flux J, can also be 
considered: 
dt
dC
VJ  (24) 
bBbAOV
CCAKJ
,,
 (25) 
Wherein: J­ flux; V­ volume; 
dt
dC
­ concentration variation with time; A­ area of the membrane; CA,b­ solute 
concentration in side A; CB,b­ solute concentration in side B. 
Hence: 
bBbAOV
CCAK
dt
dC
V
,,
 (26) 
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A mass balance to the solute can also be performed, while assuming the volume is constant: 
t
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t
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CVCVCV  0
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

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B
At
B
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B
A
B
A
t
A
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V
V
C
C
V
V
CC
0
0
(27) 
Wherein: VA­ volume in side A; VB­ volume in side B; 
0
A
C ­ solute concentration in side A at time 0; 
t
A
C ­ 
solute concentration in side A at time t; 
t
B
C ­ solute concentration in side B at time t. 
Using side A (higher concentration) 
0t tA
B A A
B
V
C C C
V
  
Resolving equation (26) taking into account side A measurements: 
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(28) 
Defining 
A
B
V
V
   and integrating equation 28, the following relation is obtained: 
0
0
0
1
t
A
A
C t
t OV
At t
AA A AC
K A
dC dt
VC C C
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  (29) 
Thus: 
0
0
1
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1 1
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t
A A A
K AC
t
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(30) 
From equation 30, a plot of 
0
0
1
ln
1 1
A
t
A A
C
C C  
 
  
   	 

 vs. t is a straight line, and KOV can be estimated. 
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Appendix 3. DIFFUSIVITY EXPERIMENTS
Appendix 3.1. Flat-sheet high-uptake membrane 
Figure 122. Results for the overall mass transfer coefficient experiments of glucose through the four different flat-sheet high-uptake 
membranes: polyethersulphone with 5KDa MWCO (A); polyethersulphone with 10KDa MWCO (B); regenerated cellulose with 5KDa 
MWCO (C); and regenerated cellulose with 10KDa MWCO (D). 
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Appendix 4. FLOW CYTOMETRY CONTROLS
Appendix 4.1. Flat-sheet low-uptake membrane 
Figure 123. Flow cytometry initial controls for the studies on cellular crossing through the 2µm polycarbonate flat-sheet membrane: 
side scatter (SS) vs. forward scatter (FS) plot (A), negative control (B) and CD45-FITC (C) and CD235a-PE-Cy5 (D) positive 
controls. 
Figure 124. Flow cytometry gates represented in a SS vs. FS plot used for each experiment to study cellular crossing through 2µm 
polycarbonate flat-sheet membranes: experiments 1 (A), 2 (B) and 3 (C) are represented. 
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Appendix 4.2. Single-type Hollow Fibre Bioreactor 
Figure 125. Flow cytometry isotype controls for the biological evaluation of the single-type hollow fibre bioreactor: side scatter (SS) 
vs. forward scatter (FS) plot (A), FITC vs. PE (B), PE-Cy5 vs. PE (C) and PE-Cy5 vs. FITC (D). The “Cells” gate used for the 
analysis of all samples is also represented in plot (A). 
Figure 126. Flow cytometry positive controls for the biological evaluation of the single-type hollow fibre bioreactor: CD45-FITC (A, B 
and C), CD34-PE (D, E and F) and CD235a-PE-Cy5 (G, H and I), represented in 2D dot plots of FITC vs. PE (A, D and G), PE-Cy5 
vs. PE (B, E and H) and PE-Cy5 vs. FITC (C, F and I). 
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Appendix 4.3. Dual Hollow Fibre Bioreactor 
Figure 127. Flow cytometry isotype controls for the biological evaluation of the dual hollow fibre bioreactor: side scatter (SS) vs. 
forward scatter (FS) plot (A), FITC vs. PE (B), PE-Cy5 vs. PE (C) and PE-Cy5 vs. FITC (D). The “Cells” gate used for the analysis of 
all samples is also represented in plot (A). 
Figure 128. Flow cytometry positive controls for the biological evaluation of the dual hollow fibre bioreactor: CD45-FITC (A, B and 
C), CD45-PE (D, E and F) and CD45-PE-Cy5 (G, H and I), represented in 2D dot plots of FITC vs. PE (A, D and G), PE-Cy5 vs. PE 
(B, E and H) and PE-Cy5 vs. FITC (C, F and I). 
Figure 129. Flow cytometry 3D plots of the isotype controls for samples collected at days 0 (A), 7 (B), 22 (C) and 31 (D) of culture, 
analysing CD71 (y axis), SYTO16 (x axis) and CD235a (z axis) to study the development of erythroid cells within the dual HF 
bioreactor A.
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Appendix 5. BIOPROFILER ANALYSIS OF THE CULTURE MEDIA FROM THE DUAL HFB 
Figure 130. Analysis of glucose concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the 
high-uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). Glucose consumption flux through the 
HU membrane is also represented (line plots) – positive values represent direction of the flow from the HU membrane into the 
bioreactor. 
Figure 131. Analysis of lactate concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). Lactate production flux through the HU 
membrane is also represented (line plots) – positive values represent direction of the flow out of the bioreactor into the HU 
membrane. 
Figure 132. Analysis of pH profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-uptake side (A) 
and low-uptake side (B) for both bioreactors A (in blue) and B (in red). 
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Figure 133. Analysis of oxygen tension (pO2) profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). 
Figure 134. Analysis of carbon dioxide tension (pCO2) profile in both streams of the dual hollow fibre bioreactors: bar plots represent 
the high-uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). 
Figure 135. Analysis of glutamine concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the 
high-uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). Glutamine flux through the HU 
membrane is also represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
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Figure 136. Analysis of glutamate concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the 
high-uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). Glutamate flux through the HU 
membrane is also represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
Figure 137. Analysis of NH4+ concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). NH4+ flux through the HU membrane is also 
represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
Figure 138. Analysis of K+ concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). K+ flux through the HU membrane is also 
represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
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Figure 139. Analysis of Na+ concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). Na+ flux through the HU membrane is also 
represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
Figure 140. Analysis of HCO3 concentration profile in both streams of the dual hollow fibre bioreactors: bar plots represent the high-
uptake side (A) and low-uptake side (B) for both bioreactors A (in blue) and B (in red). HCO3 flux through the HU membrane is also 
represented (line plots) – positive values represent direction of the flow from the HU membrane into the bioreactor. 
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Appendix 6. SOP FOR THE FABRICATION OF THE 3D DUAL HF BIOREACTOR
Appendix 6.1. Schematic diagram of the 3D dual HF Bioreactor 
Figure 141. Experimental setup for the culture of cells in the dual hollow fibre bioreactor. Serum- and cytokine-free fresh media is 
perfused in the lumen of PAN hollow fibres, which contain the high-uptake (HU) circuit (blue) and discarded; serum and cytokines 
are provided through perfusion in the lumen of ceramic hollow fibres, which contain the low-uptake (LU) circuit (red) by re-circulating 
throughout the entire culture period. 
Appendix 6.2. Preparation of the ceramic hollow fibres (for the low-uptake circuit) 
i. An alumina solution is prepared and thoroughly mixed overnight in order to create an 
homogeneous solution; 
ii. Using a small spinneret with an inlet air flow, the alumina solution is casted into a water bath 
and allowed to settle there for 5min; 
iii. The fibres are then moved into a new deionized water bath and left there overnight with 
constant change of the water; 
iv. The prepared fibres are then cut into 40cm length and allowed to dry at room temperature; 
v. The final step involves sintering the fibres, using the sintering profile as shown in figure 142; 
Figure 142: Sintering profile used for preparing the ceramic hollow fibres.
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Appendix 6.3. Preparation of the PAN hollow fibres (for the high-uptake circuit) 
Polyacrylonitrile (PAN) membranes are prepared by the phase inversion method. The following protocol is 
used, where PAN (CAS number 25014­41­9, app. MW= 150 kDa) is obtained from Scientific Polymer (USA): 
i. Prepare an 18wt% solution PAN in dimethylformamide (DMF) by mixing 10.8g of PAN with 
49.2g of DMF in a vessel with a cap and cover well with parafilm; 
ii. Put the dope solution into a water bath with constant temperature at 70°C stirring with a 
magnetic stirrer (usually overnight or until the solution becomes totally homogeneous); 
iii. Afterwards, when the solution turns from white opaque to transparent yellow, transfer the 
dope solution into 50mL centrifuge flasks, and centrifuge at 4000rpm for 40min at 30°C; 
iv. Fully degas the polymeric solution in a vacuum chamber for one hour, transfer into a 200mL 
stainless steel syringe and extrude through a tube­in­orifice spinneret (orifice­diameter / 
inner­diameter of 1.0/0.7 mm) into an external coagulant bath containing tap water. The 
internal coagulant should be deionised water; 
v. The extrusion rate of the spinning polymeric solution and the flow rate of the internal 
coagulant are controlled by Harvard syringe pumps (Harvard Apparatus, model PHD 2000) 
and set to 2mL.min
­1
 and 1.5mL.min
­1
, respectively. The air gap is set to 20 cm during the 
spinning. To complete solidification, fabricated hollow fibres are kept in a water bath for at 
least 24 hours, before surface treatment. 
vi. Store PAN membranes in 0.5% aqueous formalin (or 0.2wt% paraformaldehyde) at 4°C until 
further use, in order to avoid any bacterial or fungi growth on the membrane surface 
during storage (Lohokare et al. 2006). Formalin solution is prepared by adding 6g of 
paraformaldehyde to 3L of deionised water and immersing the membranes in this solution 
and stored in the fridge (formalin 100% is defined as an aqueous solution of formaldehyde 
at 40wt%); 
vii. Anneal the PAN hollow fibres at 96°C for 10s in distilled water. Immediately transfer the fibres 
into cold distilled water (at 4°C); 
viii. Prepare 100mL of a 1M NaOH solution (dissolve 4g of NaOH in 100mL of distilled water); 
ix. Pre­heat the NaOH solution to 80°C and then immerse the annealed PAN hollow fibres into it 
and allow hydrolysing for 25min. Immediately transfer the fibres into cold PBS (at 4°C) and 
wash the fibres well with this solution in order to remove excess NaOH – keep the fibres in 
PBS at 4°C overnight for complete removal of NaOH; 
x. Conserve the fibres by dipping them into Glycerol overnight, and afterwards allow them to dry; 
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Appendix 6.4. Preparation of the hollow fibre bioreactor 
i. Insert 4 ceramic hollow fibres inside the bioreactor shell described in figure 141; 
ii. Insert 4 PAN hollow fibres inside the bioreactor as well; 
iii. Use small pieces of cotton to hold the fibres equally distributed within the bioreactor, making 
sure not to push too much cotton inside the bioreactor; 
iv. Using chemically resistant epoxy resin, pot the fibres to the entrance of the bioreactor (in side 
A, figure 141), by making sure that enough amount is used to properly seal both edges of 
the bioreactor such that the only opened inlets are through the inside of the fibres; 
v. Leave the epoxy to dry overnight on both sides; 
vi. Insert a guitar string (number 13) into each ceramic hollow fibre; 
Appendix 6.5. Preparation of the scaffold 
i. Prepare around 15mL of a 5wt% solution of polyurethane (0.75g) in 1,4­dioxane (15mL); 
ii. Mix the solution overnight at 80˚C and afterwards leave to cool down to room temperature 
before use; 
iii. Cover the extremities of side A of the bioreactor, using a cap; 
iv. Using a syringe, insert 9mL of the prepared polymer solution into the bioreactor, through the 
cell seeding ports (figure 141), making sure to remove all the air bubbles inside the 
bioreactor. Then cover the inlets of side B using a cap and put the bioreactor immediately 
inside the ­86˚C freezer for 2hours; 
v. Afterwards, remove the two caps protecting side B protecting and connect them to the 
vacuum system; 
vi. Put the bioreactor into a temperature­controlled ­15˚C polyethylene glycol bath, and turn on 
the vacuum system, making sure to use a gas trap with liquid nitrogen in the solvent circuit 
to avoid damage to the vacuum pump; 
vii. Leave the solvent to be totally lyophilized for 3 days. 
Appendix 6.6. Coating of the scaffold with Collagen 
i. Prepare 100mL of a solution of 62.5μg.mL
­1
 of collagen I in a solution 0.1M acetic acid, 
adjusting the pH to ~7.0; 
ii. Close extremities of side A of the bioreactor and using a syringe insert 10mL of the prepared 
solution into the bioreactor through side B; 
iii. Connect the flow circuit to side B and perfuse the prepared volume of collagen through side B 
for 1 hour at maximum speed of the peristaltic pump; 
iv. Afterwards, disconnect the circuit and close side B with the collagen solution inside and leave 
it overnight for coating of the PU scaffold. 
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Appendix 6.7. Sterilization of the bioreactor 
i. Wash  all  the  tubing  that  will  be  used  in  the  bioreactor,  as  well  as  the  bottles  and  other 
components using distilled water; 
ii. Use  steam  sterilization  for  all  those  components  that  can withstand high  temperatures  (the 
bioreactor cannot!); 
iii. To sterilize the bioreactor, start by UV sterilization for 15min, followed by 2 hours with ethanol 
inside and then wash with PBS and leave overnight; 
iv. Afterwards, make all the connections for the bioreactor, and add 100mL of fresh media to the 
circuit,  place  it  inside  an  incubator  at  37ºC  and  5%  CO2  and  leave  it  with  perfusion 
overnight to test for sterility and leaks; 
Appendix 6.8. Culture of Mononuclear Cells 
i. After  Ficoll­Paque  separation  of  the  buffy  coat  from  cord­blood  collected  from  a  new­born, 
mononuclear  cells  are  counted  and  resuspended  in  5mL of  IMDM containing  30%  foetal 
bovine serum (FBS); 
ii. Take  some  cells  for  performing  a  CFU  assay  and  flow  cytometry  analysis  of  the  day  0 
population; 
iii. This solution is then added to the bioreactor, through side B, using a syringe needle in one of 
the inlets and another one on the outlet to use a small negative pressure to distribute the 
cells within the PU scaffold; 
iv. Replace the previously used media with 200mL of fresh IMDM with 30% FBS; 
v. Place the assembled bioreactor with the seeded cells within an incubator as described above, 
and allow to settle for 1 hour, for the cells to attach the scaffold without perfusion; 
vi. After 1 hour, start the perfusion at around 2.5mL.h
­1
 in both circuits and leave the cells to be 
cultured throughout the desired time; 
vii. Collect ca. 1.2mL of media on the outlet of the bioreactor every two days of culture, using a 
septum  to  puncture  the membrane  on  the  T­connector  and  push  the  fluid  using  a  5mL 
syringe  under  sterile  conditions.  Add  this  media  to  an  eppendorf  tube  and  analyse 
immediately using the Bioprofiler (or store at ­86°C for later analysis); 
viii. Every  7  days,  collect  ca.  50mL  of  the media within  the  bottle  and  centrifuge  it  at  180g  for 
10min,  discard  the  supernatant  and  analyse  the  resulting  cells  with  flow  cytometry  for 
evaluating the number and type of cells that crossed the hollow fibres. 
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